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Background: Childhood asthma, allergic rhinitis and eczema are complex heterogenic chronic 
inflammatory allergic disorders.  They constitute a major burden to children, their families and 
society, hugely affecting physical, social and psychological quality of life.  The prevalence of 
childhood allergic disorders is increasing worldwide and merely rudimentary understanding 
exists regarding causality, or the influence of the environment on disease expression.  Phase 
Three of the International Study of Asthma and Allergy in Childhood (ISAAC) reported that 
Irish adolescents had the 4
th
 highest eczema and rhinoconjunctivitis prevalence and 3
rd
 highest 
asthma prevalence in the world.  There are no ISAAC data pertaining to young Irish children.  
In 2002, using the ISAAC methodology and protocol, Sturley reported a high prevalence of 
current asthma in Cork primary school children aged 6-9 years.   
 
Aims: The overall aims of this thesis are: 
1. To establish the 2007 prevalence and trends of prevalence of allergic disorders in Cork 
schoolchildren aged 6-9 years and in Irish adolescents (aged 11-13 vs. 13-14 years) and 
to stratify prevalence results by sex.   
2. To examine the natural history of allergic disorders in a cohort of children from 6-9 
years to 11-13 years.  
3. To investigate putative protective and risk factors associated with prevalence of 
childhood allergic disorders in young school children from rural and urban locations 
(age 6-9 years).   
 
Methods: This thesis comprises of three cross-sectional studies and a quasi-retrospective cohort 
study.  Although not part of ISAAC, data was attained by parentally completed ISAAC-based 
questionnaires, using the ISAAC protocol.    
 
Study1: Prevalence data from two identical cross-sectional studies performed in 2002 and 2007, 
pertaining to children aged 6–9 from the same 24 Cork City schools, were compared (Sturley, 
2002 n=1474, response rate=74.8% vs. Duggan, 2007, n=1535, response rate=76.2%), to 
examine trends of prevalence in young children aged 6-9 years.   
 
Study 2: In 2007, a cross-sectional study was performed in 110 randomly selected, rural and 
urban, state-funded primary schools, to assess prevalence of allergic disease and putatively 
associated factors, in children (n=3464, age 6-9, response rate=75.8%), living in rural and urban 
environments in Cork.  
 
Study 3: In 2007, a quasi-retrospective cohort study examined the prevalence of allergic disease 
in children aged 6-9 years until 11-13 years, to examine the natural history of allergic disease in 
this population. The cohort study re-examined children from year 3 of school (1st class) in 2002 
(Sturley, n=1474, age 6-9, response rate 74.8%), in the 8th and final year of primary school in 
2007 (Duggan, n=706, age 11-13, response rate=70.8%).  
 
Study 4: Prevalence data from adolescents in the Duggan, 2007 study (n=706, age 11-13) were 
compared against prevalence data from the Manning 2002, Irish ISAAC Phase 3 study (n=3089, 
age 13-14), to examine the trends of prevalence of allergic disease in Irish adolescents.  
 
Results: Study 1 revealed that the prevalence of asthma had plateaued at 23.5%, but remained 
high in relation to many other countries. Significant increases were found in the prevalence of 
rhino-conjunctivitis (7.6 to 10.6%, p=0.005) and current eczema (8.9 to 13.5%, p<0.001). The 
prevalence of lifetime eczema had significantly reduced (21.6% to 15.0%, p<0.001). An 
alteration in the sex-specific profile of current asthma and lifetime allergic rhinitis towards 
equalization in distribution was also evident.   
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Study 2 observed many positive and negative associations with parental and child exposures. 
Early childhood antibiotic consumption was positively associated with allergic rhinitis 
(p<0.001) and in a dose-dependent manner with the development of current asthma (p<0.001).  
Early respiratory infection was a risk factor for current asthma (OR 1.9; 95% CI 1.55, 2.4) and 
lifetime asthma (OR 2.1; 95% CI 1.74, 2.64), current allergic rhinitis (OR 1.3; 95% CI 1.04, 
1.55) and lifetime eczema (OR 1.3; 95% CI 1.02, 1.58). Gastrointestinal infection, prior to 3 
years of age, was a risk factor for current asthma (OR 1.3; 95% CI 1.07, 1.67) and current 
allergic rhinitis (OR 1.5; 95% CI 1.12, 1.91).  Passive smoking was a risk factor for current 
asthma (OR 1.4; 95% CI 1.07, 1.73), while maternal smoking in the child’s first year of life was 
found to protect against lifetime eczema (OR 0.8; 95% CI 0.58, 0.97) and current eczema 
prevalence (OR 0.7; 95% CI 0.57, 0.94).  An inverse association was observed between current 
exposure to farm animals and both current asthma (OR 0.6; 95% CI 0.4, 0.98) and lifetime 
asthma (OR 0.6; 95% CI 0.43, 0.9). Current barn exposure was protective against the 
development of current allergic rhinitis (OR 0.6; 95% CI 0.35, 0.95), while positive associations 
between lifetime eczema and the mother being farm reared were observed (OR 1.4; 95% CI 
1.06, 1.83).  Pregnancy barn exposure (OR 2.0; 95% CI 1.27, 3.04) and year 1 stable exposure 
(OR 3.7; 95% CI 1.55, 8.93) were risk factors for current eczema.  An inverse association was 
found between exposure to furry pets during pregnancy and lifetime eczema (OR 0.8; 95% CI 
0.61, 0.95) and current furry pet exposure was positively associated with current 
rhinoconjunctivitis (OR 1.3; 95% CI 1.02, 1.75).  Damp bedroom exposure during the first year 
of life was positively associated with lifetime asthma (OR 1.4; 95% CI 1.07, 1.89).  Full time 
crèche attendance in the first year of life was inversely associated with current asthma (OR 0.7; 
95% CI 0.53, 0.94).  
 
Study 3 demonstrated many variations in allergic disease prevalences from 2002-2007 in this 
cohort of children (aged 6-9 until 11-13). The prevalence of asthma decreased (21.7% to 
17.1%), lifetime asthma remained stable. Current rhino-conjunctivitis prevalence (7.6% to 
13.7%) and lifetime hayfever prevalence (9.0% to 14.9%) increased, while current allergic 
rhinitis prevalence remained stable (26.1%). Current eczema prevalence stabilised (8.9% to 
10.5%), whereas, lifetime eczema reduced dramatically (21.6% to 12.1%) in this cohort of 
children. Co-morbidity of allergic disease remained high. There was a shift from male 
dominance to equalisation in the ratio of asthma symptom prevalence, although severe 
symptoms were more prevalent in females.   
 
Study 4 revealed a decrease in the prevalence of current asthma (26.7% to 17.1%) and a 
stabilisation in the prevalence of lifetime asthma (21.6% to 24.6%). Lifetime hayfever had 
decreased (31.5% to 14.9%), while allergic rhino-conjunctivitis prevalence remained stable 
(15.5% to 13.7%).  The prevalence of current eczema had increased (8.6% to 10.5%), while 
lifetime eczema prevalence had stabilised (14.3 to 12.0%).   
 
Conclusions: The prevalence, natural history and risk factors of childhood allergy in Ireland, as 
described in this thesis, echo those in worldwide allergy research.  The variations of prevalence 
in different populations worldwide and the recurring themes of associations between childhood 
allergy and microbial exposures, from farming environments and/or gastrointestinal infections, 
as shown in this thesis, strengthen the mounting evidence that microbial exposure on GALT 
may hold the key to the mechanisms of allergy development.  In this regard, probiotics may be 
an area of particular interest in allergy modification.  Although their effects in relation to 
allergy, have been investigated now for several years, our knowledge of their diversity, complex 
functions and interactions with gut microflora, remain rudimentary. Birth cohort studies which 
include genomic and microbiomic research are recommended in order to examine the 
underlying mechanisms and the natural course of allergic diseases.   
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1.1 BACKGROUND TO THESIS 
Childhood asthma, allergic rhinitis and eczema are chronic, inflammatory, 
heterogenic allergic disorders.  They constitute a major burden to children, their 
families and society, hugely affecting physical, social and psychological quality of 
life (1-4).  Asthma is an allergic airway disorder involving recurrent episodes of 
wheezing, breathlessness, chest tightness, and coughing (5).  Allergic rhinitis also 
involves the upper airways and is characterised by nasal congestion, rhinorrhoea, 
sneezing, and nasal itching (2).  Eczema is a chronic inflammatory skin disorder 
which presents with itchy skin lesions on the cheeks, forehead and flexural areas (6).  
   
The prevalence of childhood allergic disorders is increasing worldwide, especially in 
developing countries (7).  The International Study of Asthma and Allergy in 
Childhood (ISAAC) is a four-phase worldwide initiative, developed to investigate 
prevalence, elucidate associations and monitor prevalence trends of childhood 
asthma, allergic rhinoconjunctivitis and eczema, (using validated and standardised 
questionnaires and protocols), while aiming to develop a database of evidence-based 
best practice guidelines to improve childhood allergy diagnosis and management (8-
10).   Phase Three of ISAAC (examining trends of prevalence) reported that, despite 
recent reductions, Irish adolescents had the 4
th
 highest eczema and 
rhinoconjunctivitis prevalence and 3
rd
 highest asthma prevalence in the world (7).  
There are no ISAAC data pertaining to young Irish children.  Few Irish data examine 
the prevalence of asthma and allergy in young Irish children.  In 2002, using the 
ISAAC methodology and protocol, Sturley examined primary school children aged 
6-9 years from Cork city and suburbs and found the prevalence of current asthma 
was 21.5% (11), which  was significantly higher than that of 15.5% found in a 
similar age group of children in Galway in 1996 (12).   
 
Despite extensive research focus, only rudimentary understanding exists regarding 
causality and disease expression (13-16).  Many environmental factors have been 
investigated in an effort to increase our understanding of these complex diseases.  A 
theory called the Hygiene Hypothesis has been the focus of much investigation since 
it was first proposed by Strachan in 1989, in response to the increasing prevalence of 
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childhood atopic disease.  The hypothesis asserts that growing up in a more hygienic 
environment with less microbial exposure is associated with allergic sensitisation 
and the development of atopy, especially rhinitis (17, 18).  Substantiating this theory, 
some early life exposures to certain allergens have been found to have a protective 
effect on the development of childhood atopy.  For example, children reared on 
farms demonstrate a lower prevalence of asthma and atopy than their non-farming 
peers (19).  Contact with livestock and unpasteurised milk consumption appear to be 
the mediating exposures which convey protection (20).  Other markers of bacterial 
and viral encounters which have been investigated include day-care attendance, 
immunisation and sibship size but results have been inconsistent regarding their 
association (21).  Research evidence has resulted in a new interpretation of the 
hygiene hypothesis, that allergy is not only mediated by microbial stimuli, but also 
by gene-environment interactions, gene-gene interactions and predisposition to atopy 
(21, 22).  Furthermore, increased knowledge of the critical role of T regulatory cells 
(Tregs), in immunoregulation has moved the understanding of allergy development 
away from the original concept of T helper cell (Th)1-Th2 imbalance (23, 24).   
 
The potential effect of gastrointestinal infections on allergy development has been 
extensively researched, as infections potentially enhance immune maturation by 
stimulation of the vast lymphoid tissue containing Tregs in the gut (25).  Exposures to 
foodborne infections and Hepatitis A virus (markers of unhygienic exposure to 
orofaecal and foodborne microbes) have been found to protect against the 
development of allergy (26-28).  However, the literature is inconsistent, as other 
studies have found a positive association (29), or no association (30) with allergy 
development.   
 
The association between antibiotic consumption in early childhood and the 
development of childhood allergic disease has also been extensively examined.  The 
association is biologically plausible considering the immunomodulatory capacity of 
the gut.  Antibiotics reduce the commensal gut flora biodiversity and potentially 
disrupt immunoregulation (31).  However, the examination of the effect of 
antibiotics on allergy development has produced conflicting results (32-36).  For the 
most part, when the association with asthma development has been examined, 
positive associations have been predominant when studies were confined to early 
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exposure (prior to 2 years of age) (32).  In ISAAC, antibiotic use in the first year of 
life was associated with childhood current asthma throughout most regions in the 
world (37).  They found a weaker association between antibiotics and the 
development of rhino-conjunctivitis and eczema in 6-7 year old children.   
 
Another linked factor of considerable focus is the association between viral 
respiratory infections and the development of asthma.  Respiratory infections such as 
bronchiolitis commonly occur in young babies, are usually viral in origin and present 
with wheezing, tachypnoea, airway inflammation and respiratory distress, similar to 
symptoms of asthma.  Approximately one third of children with acute wheezing 
from viral infections such as bronchiolitis progress to develop asthma (38).  
Similarly, frequent upper respiratory infections are also positively associated with  
allergic rhinitis (39).  The relationship between early viral infection and asthma and 
rhinitis is complex; it has been found to present most risk for children who are 
already pre-disposed to atopy (39-42).    
 
Ireland is an ideal setting in which to examine the prevalence of asthma and allergy, 
as it underwent huge economic changes in the “Celtic Tiger” period, between 1995 
and 2008.  To put the changes into context, in 1988, The Economist described 
Ireland as “the poorest of the rich”; with a gross domestic product only 64% of the 
EU average (43).  Within a decade, in 1997, Ireland was pronounced as “Europe’s 
shining light”, with an economy which was among the most prosperous in Europe 
(44, 45).  The economic success was accompanied by many environmental and 
lifestyle changes including increased standards of living, higher levels of education, 
less unemployment and increased private car ownership with significantly higher 
greenhouse gas emissions (46, 47).   
 
The population in the Sturley study was primarily urban and suburban; therefore, it 
is important to extend the examination to children from rural areas.  Cork city and 
county provide a diverse setting in which to compare populations from urban and 
rural locations.  Cork is the largest county in Ireland covering an area of 7,454 sq. 
km, with a coastline of 1,100 km.  It has a lower population density than the EU 
average (39 vs. 115 persons per square kilometre).  The hinterlands of main towns in 
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the north and west of the County are predominantly rural; here the population 
density reduces to an average of 23 persons per square kilometre (48).   
 
Cork city, being the principal population centre in the Southwest region of Ireland, is 
a relatively busy urban area, with a variety of industries located in the surrounding 
environs (49).  In the 2006 Census, the population of Cork City and suburbs was 
190,384 with 290,911 people living in the rural towns, villages and farms (50).  In 
Cork, there are over 14,000 active farms (51) of which 4293 specialise in dairy 
farming (52).  Typically in Ireland, the average farm size is small (81 acres), not 
intensive and family run.  In total, 91% of land is given to grass production (silage, 
hay and grazing) for feeding livestock.  For the most part (93%), Irish farming is 
devoted to dairy and livestock production (51, 53).  In Irish small holdings, family 
consumption of raw (unpasteurised) milk is common.  In 1998, a study of farms in 8 
Irish counties, (including Cork), found that raw milk was consumed in 84% of farms, 
many of which were home to young children (54).  This practice persists as farm 
families consider the consumption of raw milk to be cost-effective, convenient, safe, 
healthier and, of higher quality than pasteurised milk (55, 56).    
 
The question remains, why is the prevalence of allergic disease in Irish children so 
high?  No genetic evidence exists that Irish children are more susceptible to atopic 
conditions than their counterparts worldwide.  The alteration in the economic climate 
and resultant different exposures, coupled with the high asthma prevalence in young 
Cork schoolchildren (11), warrants continued investigation of the trends of 
prevalence allergic conditions in this young population.  Altered allergen exposures 
during the economic boom may have resulted in different gene-environment 
interactions, and gene-gene interactions, causing varying sensitisation effects.  
Previous studies have demonstrated that interactions between exposures and 
antibody responses are specific to the allergens found in each environment (57).  The 
diversity of exposures in Cork City and County facilitates investigation of a range of 
rural and urban putative associated protective elements and risk factors in this young 
population.   
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1.2 SUMMARY OF THESIS 
Overall, this Thesis is comprised of 4 studies which explore prevalence trends and 
factors associated with childhood asthma, allergic rhinitis and eczema in the Irish 
context.  Using the ISAAC core questionnaire and protocol, it examines school 
children from two age groups, namely, 6-9 years and 11-13 years living in Cork City 
and County.  The broad aims of the thesis include: 
1.2.1 Aims  
1. To establish the 2007 prevalence and trends of prevalence of asthma and 
allergic disorders in Cork schoolchildren. 
2. To explore the natural history of asthma and allergy in Cork young 
schoolchildren until they reach early adolescence.  
3. To examine the trends of prevalence of allergic diseases in Irish adolescents. 
4. To examine the protective elements and risk factors associated with the 
development of asthma and allergic disorders in Cork schoolchildren. 
5. To explore the relationship between exposure to a farming and/or rural 
environment and the development of childhood allergic disease. 
6. To study the effect of antibiotic consumption on the development of 
childhood atopic conditions. 
7. To examine the effects of early childhood infections on the development of 
childhood allergic disease. 
1.2.2 Objectives  
1. To measure the prevalence of symptoms indicative of childhood allergic 
diseases within the sample populations of younger and older children in the 
study. 
2. To examine the trends of prevalence of symptoms of allergic diseases within 
the sample populations of younger and older children in the study.  
3. To examine the natural history of childhood allergy in Cork schoolchildren 
aged 6-9 until 11-13 years. 
4. To stratify the prevalence of all allergic symptoms by sex. 
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5. To investigate the symptoms of childhood allergic disease prevalence in 
relation to protective associations and/or risk factors. Specifically: 
a. To study the effects of the exposures of a rural or farming 
environment on the development of childhood allergic disease.   
b. To examine the effects of early childhood infections on the 
development of childhood allergic disease. 
c. To investigate the effects of early childhood antibiotic consumption 
on the development of childhood allergic disease. 
1.2.3 Thesis study components  
This thesis contains 4 studies.  The population involved in each study are presented 
in Figure 3.1 (Chapter 3, page 72).  Studies 1 and 2 examine children aged 6-9 years, 
while studies 3 and 4 are concerned with older children aged 11-13 years.  The 
ISAAC core questionnaire and protocol were used to obtain data for all four studies.  
The studies are explained in more detail in the following section. 
1.2.3.1 Children aged 6-9 years 
Study 1  
Study 1 aims to examine the prevalence trends of childhood asthma and allergy in 
children aged 6-9 years from 2002 to 2007.  Previously, Sturley (2002), in a 
prevalence study of 1474 urban/suburban children (aged 6-9), reported higher 
prevalence rates of asthma than previous Irish studies of similar age groups.  No 
trend data for this age group exists in the Irish context.  Study 1 aims to fill this gap 
in the literature by performing a follow-up to the Sturley 2002 study.  In 2007, 
children (n=1535, aged 6-9), from the same 24 schools as the 2002 Sturley study 
(n=1474, age 6-9), were examined using the same ISAAC methodology.  This study 
was motivated by the huge changes in the Irish socio-economic climate in the 5 years 
between 2002 and 2007, resulting in a higher standard of living and altered 
environmental exposures.  Therefore,  given that ISAAC deemed five years as the 
acceptable time interval for trend studies (7), the study was pragmatically designed 
to avail of the opportunity to concurrently perform the trends study along with a 
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retrospective cohort study in older children within the same schools.  Otherwise, this 
opportunity would have been missed, as the older children were leaving school and 
would be untraceable.  Research evidence demonstrates that gene-environmental 
interactions mediate the prevalence of childhood allergic disease.  Study 1 examines 
the prevalence trends of childhood allergic disease and explores possible effects of 
alterations during the economic changes during the intervening years from 2002 to 
2007.   
 
Hypothesis – “The hygiene hypothesis” 
Underpinned by the hygiene hypothesis, study 1 hypothesises that the prevalence of 
childhood allergic disease will have increased between 2002 and 2007, in line with 
the increased standards of living and associated increased levels of hygiene in the 
intervening years.  
Study 2  
The Sturley (2002) study examined factors associated with of allergic disorders in 
children from urban/suburban schools (n=24 schools, 1474 children).  Study 2 
repeats the examination of children from these 24 schools and, to facilitate the 
comparison between the exposures from urban and rural environments; it also 
examines children from an additional 87 schools in rural locations.  In total, the 
study population of Study 2 includes 3464 children from 110 schools throughout 
Cork city and County.  Study 2 examines the potential factors associated with the 
development of allergic disorders in this age group.   It examines three main 
hypotheses: 
 
Hypothesis A – “The farming effect” 
Hypothesis A is underpinned by the hygiene hypothesis and associated supporting 
international evidence.  It proposes that the increased microbial exposures associated 
with living in a rural and/or farming environment in Cork protect against the 
development of childhood allergy. The specific elements of the hypothesis include: 
 
1. Cork schoolchildren who are regularly exposed to farm animals are protected 
against the development of allergy. 
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2. Cork schoolchildren who are regularly exposed to barns/stables are protected 
against the development of allergy. 
3. Cork schoolchildren who consume unpasteurised milk in early childhood are 
protected against the development of allergy. 
4. Cork schoolchildren living in the countryside, who drink water from a home 
well water source, are protected against the development of allergy. 
5. Parental childhood exposure to a rural or farming environment is protective 
against the development of childhood allergy in the offspring.  
6. Maternal prenatal exposure to a rural or farming environment is protective 
against the development of childhood allergy in the offspring. 
 
Hypothesis B – Childhood infections 
Also, theoretically grounded by the hygiene hypothesis, Hypothesis B examines the 
role of early childhood infections on the development of childhood allergic disease.  
The specific hypotheses include: 
 
1. Early childhood gastrointestinal infections protect against the development of 
childhood allergy in Cork schoolchildren. 
2. Early childhood respiratory infections are positively associated with the 
development of childhood allergy in Cork schoolchildren. 
 
Hypothesis C - Antibiotics 
Underpinned by the understanding of the importance of gut microflora in the 
maintenance of normal immunoregulation (development from the hygiene 
hypothesis), Hypothesis C examines the effect of receiving antibiotics in early 
childhood on the prevalence of childhood allergic disease.  The hypothesis is that 
consumption of antibiotics in early childhood is positively associated with the 
development of childhood allergic disease in Cork schoolchildren.   
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1.2.3.2 Children aged 11-13 years 
Study 3 
The high ISAAC adolescent rates of asthma, rhinitis and eczema merit on-going 
examination of this age group in the Irish context.  Yet, no cohort study exists in the 
Irish context to examine the natural history in this population.  Therefore, when 
faced with the unique opportunity to attain data from the same cohort of children 
over two time periods, a quasi-retrospective cohort study was performed.  This 
cohort study is a repeat study of children who were aged 6-9 during the Sturley 2002 
study and were aged 11-13 in 2007 (their last year in primary school).  It investigates 
the natural history of asthma and allergy in children from Cork city and suburbs from 
6-9 years until 11-13 years (Sturley, 2002, age 6-9, n=1474 and Duggan, 2007, age 
11-13, n=706).  
 
Hypothesis – Natural history of childhood allergy 
The hypothesis is that the natural history of asthma and allergy in Irish adolescents 
may be different to their international counterparts because of different gene-
environmental interactions. 
Study 4 
It is important to assess trends in Irish adolescents, because of the high prevalence in 
comparison to international rates.  Therefore, the purpose of Study 4 is to examine 
prevalence trends of allergic diseases in Irish adolescents (2003-2007).  In 2003, 
Manning published the prevalence of childhood allergic disease in ISAAC Phase 3 
(age 13-14, n= 3089).  These results were compared to the prevalence rates of the 
children in the 2007 aspect study 3 described above (Duggan, 2007, age 11-13, 
n=706).   
 
Hypothesis – Trends of prevalence in adolescents  
The hypothesis is that the trends of prevalence of allergic disease in Irish adolescents 
may be different to those internationally, because of different environmental 
exposures and genetic make-up. 
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1.3 SCOPE OF THESIS 
This study examines the atopic diseases of asthma, allergic rhinitis and eczema in 
childhood.  It is primarily epidemiological in nature and therefore the literature 
review and thesis will focus on the prevalence and potential modifying factors 
associated with these diseases.  Genetic and immunological factors are also 
discussed, as they support the biological plausibility of associations found in the 
study.    
 
Although asthma, allergic rhinitis and eczema are referred to as allergic conditions 
throughout the thesis, it is accepted that without biological markers, one cannot 
differentiate between allergic and non-allergic presentations (58).  Nevertheless, this 
study uses the ISAAC questionnaire and protocol, which is a standardised, validated 
tool used to elucidate the prevalence of these three allergic disorders; it is therefore 
deemed acceptable practice to refer to the conditions as allergic (59).   There are 
many putative risk and protective factors linked with the development of childhood 
allergic disorders; however, it is beyond the scope of the study to investigate all of 
them.   
1.4 OUTLINE OF THESIS 
Chapter 1 is an introductory chapter.  It commences with a brief background to the 
childhood allergic diseases of asthma, allergic rhinitis and eczema.  It outlines the 
main putative associated factors which are examined in the study and the context of 
the location of study is described.  Finally, the aims, objectives, rationale, 
hypothesis, scope and outline of the thesis are summarised.  Chapter 2 is a review of 
the current literature pertaining to the childhood allergic conditions of asthma, 
allergic rhinitis and eczema.  It concludes with the expected contributions of this 
thesis to the body of knowledge.  Chapter 3 describes the study design, tools and 
research methods employed in thesis.  It also describes and rationalises the use of 
statistical analyses and data management.  In Chapter 4, the results of the thesis are 
presented.  Results commence with the socio-demographic and descriptive data 
pertaining to the study participants, followed by the results of the four studies within 
the thesis.  In Chapter 5, the results are discussed in relation to the current evidence.  
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The novel aspects and implications, strengths and limitations are also debated.  It 
concludes with recommendations for future research.  The contributions of the 
author and others involved in the Thesis are presented in Table 1.1. 
 
Table 1.1   Contributions to the thesis 
 
 Author’s personal 
contributions 
Assistance received  
Study concept and 
design 
 
Performed a literature review 
 
Adapted the modifying factors 
aspect of the questionnaire 
 
Prepared research protocol. 
Applied for and received 
ethical approval. 
Expert advice from the Research Team:  
o Professor Jonathan Hourihane, 
Department of Paediatrics UCC 
o Professor Ivan Perry, and Dr 
Tony Fitzgerald, Department of 
Epidemiology and Public health, 
UCC 
o Dr J. Sturley, Department Early 
Childhood Care and Education, 
Mary Immaculate College, 
Limerick. 
Questionnaire design 
and layout 
 
Designed questionnaire layout 
into suitable format for upload 
to Teleform
®
 Scanner 
Software 
 
Uploaded the questionnaire to 
Teleform
®
 
Educated regarding the use of the 
Teleform
®
 software and scanner by: 
o Ms. Vera McCarthy (Dept. of 
Epidemiology and Public 
Health).  
 
Study process 
 
Contacted previously involved 
schools and recruited 87 
further schools in rural areas 
 
Data collection 
 
Collected data from 110 
schools in Cork City/County 
Kindly facilitated by: 
o School headmasters/mistresses 
o Teachers 
o Parents and children 
Data entry 
 
Entered 4170 questionnaires 
into Teleform
® software for 
export to Microsoft Excel, via 
sidekick scanner 
Eight hours of student assistance to enter 
data, provided by: 
o The Department of Paediatrics 
and Child Health, UCC 
Data analysis 
 
Analysed data for all studies Statistical advice received from: 
o The research team 
o Dr Anthony Fitzgerald  
o Ms. Jennifer Lutomski   
(Department of Epidemiology and Public 
Health) 
Publication and 
Dissemination 
 
Presented research findings in 
the form of a Thesis 
 
Published 1 research article 
Two articles in preparation 
Guidance, proof-reading and corrections 
provided by: 
o All members of the research 
team. 
 
 
  
 
 
 
2 Chapter 2 Literature Review 
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2.1 INTRODUCTION 
This literature review commences with an overview of atopy and the atopic diseases 
of asthma, eczema and allergic rhinitis.  Epidemiological evidence surrounding 
allergy development in relation to smoking, breastfeeding and the hygiene 
hypothesis will be reviewed.  Although this is an epidemiological study, the 
literature pertaining to the genetic and immunological pathophysiology of allergic 
disease is included in the literature review, as it is often essential in order to support 
the biological plausibility of the study findings.  The chapter concludes with the 
expected contributions of this thesis to the body of knowledge.   
2.2 ATOPY 
The term ‘atopy’ has been used since the 1930s to describe conditions associated 
with the clinical and biological responses (skin-prick test hypersensitivity and high 
serum levels of specific associated immunoglobulin E (IgE) molecules) when 
exposed to inhaled or digested or environmental allergens (60).  According to the 
revised nomenclature for allergy for global use, atopy is defined as ...a personal 
and/or familial tendency usually in childhood or adolescence to become sensitised 
and produce IgE antibodies in response to ordinary exposures to allergens, usually 
proteins, as a consequence, these persons can develop typical symptoms of asthma, 
rhinoconjunctivitis or eczema (58).  The childhood atopic allergic disorders of 
asthma, allergic rhinitis and eczema are a major burden to children and their 
families, as they often impair a child’s ability to partake in normal childhood 
activities, can severely impair the quality of life if left untreated, and are often 
responsible for many hospitalisations/healthcare visits, absenteeism from 
school/day-care resulting in missed days from work by parents (1-4, 61, 62).  
Childhood allergic diseases are extremely complex and heterogeneous disorders, 
which are both genetically and environmentally mediated.  Several phenotypes exist 
which differ with age of onset, sensitisation, gene-environment interactions, severity, 
comorbidities and development over time (63).  
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2.3 ASTHMA 
Childhood asthma is a complex inflammatory allergic airway disease resulting in 
bronchospasm and bronchial hyperresponsiveness which cause episodes of 
wheezing, breathlessness, chest tightness and coughing (64).  Despite being the most 
common chronic disease in children, a diagnostic definition remains elusive, because 
of its heterogeneity (64).  Asthma may be of allergic (IgE mediated) or non-allergic 
origin (58) and its pathophysiology depends upon complex genetic-environmental 
interactions (65).  It produces structural airway remodelling involving a plethora of 
structural changes (including epithelial damage, elastin destruction, thickening of the 
sub-basement membrane and mucous gland hyperplasia), resulting in smooth muscle 
hyperplasia and hypertrophy and impaired lung growth and development (66).  
Consequentially, the epithelium in asthmatic airways is more fragile and permeable, 
allowing increased entry of inhaled allergens, pollutants and irritants (66).   
 
The global burden of childhood asthma is considerable; it affects approximately 7 
million (9.4%) children in America (67).  Up to 9.3 million children are affected in 
Europe, costing as much as €5200 million per year (68).  The burden of asthma on 
children’s quality of life is also extensive.  In a qualitative study to develop a quality 
of life questionnaire for children with asthma, the themes which emerged from focus 
groups were that asthma negatively influenced children’s lives on many levels.  
Children reported that they were not just affected by the physical aspects such as 
shortness of breath and cough, but there were many emotional and social 
implications.  They complained of feeling dependant on medication, and being 
bullied as they stood out as being different and often unable to participate in 
activities (69).   
2.3.1 Diagnosis of asthma  
In recognition of the difficulty with diagnosis and management of childhood asthma, 
(owing to the heterogeneity of clinical presentations) and the associated mortality 
and morbidity, the Global Initiative for Asthma (GINA, a World Health Organisation 
initiative) devised child-specific criteria for asthma diagnosis and management (5).  
The overall aims of GINA are improved assessment, monitoring, and control of 
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asthma, through which, the enormous burden may be reduced for many children, so 
that they may enjoy the normal activities of life.  The GINA guidelines recommend 
that a diagnosis of asthma ought to be considered if any of the following signs or 
symptoms are present: 
 Frequent episodes of wheezing – more than once a month 
 Activity induced cough or wheeze 
 Cough particularly at night during periods without viral infections 
 Absence of seasonal variation in wheeze 
 Symptoms that persist after the age of 3 
 Symptoms occur or worsen in the presence of: 
o Allergens (house dust mites, companion animals, cockroach, fungi) 
o Exercise 
o Pollen 
o Respiratory (viral) illness 
o Strong emotional expression 
o Tobacco smoke 
 Child’s colds repeatedly “go to the chest” or take more than 10 days to clear  
 Symptoms improve when asthma medication is given 
2.3.1.1 Night cough 
Night cough is a recognised associated symptom of asthma and shares many of the 
long-term effects of classic wheezing asthma e.g. airway remodelling (70).  
However, while cough variant asthma is well recognised in adults (71), there is a 
paucity of related empirical data in children (72).  Caution is advised when 
diagnosing and treating asthma in children based only on the presence of a persistent 
cough (73-76), as other possible aetiologies exist (77-79)  and unnecessary treatment 
from incorrect diagnosis can have adverse effects (80).   Recognition and treatment 
of cough variant asthma is included in the GINA guidelines (5).    
2.3.2 Natural history of asthma 
Asthma symptoms have been recorded far back in history, but, despite much 
research, the classification and natural course of this complex disease still remains an 
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issue for investigation (81).  Anecdotally, there was always an awareness that many 
children “grew out of asthma” and as asthma prevalence is lower in adults than in 
children, there is an acceptance that remission occurs in many children (7, 67, 81).  
Initially, long term cohort studies were set up to examine the natural history of 
asthma, however, they have developed to provide a framework within which to 
understand the complex nature and prognosis of different presentations of asthma in 
early years of life (82).  
  
Some long-term trajectories of the natural course of asthma have been reported from 
older long running cohort studies.  The Australian Melbourne Asthma Study found 
an association between severe childhood asthma and asthma persistence into 
adulthood.  They recruited 295 children with a history of wheezing and 106 without 
(aged 7 years in 1964, 3 years later they added 83 children with severe asthma).  On 
examination at 42 years old (87% cohort retention), 20% who had asthma at 7 years 
of age reported asthma symptoms aged 42 years, compared to 50% of the cohort of 
children recruited at age 10 with severe asthma symptoms in childhood (83).  There 
were limitations to this study’s methodology and also treatments have altered 
significantly since the study commenced.   
 
However, treatment has been demonstrated not to have an effect on the long-term 
outcome of disease.  The Childhood Asthma Management Program (CAMP) initially 
started as a randomised controlled trial (4.3 years) comparing two treatments (anti-
inflammatory drugs – budesonide or nedocromil, each versus placebo, followed by 4 
additional years of observation) in order to establish if treatment had an impact on 
remission.  The trial was followed by a four year observation period.  They 
concluded that the progression or remission of asthma does not appear to be decided 
by treatment choice rather than by issues such as sensitization and exposure, lung 
function, and airway hyper responsiveness (84).  The presentation of asthma is 
heterogeneous in childhood, making it very difficult to examine the pathways of 
asthma development.   
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2.4 ALLERGIC RHINITIS 
Allergic rhinitis (AR) is a chronic disease affecting the upper airways which is 
characterised by nasal itching, sneezing, watery rhinorrhoea and nasal obstruction 
(85).  When AR includes the ocular symptoms of eye itch, tearing, redness and lid 
puffiness, it is termed “rhino-conjunctivitis” (86).  AR is IgE-mediated, involving 
mast cell degranulation, release of mediators and subsequent release of inflammatory 
cells (85).  The major aggravating allergens are from pollens (grass, tree and weeds), 
pets (cats, dogs, rabbits, horses) and house dust mite (14).  
 
 Allergic rhinitis frequently occurs in children with asthma, typically presenting after 
the second year of life (87) and has been found to predict asthma incidence and 
persistence into middle age (88).  The prevalence of AR in young children (age 6-7) 
increased in most countries globally in ISAAC Phase Three and was found to be as 
high as 40% in some centres (7).   The German Multicentre Allergy Study (MAS, 
birth cohort study, 0-10 years, n=1314) reported a rising prevalence from early 
childhood to adolescence, with a higher risk associated in children with allergic 
predisposition who were sensitised to aero-allergens (89).  MAS also reported that 
children with severe persistent AR suffered proportionately more wheezing 
symptoms than children with mild persistent or intermittent AR.  Asthma and AR 
commonly co-exist and there are many similarities in their pathogenesis, giving rise 
to the concept of “one airway, one disease” (85).   
 
The impact of childhood allergic rhinitis is substantial, often affecting children’s 
cognitive performance and overall quality of life (62, 90, 91).  In America, Meltzer 
et al. conducted a telephone survey of parents and children (n=500 children with 
allergic rhinitis, n=504 without rhinitis) to elucidate the burden of allergic rhinitis on 
children’s and families lives (2).  The cardinal physical symptoms of AR were 
reported to be moderately to severely bothersome and frequently extended to 
headaches, facial pain, ear pain and dry irritable cough, practically on a daily basis 
during exacerbations.  Many children suffered sleep deprivation and resultant 
tiredness, misery and irritability.  Children with allergic rhinitis were twice as likely 
to suffer impaired involvement in their daily activities of living and 4 in 10 children 
with allergic rhinitis reported that it affected their performance at school.  Parents 
  
Chapter 2.   Literature Review Page 33 
 
complained about the lack of efficacy of the medication and children found it to be 
unpleasant both in taste and sensation (running down the back of their throat).    
 
The Environment and Childhood Asthma (ECA, birth cohort study 0 – 10 years, 
allergic sensitisation tests, parental interviews, clinical examination, lung function 
tests, n=1019) study, in Norway found that 87.4% of children with rhinitis had at 
least one co-morbid allergic condition (92). The reported prevalence of co-morbid 
conditions was very high (conjunctivitis = 75.5%, current asthma = 31.7%, current 
atopic eczema = 30.3%).  Children with allergic sensitisation and rhino-
conjunctivitis had more frequent and severe bronchial hyperresponsiveness (BHR).  
Children who suffered AR symptoms associated with exposure to pollen and furry 
pets were more likely to suffer from concomitant asthma than those who suffered 
symptoms of AR from just pollen exposure.  Overall, symptoms triggered by 
exposure to pollen resulted in higher impairment of the activities of daily living (92).   
2.4.1 Allergic rhinitis and its impact on asthma (ARIA) 
In recognition of the high prevalence of AR patients with concomitant asthma and 
the negative impact of undiagnosed, untreated or mismanaged AR on asthma, the 
Allergic Rhinitis and its Impact on Asthma (ARIA) workshop was set up by the 
World Health Organisation (85, 86).  The ARIA classification and guidelines 
provide an evidence based, systematic stepwise approach to the diagnosis and 
management of AR, aiming to improve patients’, clinicians’ and policy makers’ 
knowledge in order to improve management of AR and in turn, asthma.  They have 
been validated in the paediatric population (86).  The ARIA definitions of allergic 
rhinitis are as follows: 
Intermittent –symptoms are present < 4 days a week or < 4 consecutive weeks 
Persistent - symptoms are present > 4 days a week and > 4 consecutive weeks 
Mild - none of the following items are present: sleep disturbance, impairment of 
daily activities, leisure and/or sport, impairment of school or work, symptoms are 
present but not troublesome. 
Moderate/severe - one or more of the following items are present: sleep disturbance, 
impairment of daily activities, leisure and/or sport, impairment of school or work, 
troublesome symptoms. 
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2.5 ECZEMA 
Eczema is a highly pruritic chronic inflammatory skin condition which is often the 
first manifestation of allergy in children (93).  It is characterised by skin dryness and 
the presence of lesions which appear as pruritic red plaques which ooze when 
scratched (94).  Eczema usually presents in infancy and early childhood with 
remission after adolescence in many cases, although it may recur in some adults at a 
later stage (95).  It can present anywhere in the body, but in children it usually 
affects flexural areas and the face (96).   Clinical diagnosis of eczema can be 
difficult, as other differential diagnoses exist, (for example, seborrhoic dermatitis or 
scabies) (95).  To counteract misdiagnosis, guidelines were developed, such as those 
by Hanifin and Rajka (97) or the UK working Party (98-100).  The UK working 
party diagnostic criteria which are the most validated are as follows:  
 
The child must have:  An itchy skin condition (or parental report of scratching or 
rubbing) in the past 12 months AND three or more of the following:  
 History of involvement of the skin creases (fronts of elbows, behind knees, 
fronts of ankles, around neck or around eyes)  
 Personal history of asthma or hay fever (or history of atopic disease in first-
degree relative if child aged < 4 years)  
 History of generally dry skin in the past year  
 Onset before the age of 2 years (not used if child aged < 4 years)  
 Visible flexural dermatitis (including dermatitis affecting cheeks or forehead 
and outer areas of limbs in children aged < 4 years) 
 
The severity of eczema may be assessed using validated scores, such as Eczema Area 
and Severity Index (EASI) or Severity Scoring of Atopic Dermatitis (SCORAD) 
(101).  Without diagnosis confirmed by IgE antibody determination or a skin test, the 
World Allergy Organisation (WAO) recommend that the terms atopic 
eczema/dermatitis should be replaced by the term eczema (58).  The prevalence of 
childhood eczema is at times difficult to ascertain, as it depends upon the definition 
used by the researchers; for epidemiological purposes ISAAC defined current 
eczema as having a persistent flexural rash which was coming and going for at least 
6 months, in the previous 12 months.   ISAAC Phase Three found a worldwide 
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increase in the prevalence of eczema with a large range of variability in prevalence 
rates (1.5% to 20.9%) in 6-7 year old children (102).    
 
Childhood eczema impacts hugely on the quality of life of the child and their 
parents.  A recent review of the effects of the symptoms describes the misery of 
living with the effects of itching, soreness, sleeplessness and the resultant 
exhaustion, lack of concentration, impaired cognitive and psychosocial functioning 
(together with many more negative impacts) (4).  The impaired quality of life also 
extends to other family members as parents express feelings of exhaustion, guilt, 
anger and depression (4).   
 
There is a strong link with eczema and atopy, as it often coexists with, or predicts the 
other two atopic conditions of asthma and rhinitis (61) and a systematic review of 13 
prospective cohort studies reported that 1 in 3 children with eczema will go on to 
develop asthma (103).  The natural history of eczema can be divided into 3 stages 
which are defined by the age of manifestation; namely, infantile (appears in the first 
year of life with itchy red bumps on cheeks, forehead, scalp, sometimes spreading to 
trunk and in more severe cases skin on hand and feet are dry), childhood (occurs 
from age 4-10 and is associated with itchy eruptions on face, trunk and flexural areas 
of arms or legs - scaly, dry and thickened skin) and adolescent/adult stage (develops 
post-puberty and may persist into adulthood.  It is characterised by lichenified 
eczematous areas in face, neck, wrists, hand and flexural areas) (93, 104).  Risk 
factors for the continuance of eczema symptoms and progression to the atopic march 
are severe childhood eczema, family history, filaggrin mutation, early wheeze and 
atopic sensitisation (93, 104).   
2.6 PATHOPHYSIOLOGY OF ALLERGIC DISEASE 
The childhood allergic conditions of asthma, rhinitis and eczema are characterised by 
inflammation, which is usually IgE mediated.  They are the result of a complex 
interplay between inflammatory cells and synergistically orchestrated by several 
transcription factors and epigenetic modulation (105).  
  
Chapter 2.   Literature Review Page 36 
 
2.6.1 Immunological processes and allergy 
The normal immune response to environmental allergens is that the immune system 
works in a synchronised manner to maintain homeostasis (23).  Allergic diseases are 
the manifestation of an abnormal immune response, resulting in the development of 
IgE antibodies against common environmental allergens, in genetically predisposed 
children (106).  The IgE orchestrated inflammatory process involves synergistic 
complex interplay between mast cells, basophils, lymphocytes, dendritic cells, 
eosinophils and, in severe cases neutrophils (105).   
 
Mast cells exist in tissues throughout the body and when exposed to allergen release 
inflammatory mediators such as proteases, cytokines, and chemokines (105).  
Following allergen exposure, they initiate allergic inflammation in the mucosa by 
cytokines IL-9 and stem-cell factor (SCF) and in the skin by the cytokine (TSLP) 
(107).  This is rapidly followed by release of synthesised mediators (Table 2.1) 
which cause result in bronchoconstriction, vasodilation, and plasma exudation 
causing asthma symptoms or, nasal secretions and inflammation causing allergic 
rhinitis symptoms (105).  In the skin, mast cells appear to act as sensors of 
environmental and emotional stress (108), which, when activated, result in the 
inflammatory symptoms of the skin in eczema (109).   
 
T-cell tolerance is the key mechanism promoting a normal immune response to what 
are known as self and non-self antigens (24).  Antigen presenting cells called 
dendritic cells (DCs) play a key role in the differentiation of naïve CD4
+
 T 
lymphocytes into subsets of T-helper cells (Th), namely Th1, Th2, Th9, Th17 and 
Th22 (110).  The differentiation and processing of allergens by the highly specialised 
DCs is influenced by costimulatory signals, cytokines, chemokines and regulatory T 
cells (Tregs).  Tregs are currently the only known population of lymphocytes mediating 
dominant tolerance; their suppressor function is vital for the maintenance of immune 
homeostasis (111).  Basophils work with DCs to promote optimal Th2 activation 
(112).  Th1 cells are responsible for delayed-type hypersensitivity reactions 
(secreting cytokines IL-2, IFN-γ, and TNF-α and TNF-β) and Th2 cells mediate 
against parasitic infections and produce the allergic inflammatory reactions to 
allergens, (secreting cytokines IL-4, IL-5, IL-9 and IL13) (113).  Eosinophil 
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production is induced by Th2 cells (mediated by release of IL-5) and is linked with 
airway remodeling in asthma (105).  Another T cell lineage was recently discovered 
called Th17 cells (differentiate under the influence of IL-6, IL-21 and IL-23 and 
TGF-β), which are also associated with allergy (especially eczema) (114) and with 
neutrophilia in severe allergic asthma (105).  
 
Experimental evidence demonstrates that the neonatal immune system displays a 
Th2 cell phenotype, which, through environmental exposures, matures towards a 
balanced interaction of Th1 and Th2 cells (115-117).  Atopy occurs when there is 
Th2 skewed response to allergen exposure, leading to secretion of Th2-type 
cytokines and the subsequent development of allergen-specific IgE antibodies.  
Previously, allergy was thought to occur solely as a result of dysregulation in the 
Th1/Th2 balance.  However, Tregs with their distinct phenotypes and mechanism of 
action to suppress or induce the production of IgE, are now known to play a key role 
in immune homeostasis (24).   
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Figure 2.1   Effects of the release of mediators on allergic airway inflammation 
 
Cells differentiated and infiltrated in 
the lung 
Cytokines/mediators Biological effects 
 
Cells that exacerbate inflammation and asthma 
Mast cells IL-9,  Stem cell factor (SCF) Bronchoconstriction, vasodilation, plasma 
exudation 
Eosinophils Toxic granules; MBP, EDN, EPO, cytokines Prolonged bronchoconstriction, damaged 
epithelium, airway remodelling 
TH2 cells IL-4, IL-5, IL-13 Humoral antibody production, chemotaxis and 
survival of eosinophils 
Th17 cells IL-17, IL-17F, IL-22, IL-26 Neutrophilia, AHR, airway remodelling 
Dendritic cells IL-4, GM-CSF (cholera toxin, PGE2, histamine 
may potentiate the effect) 
Induction of TH2 cells; suppression of TH1 cells 
CD8+ T cells IL-5, IL-13 AHR, eosinophilia 
 
Cells that suppress allergic and asthmatic response 
Regulatory T cells IL-10, TGF-β Prevention of T-cell expansion 
CD8+ T cells IFN-γ Suppression of allergic immune response 
TH1 cells IL-2, IFN-γ, lymphotoxin Enhanced cellular response; suppression of TH2 
cells 
Plasmacytoid DCs and Regulatory 
Dendritic cells 
IL-10, IL-12 (LPS, bacterial CpG, CpR 
oligonucleotides) 
Induction of TH1 cells and T cell suppression 
AHR–airway hyperresponsiveness; CpG–cytosine-phosphorothiolated guanine; CpR–cytosine-phosphorothiolated 2′-dioxy-7-deazaguanosine; EDN–eosinophil-derived 
neurotoxin; EPO–erythropoietin; GM-CSF–granulocyte-macrophage colony-stimulating factor; IFN–interferon; IL–interleukin; MBP–myelin basic protein; TGF–
transforming growth factor; TH–T helper 
 
Adapted from Agrawal et al. (111)  
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2.6.2 Genetic factors and allergy 
Immune function is modified by genetically determined cellular surface structures.   
Naturally-occurring CD4
+
CD25
+
 Tregs (NTregs) are generated in the thymus and 
express CD25
+
 and transcription factor Foxp3, which prevent deviation of Tregs into 
effector T cells (118).  Transcription factors are master regulators which commit 
cells to a specific cell lineage, i.e. cell differentiation (119).  The constant expression 
of Foxp3 in mature Treg cells is necessary for them to maintain their phenotype of 
suppression of the immune response (120, 121).  Suppression of immune responses 
occur in many ways, for example through the production of anti-inflammatory 
cytokines, direct cell-cell contact, and by modulating the activation state and 
function of antigen presenting cells (111).  Loss or reduced expression of Foxp3 in 
Treg cells leads to Tregs gaining effector T cell properties and subsequent production 
of immune response-promoting cytokines such as IL-2, IL-4, IL-17, and IFN-γ
(119, 120).  As well as developing in the thymus, Foxp3
+
 Tregs can also be 
differentiated in the periphery, in which case they are called induced T regulatory 
cells (iTregs) (23).  iTreg cell differentiation favours particular environments, such as 
the gut mucosal system in gut-associated lymphoid tissue (GALT) (25).  Currently, 
factors which influence the expression of Foxp3 are largely unknown (118).   
 
Childhood allergic diseases are complex geno-environmentally mediated disorders 
(122).  A child’s predisposition to allergy is as a result of genetic variations, caused 
by inheriting several mutant genes.  For example, polymorphisms (mutations) in 
filaggrin (FLG, the filament-aggregating protein which is of direct key importance to 
epidermal barrier function) were found to be a risk factor for eczema development 
and moreover as a risk factor for asthma and atopy (123).  This knowledge may 
prove to be a critical predictor of which children are likely to progress on the allergic 
march (124).  Geneticists have now identified three new risk loci for eczema, 
confirming the involvement of the FLG locus and the importance of deviations in 
skin barrier function in the development of eczema (125).   
 
Gene-environment interactions can be protective or causative.  Pattern recognition 
receptors CD14 and toll-like receptor (TLR) 4 are important in recognising and 
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eliminating endotoxin by activating the innate immune response (65).  The pathway 
of gene modification from environmental exposure was evident in the PARSIFAL 
study where, in children whose mothers were exposed to farm animals prenatally, 
TLR2 and TLR4 and CD14 upregulated in a dose-response fashion to each farm 
animal encountered (126).  The specificity of the roles of genes in the pathogenesis 
of asthma is highlighted in the Copenhagen Prospective Study on Asthma in 
Childhood (COPSAC).  They found variants on the 17q21 asthma locus, (which 
encode the ORMDL3 and GSDML genes) are associated with increased risk of non-
atopic asthma (hazard ratio: 1.88; 95% CI, 1.15-3.07, p = 0.01), but not atopic 
asthma or any other atopic condition (127).  Table 2.2 outlines some of the 
discovered genetic associations with different stages of asthma and atopy.  Although 
advances in genetic studies have increased our understanding of the pathogenesis of 
asthma, they currently are poor predictors of disease progress.   
 
Polymorphisms in gene-gene interaction are also associated with the development of 
allergy.  Genetic studies in 3 birth cohorts revealed polymorphisms in gene-gene 
interactions in IL2RA, TLR2, TGFBR2, and Foxp3, all of which are involved in 
regulatory T-cell development and function (128).  Investigation continues into the 
genetic complexities in allergic disease. 
2.7 PREVALENCE OF ALLERGIC DISORDERS IN CHILDREN 
Using a standardised questionnaire, the International Study of Asthma and Allergies 
in Childhood (ISAAC) measured the prevalence of asthma, allergic rhinitis and 
eczema in children and demonstrated a worldwide increase in their prevalence (129). 
The main outcome measures used in the ISAAC study are the 12 month prevalence 
of symptoms of asthma (current wheeze), allergic rhinitis (current allergic rhinitis) 
and atopic eczema (current eczema).  Phase One reported an increase in worldwide 
prevalence of all three allergic conditions, with variations according to location 
(129).  Ireland ranked within the top 4 in the World in this phase, for each condition 
(7).  Phase Two performed clinical examinations and collected objective biomarkers 
(e.g. skin prick testing for sensitisation and bronchial challenge tests) from a 
subsample of children to investigate putative associations and validity of 
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questionnaires.  This phase confirmed that childhood allergic disorders involve a 
complex panorama of gene-environment interaction while also validating the ISAAC 
questionnaires as epidemiological tools in many populations (7, 130).  Phase Three 
examined trends, and found rising prevalence in developing countries, with 
reductions in areas of high Phase One prevalence (such as Ireland).  The Irish 
element of this study highlighted that Ireland has the fourth highest 12-month 
prevalence of asthma in 13 -14 year old children in the world (131).  The Northern 
Ireland ISAAC protocol study findings concurred with those of the Republic (132).  
The combination of the findings of both studies revealed that between 21 – 27 % of 
children who reported disturbed nights and/or moderate or greater disturbance of 
daily activity were neither diagnosed as, nor treated for, asthma.  This highlights the 
demand for empirical evidence within the Irish setting to increase both professional 
and non-professional awareness of the prevalence and symptoms of asthma, thus 
facilitating its detection and treatment. 
2.7.1 Secular trends of prevalence 
Trends of prevalence are crucial to healthcare management and planning.  
Worldwide time trend analyses using the ISAAC protocol have yielded inconsistent 
results.  Many studies suggest that the prevalence of symptoms indicative of asthma 
and atopic conditions may have plateaued from the late nineties (133-135).   In 
Switzerland, although the prevalence of asthma and hay fever plateaued, symptoms 
of atopic dermatitis continued to rise, especially in girls (136).  Sex predominance 
was also evident in Germany, where the prevalence and severity of childhood and 
adolescent asthma and atopic conditions had increased from 1995 to 2000 (137).  In 
Spain, the prevalence of asthma was found to have stabilised in adolescents but 
increased in the younger age-groups (138).  In Hong Kong, rates of asthma were 
found to be decreasing in adolescents and stabilizing in 6 – 7 year olds, but 
increasing rates of allergic rhinitis and eczema were found the latter age group (139).   
A Norwegian 10 year cohort study found that the prevalence of childhood asthma 
had doubled over a 10 year period to a prevalence of 20.2% (140).   
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2.7.2 Sex-specific prevalence of atopic conditions 
The sex-specific prevalence of asthma has been widely reported with inconsistent 
results.  Male preponderance to asthma in young children had traditionally been the 
accepted norm (141-144).  This has partly been attributed to differences in the 
physiological development of the lungs between the sexes.  From the prenatal period, 
although males have larger lungs than females, they have narrower airways (airways 
are made up of parenchymal tissue) (145), boys’ airways also grow at a slower rate 
than girls (dysanaptic growth) (146).    
 
There is a switch to female dominance in the prevalence of asthma in adulthood 
(142, 147).  The main hypothesis for the reversal in prevalence following puberty is 
that sex hormones play a major role in the pathogenesis of asthma (148).  Oestrogens 
enhance the production of antibodies and the subsequent immune response, while 
testosterone and progesterone seem to suppress immunity and inflammation (149, 
150).  Testosterone has been suggested as a treatment, at levels which would not 
produce virilisation (151-153).    
 
The male dominance in the prevalence of childhood asthma has been challenged.  It 
has been questioned as being attributable to bias in health professional diagnosis 
(154-156) or  the fact that girls are less likely to report their symptoms of asthma 
(155).  The “Yentyl” syndrome in relation to asthma diagnosis has been described as 
being a possible contributor to the under-diagnosis of asthma (156); this refers to the 
phenomenon whereby females need to present similarly and with the same severity 
as males to be diagnosed as having a disease.  Girls present differently to, and are 
often less atopic than, boys (157-159).  As some doctors may perceive asthma to be 
purely atopic, they may be less likely to diagnose females as asthmatic and they may 
remain untreated (160). 
 
In young children, differing patterns of sex-specific prevalence of allergic disorders 
are emerging from ISAAC centres.   In Munster, Germany (137), Maziak et al. 
reported that the prevalence of current asthma had moved from male predominance 
to equal sex distribution from ISAAC Phase I to phase III (age 6-7).  Rhinitis 
showed male preponderance, while eczema moved from sex equalisation to female 
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dominance.  Conversely, in Lithuania, current asthma was more prevalent in boys 
during both timeframes of ISAAC (p<0.05), while lifetime asthma had moved from 
equal distribution to male predominance ((p<0.01).  They reported that eczema 
symptoms were equally distributed between the sexes during both timeframes.  Of 
allergic rhinitis, only lifetime rhinitis was found to be more prevalent in boys during 
both studies (p<0.05) (161).  ISAAC in England reported male preponderance to 
asthma in Phases I and III, although the gap had narrowed during the intervening 
years (162).  The increases in female asthma prevalence and the subsequent move 
towards sex equalisation in asthma distribution was apparent in younger children 
(age 6-9) in many ISAAC centres where stratification by sex was reported, although, 
overall, higher male prevalence remained evident, (137, 161-163).   As the sex-
specific prevalence of eczema and allergic rhinitis are less reported, no clear pattern 
has emerged (137, 162). 
 
The M:F gap also appeared to diminish in slightly older children, as studies reported 
substantial increases in asthma prevalence in female children, aged 9-12 years (164-
166).  This alteration in the sex profile of asthma and allergic disease was 
particularly apparent in a study in Aberdeen where, Osman et al. performed four 
cross-sectional studies in the same schools in 1989 (n=3,390, response rate 86%), 
1994 (n=4,047, response rate 96.4%), 1999 (n=3,540, response rate 84%) and 2004 
(1,920, response rate 57.2%).  Parent completed questionnaires were used to obtain 
information regarding the prevalence of symptoms of asthma and allergy in children 
aged 9-11 years.  They reported a decline in male predominance for wheeze, 
diagnosed asthma and AR and a complete reversal in the prevalence of eczema 
which now had moved to female predominance.    
 
The altering sex-specific profile of equalising distribution has come under scrutiny; 
the question being, whether it is artefact, improvement in diagnosis or genuine (166).   
One theory is that complex interactions of environmental influences may have 
altered the fine hormonal balance that traditionally made young boys more 
susceptible than girls to asthma (166).  Oestrogen-like endocrine disrupting 
chemicals (ubiquitously found in many man-made products e.g. pesticides, baby 
feeding bottles and toys) have been identified as a possible cause, by potentially 
decreasing age of puberty, thereby decreasing the age of disadvantage for young 
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males, while in turn, contributing to the relatively higher increases in asthma 
prevalence in girls than in boys (166). 
 
2.7.3 Co-morbidity of allergic disease 
A high percentage of young Irish children suffer symptoms of more than one atopic 
disorder.  Sturley reported 3.2% current symptom prevalence for all three conditions 
in 2002 (11), significantly higher than ISAAC Phase Three findings of only 1% 
internationally of 6-7 year old children and 1.2% of adolescents suffering symptoms 
of all three conditions (7).  Punekar and Sheikh (2009) in a retrospective cohort 
study (n=43,477, birth – 18 yrs.) examined co-prevalence of multiple atopic 
disorders and found a high co-prevalence of 2.5% for all three allergic conditions 
(59).  They reported the clinician diagnosed prevalence and incidence of asthma, 
eczema and rhinitis, and co-prevalence in a retrospective cohort study (n=43,477, 
birth - 18 yrs.), using validated coding measures from the UK General Practice 
Research Database.   
 
Worldwide ISAAC percentages of children suffering from two allergic conditions 
ranged from 1% to 3.5% in both age groups (7).  Again, these were lower than the 
Sturley finding that 1.5% to 6.7% of young Irish children suffer the co-morbidity of 
two allergic conditions (11).   
2.8 ASSOCIATIONS WITH CHILDHOOD ALLERGIC DISEASE 
Many putative associations have been interrogated over recent years.  Cross-
sectional studies have been useful in highlighting possible associations.  Several 
birth cohort studies have emerged which target the examination of these associations. 
Causation, associations and hypotheses emerging from cross-sectional studies, 
systematic reviews and birth cohort studies are discussed in the following section.   
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2.8.1 Breastfeeding  
One of the first factors placed under scrutiny in relation to childhood allergy was 
breastfeeding.  The protective effect of breastfeeding in relation to allergy was first 
proposed in 1936 in relation to eczema (167).  However, empirical evidence suggests 
that its role in the prevention of allergic diseases is uncertain.  Biologically it is very 
plausible that breastfeeding would have a protective effect, as it has many 
immunomodulatory components such as antigens, cytokines, immunoglobulins, 
chemokines (168) and lactoferrin (a protein which has microbicidal, 
immunostimulatory, and anti-inflammatory actions, which inhibit the cascade of 
activation of proinflammatory cytokines (169)).  In 2010, a systematic review of the 
link between transforming growth factor-beta (TGF-β) in human milk and 
immunological outcomes in infancy and early childhood, concluded that high levels 
of TGF-β in human milk appear to protect against the development of allergic 
disease.  However, they recommended more investigation, as they found large 
inconsistencies between studies (170). 
 
A recent meta-analysis on the effect of breastfeeding on asthma found that current 
evidence supports a beneficial effect of breastfeeding on wheeze in early childhood 
until approximately 7-8 years old, but thereafter it becomes a risk factor in the 
development of asthma (167).  They found that it was mainly earlier reviews (2000 – 
2001) that reported a protective effect of breastfeeding on asthma, and that 
definitions of asthma in many studies were not robust (171, 172).  The evidence of 
protection against wheeze in early childhood may be confounded by the protective 
effect of breastfeeding on respiratory infections (173).  The rationale behind the 
positive association thereafter is uncertain, but is supported by many prospective 
cohort studies, such as The Tucson Children's Respiratory Study, which found 
breastfeeding was positively associated with asthma after the age of 6 years (174).  
Evidence of this risk extending into later life also exists, as the Tasmanian 
Longitudinal Health Study found that exclusive breastfeeding for the first 3 months 
of life was positively associated with asthma between 14 and 44 years (175).  Similar 
findings were reported from the Dunedin Multidisciplinary Health and Development 
Research Study, which found that breastfeeding was associated with an increased 
risk of asthma between 9 and 26 years (176).  A recent meta-analysis of the 
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association between breastfeeding and childhood asthma, recommended further 
investigation with attention to study design, as all studies pertaining to asthma had 
several limitations with regard to defining asthma, breastfeeding and eliminating 
reverse causation (167). 
 
With regard to allergic rhinitis (AR), a meta-analysis of the effect of breastfeeding 
found that overall, it had a non-significant protective effect on the risk of AR (177).  
No association between AR and breastfeeding was found in children with a family 
history of atopy, but a significant protective effect was found in children without a 
family history of allergy. However, all studies pertained to prior to 4 years of age, so 
many cases of AR may have been missed (167). 
 
The examination of the effect of breastfeeding on the development of eczema has 
also yielded conflicting results and methodological issues.  In 2001 a systematic 
review and meta-analysis found that breastfeeding for the first 3 months protected 
against developing eczema, especially in children predisposed to atopy (178).  
Conversely, a systematic review and meta-analysis in 2009 found no association 
between eczema and exclusive breastfeeding for the first 3 months for children with 
or without a family history of allergy (179).  Diversity of assessment and definition 
existed in studies and furthermore, there does not appear to be any study which 
examines the association into adulthood (167).   
 
A recent meta-analysis of the effect of breastfeeding on childhood allergy 
development also found overall that the current evidence was inconclusive.  The 
authors reported that studies had many methodological limitations which included 
reverse causation, recall bias, and various differing definitions of breastfeeding and 
allergic disorders.  These issues need to be addressed in future studies (167).     
2.8.2 Environmental tobacco smoke exposure 
The negative effects of passive smoking on children’s lung function have long been 
investigated, with positive associations (180, 181).  The evidence from systematic 
reviews initially supported the view that the effect of exposure to tobacco smoke was 
confined to younger children, which was explained by the negative impact of 
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exposure to tobacco smoke on the immature narrow bronchial airways producing 
transient wheezers, which resolved upon maturation (181, 182).  Also, positive 
associations were found to only pertain to children born to high-risk parents (183).  
However, a recent meta-analysis of 38 cohort studies examining the association of 
second-hand tobacco smoke on asthma induction, found a consistent pattern of 
positive association between exposure to tobacco smoke in the home and the risk of 
developing asthma in childhood, regardless of age group or population risk (184).   
 
The effect of tobacco smoke exposure on the development of childhood eczema has 
also been measured.  Wang et al. investigated the effect of smoking in pregnancy by 
obtaining maternal and cord blood for cotinine levels at birth and examining the 
development of eczema using the ISAAC questionnaire at the age of 2 years (n=150 
mother and child pairs).  They reported a dose-response increase in the risk of 
developing eczema and cord blood cotinine levels (p for trend =0.01) (185).  The 
effect of exposure to tobacco in early childhood has been examined, but the results 
are inconsistent. Studies have reported no association (186, 187), positive 
associations (185, 188) and even protective effects (189).  A possible explanation 
offered for the finding of an inverse association is that parents who perhaps ceased 
smoking when their child presented with an allergy, may have incorrectly reported 
their child as being unexposed in early life (recall bias), thereby pushing the relative 
risk downwards (184).  Furthermore, parental smoking behaviour in relation to their 
child’s health is a sensitive subject and findings may be prone to under-reporting 
(183).  
2.8.3 The hygiene hypothesis 
The Hygiene Hypothesis was first proposed by Strachan in 1989 (17).  He 
hypothesised a direct relationship between increased standards of home hygiene 
combined with decreasing family sizes and the increasing prevalence of atopic 
conditions.  Noting the increasing prevalence of childhood asthma and atopy in the 
more affluent populations within developed countries, Strachan asserted that as 
society developed and became wealthier, family size reduced and hygienic practices 
became norm.  The consequential decrease in microbial burden (antenatally and in 
early childhood) both from the surrounding environment and from reduced sibling 
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contact, delay the development of the immune system rendering it vulnerable to 
atopic immune responses (17, 18).  The theory gained plausibility as epidemiological 
studies demonstrated that farmers’ children exposed to endotoxin (gram-negative 
bacteria) in early life suffered less allergy and asthma (190).   Support for the 
hypothesis gained further credence, as murine studies provided evidence of the role 
of Th1 and Th2 cells in the immune system (191) and clinical immunological 
evidence emerged demonstrating Th cell imbalance in the immune system of 
asthmatics (117, 191, 192).  These findings supported the contention that the 
protective mechanism was mediated by microbial exposure activating the innate 
immune pathways through expression of toll-like receptors (TLRs) and CD14.  The 
move to immune system maturity by expansion of Th2 helper cells over Th1 helper 
cells prevents the development of asthma and allergy (117).  Previous approaches to 
understanding the hygiene hypothesis centred on immunological mechanisms of 
allergy, with an emphasis on the Th1-Th2 paradigm.  However, the theory has 
evolved to a more evolutionistic understanding; that the increase in allergies is due to 
gene-environment interactions (22).   
 
Subsequent to the theory, epidemiological research comparing the prevalence of 
allergic conditions between children exposed to high and low microbial 
environments (e.g. family size, birth order, antibiotic therapy; immunisations and 
infections) emerged.   
2.8.3.1  Family size and structure 
A fundamental component of the hygiene hypothesis is that decreased microbial 
exposure in early life, or prenatally, is associated with the development of allergy 
(17).  Strachan noted that increases in childhood eczema and allergic rhinitis 
prevalence occurred concurrently with reductions in family size.  Exposure to 
siblings was deemed a proxy measure for exposure to unhygienic microbial loaded 
environments and cross-infection.  The decrease in family size resulted in decreased 
microbial exposure from sibling transmitted infections (especially from older 
siblings) and caused unbalanced development of the immune system and the 
development of atopy (17, 18).  Since the inception of the hypothesis, many studies 
have been performed to examine the hypothesised sibling effect.  In 2002, a 
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systematic review of 53 studies examining the sibling effect, concluded that overall 
(n=48 studies) a protection is conferred from having a higher number of siblings 
against all or some of the outcome measures for asthma or allergy (more often for 
hayfever and atopic sensitisation, than for asthma or eczema) (193).  The reviewers 
noted that the investigation into the sibling effect produced many studies of 
heterogenic methods (different outcome measures of sibling effect), rendering it 
difficult to compare.  Since the review, the Manchester Asthma and Allergy Study 
(MAAS) a birth cohort study (n=1085 children, reviewed at 1, 3 and 5 years, 
parental report and skin-prick tests) found that the protective effect of having older 
siblings only existed in relation to rhino-conjunctivitis (OR, 0.72; 95% CI, 0.54 – 
0.97) (194).   
 
Conflicting evidence also exists.  More recently, the Prevention and Incidence of 
Asthma and Mite (PIAMA) birth cohort study (n= 3963, 0 – 8 years old) reported 
that early day-care attendance was associated with increased respiratory symptoms 
until the age of 4, with fewer symptoms thereafter, only in children without older 
siblings.  No protection was conferred by early day-care attendance against the 
development of asthma symptoms, hyperresponsiveness, or allergic sensitization at 
the age of 8 years (195).   Wickens et al. statistically refute the sibling effect as the 
sole causal link for the increase in prevalences, having calculated summary weighted 
odds ratios for the associations between birth order, family size and prevalence of 
atopic disease from 1961 to 1991 census data (196).  Similar conclusions were 
reached using identical analysis on US census data (197).  Karmaus et al. propose an 
alternative hypothesis; that the sibling effect originates in utero, as maternal blood 
IgE levels reduce with each pregnancy (198, 199).    
2.8.3.2 Day-care attendance  
As expected, attendance at day-care centres exposes children to a diverse amount of 
microbes and infections.  It is associated with increased risk of upper and lower 
respiratory tract infections (195, 200).  A systematic review of studies examining the 
effects of day-care attendance performed by Nystad in 2000 concluded that the 
results were inconclusive and recommended birth cohort studies in the future (201).  
Subsequent to the review, the Tucson Children’s Respiratory Study (year 6 and 11, 
  
Chapter 2.    Literature Review Page 50 
 
n=1035 children) reported that attending day-care before six months of age and 
having older siblings was found to increase frequent wheezing prior to 2 years of age 
(OR, 1.4, 95% CI, 1.1 – 1.8, p=0.001), but to reduce the risk of wheezing by the age 
of 6 years (OR, 0.8; 95% CI, 0.6 – 1.0, p=0.03) until 13 years (OR, 0.3; 95% CI, 0.2 
– 0.5, p<0.001) (202).   
 
In 2008, the MAAS birth cohort study found the risk of current asthma was 
significantly reduced in children who commenced day-care between 6 and 12 
months (OR, 0.25; 95% CI, 0.11-0.60) and after 12 months of age (OR, 0.65; 95% 
CI, 0.44-0.98), however, positive associations were found between entering  day-
care in the first 6 months of life and atopy (OR, 2.47, 95% CI, 1.23-4.95) (194). 
 
In 2011, the influence of Life-style factors on the development of the Immune System 
and Allergies in East and West Germany Plus the influence of traffic emissions and 
genetics study (LISAplus) birth cohort study  (n=3097 children aged 0-6 years) 
found that early day-care attendance was associated with increased incidence and 
prevalence of childhood eczema (203).   The authors suggest that the higher eczema 
incidence may be due to increased levels of stress from day-care attendance.  A 
systematic review of nine studies concluded that day-care attendance  is associated 
with higher cortisol levels than home care (204).  The Assessment of Lifestyle and 
Allergic Diseases During Infancy (ALADDIN, n=203) birth cohort study 
demonstrated an association between high cortisol levels and atopic sensitisation and 
eczema (205).  Results measuring cortisol levels need to be taken with caution as 
reverse causation may exist; sensitisation and allergic symptoms in themselves may 
induce production of higher levels of cortisol (205).  However, studies are emerging 
which further demonstrate the importance of psycho-neuroimmunological dynamics 
in the development of eczema, particularly from disruption of the family unit.  The 
LISAplus cohort study reported increased risk for developing eczema (206) and Th2 
bias of cytokine secretion (207) from exposure to the stressful early life event of 
separation/divorce.   
 
It is apparent that inconsistencies in findings persist.  Most studies appeared to make 
no allowance for variance in time spent in day-care and the size of the day-care 
  
Chapter 2.    Literature Review Page 51 
 
centres attended.  Therefore, as surrogate markers of microbial exposure, yes/no 
responses may not be truly indicative, or comparable measures (208).   
2.8.3.3 Immunisations 
The link between immunisations and asthma and allergy and direction of the 
proposed association has been investigated for many years (209-214).  A positive 
association has been suggested, as the rise in asthma and allergy has coincided with 
the development of comprehensive vaccination programmes in the western world 
(214).  The underlying hypothesis is that immunisation causes asthma or allergy 
directly by some unknown immune potentiating effect or indirectly by reducing 
childhood exposure to infections and thus priming the immune system towards a Th2 
predominant immune response (215).   
 
At ecological study level, ISAAC found no association between childhood 
immunisation and the prevalence of symptoms of atopic disease (216), although, 
ecological level studies are prone to a multitude of confounding factors.   However, 
overall, the evidence is very contradictory.  Some studies have found beneficial 
effects (217), some increased risk (29), some found no association (211, 215, 218, 
219), even in children with a predisposition to atopy (220), while others found 
different results for different vaccinations (221).   
   
Pertussis and Bacille Calmette-Guérin (BCG) vaccines are of particular interest as 
they have immune-modulatory potential (IgE production in animal (222, 223) and 
human models (224, 225)).  A meta-analysis of all available comparative studies 
(receipt vs. non-receipt of vaccine, validated by medical records) investigating the 
association between asthma and whole-cell pertussis (within diphtheria-tetanus-
pertussis vaccine) and BCG vaccinations (1996 – 2006) found the evidence could not 
support any association (positive or negative) with the development of childhood or 
adolescent asthma (226).  They noted issues around the heterogeneity of the studies 
with many being of poor methodological quality.   
 
A nationwide Danish study examined the association of the Measles-Mumps-Rubella 
(MMR) vaccine and asthma in early childhood (n=871,234) by using the outcomes 
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of hospital admissions with an asthma diagnosis and asthma medication (227).  All 
data was attained from a civil registration system which is in place for all Danish 
citizens.  They reported that MMR-vaccinated children were less often hospitalised 
with an asthma diagnosis (OR, 0.75, 95% CI, 0.73-0.78) and used less asthma 
medication (OR, 0.92; 95% CI, 0.91-0.92) than children who were unvaccinated.   
Beneficial effects of MMR were also found in children who were hospitalised with 
status asthmaticus (OR, 0.63; 95% CI, 0.49-0.82) and taking long-acting β2 
antagonist inhalant asthma medication (OR, 0.68; 95% CI: 0.63-0.73), but not for 
taking systemic b2-agonist anti-wheeze medication OR, 1.02; 95% CI, 1.01-1.02) 
(227).   A large Swiss cross-sectional study, The Swiss Surveillance Program of 
Childhood Asthma and Allergies with respect to Air Pollution and Climate 
(SCARPOL, n=1537 children aged 13-15years) also reported an inverse relationship 
between the risk of asthma and MMR vaccination (OR, 0.45; 95% CI, 0.21-
0.98).(216).  Using parentally completed questionnaires and serum tests for atopic 
sensitisation, they also found no increase in the risk of sensitisation to common 
allergens from receiving the MMR vaccine (216).  Therefore, the evidence points 
towards a protective effect against asthma from the MMR vaccine, although more 
evidence is required.  
 
Atopic predisposition has also been implicated as potentially increasing the 
immunomodulatory effect of immunisation, however, in a population of high atopic 
risk, the Tasmanian Longitudinal Health Study (n=5729, age 7 to 44 years) found no 
association between childhood immunisations and the development of asthma and 
allergy by age 7, or the prevalence of asthma and allergy at 44 years (215).   
 
A recent meta-analysis of the effect of childhood vaccinations concluded that as 
childhood vaccination programmes have been continually evolving to include newly 
developed vaccines, it was difficult to extricate individual components and 
differentiate the individual effects of each vaccine (226).  Also, the heterogeneity of 
studies and conflicting findings in research compound the lack of clarity.  Yet, 
clarity regarding the issue of childhood immunisation is imperative, as parental 
uncertainty may have a catastrophic effect upon national immunisation programmes 
and ultimately public health (228).   
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2.8.3.4 Childhood infections  
According to the hygiene hypothesis, early childhood infections confer protection 
against the development of asthma and allergy (17), however, the evidence regarding 
the effect of different infections is contradictory (39).  A recent review of the role of 
infections in the development of asthma and allergy concluded that the role of 
infections is more complex than the hygiene hypothesis first presumed (229).  
Infections may promote or protect against allergic diseases depending upon time of 
exposure, type/severity of the infection and the predisposition of the host.   
 
A cross-sectional study involving parentally completed ISAAC questionnaires 
(n=1584 children with serious notified infectious diseases 0-4 years and 2539 
children from general population) found no significant difference in the prevalence 
of current asthma symptoms between the children in the infectious diseases group vs. 
children from the general population, irrespective of type or location of infection 
(230).  A pilot study of 89 children post hospitalisation with confirmed pertussis 
infection in the first six months of life, compared with 172 children without 
pertussis, found children who had infantile pertussis were more likely to suffer 
"asthma symptoms" (OR, 2.8; 95% CI, 1.1-7.0) at toddler age (13-45 months) (231). 
Gastrointestinal infections  
The hygiene hypothesis supports the notion that enteric infections would enhance 
maturation by stimulation of the gut and protect against atopy, especially given the 
fact that the gut-associated lymphoid tissue (GALT) is the largest lymphoid organ in 
the body.  GALT contains a large number of Treg cells, including Foxp3
+
 Treg cells 
which are essential for immune homeostasis (25).  However, the literature with 
regard to the effect of gastrointestinal infections on allergy development is 
inconsistent.  Exposures to foodborne infections and Hepatitis A virus (HAV) 
(markers of unhygienic exposure to orofaecal and foodborne microbes) have been 
found to protect against the development of allergy.  A landmark study in Italy 
(n=1659 male military cadets, aged 17-24), reported that cadets with HAV 
antibodies, had significantly lower prevalence of atopy than those who were 
seronegative for HAV, irrespective of sibling status (26).  A retrospective case-
control study of the same cohort of Italian military cadets (n=240 atopic cases and 
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240 controls), demonstrated that the prevalence of atopy reduced in a dose response 
fashion with previous exposure to Helicobacter Pylori (H pylori), Toxoplasma gondii 
(T gondii) and HAV (p=0.000045 for trend).  They also reported very low incidence 
of allergic asthma and allergic rhinitis in the cadets who were exposed to at least two 
of the infections (28).  An inverse association between HAV seropositivity and 
atopic prevalence, was also reported  in men and women living an anthroposophic 
lifestyle (n= 1527, aged ≥20 years, serum obtained from the Enzyme Linked 
ImmunoSorbent Assay (ELISA) study) (27).   
 
H pylori was found protective against the childhood (≤15 years old) development of 
asthma (OR; 0.63, 95% CI, 0.43-0.93) and allergic rhinitis (OR, 0.55; 95% CI, 0.37-
0.82) in the US Third National Health and Nutrition Study (n=7663, age >17 years) 
(232).  In 2012, a meta-analysis (n=19 studies) examining the effect of H pylori on  
asthma prevalence concluded that although the evidence is weak, it demonstrates a 
protective effect of H pylori exposure on asthma development (233).   
 
A Sardinian study comparing pre-school children (0- 4years) hospitalised for 
Salmonella (n=148) and non-bacterial enteritis (n=167), reported lower prevalences 
of asthma and allergic rhinoconjunctivitis by school age, in children with Salmonella 
(asthma: 3.4% vs. 12.6%, p=0.006, allergic rhinoconjunctivitis: 5.4% vs. 13.8%, 
p=0.019) (234).   
 
Conversely, recurrent gastroenteritis (>3 episodes) in the first two years of life was 
found to be associated with the development of asthma by age 6 (OR, 2.0; 95% CI, 
1.5 – 2.75) in the Melbourne Atopy Cohort Study (MACS) (29).  No association has 
also been reported.  A retrospective UK study using a GP database (n=29,238 
children, range of follow-up=birth to 11 years and median follow-up = birth to 2.9 
years) of personal medical history, reported no effect of early gastrointestinal 
childhood infections in the development of childhood allergy (30).   
Respiratory infections 
A German longitudinal Multicentre Allergy Study (MAS, n=499 children of high 
atopic risk and 815 children of low atopic risk, 0 – 7 years) found infectious diseases 
other than lower respiratory tract infections in the first three years of life were 
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inversely related to a diagnosis of asthma by 7 years of age (OR, 0.31; 95% CI, 0.11 
- 0.85  >4 infections vs. <3 infections), current wheeze at age 7 (OR, 0.55; 95% CI, 
0.20 - 1.48), and bronchial hyperreactivity at age 7 (OR 0.40; 95% CI, 0.16 - 1.01) 
(235).  On further dissection of results, only viral infections showed a significant 
negative association with asthma; bacterial, fungal, gastrointestinal or urinary tract 
infections had no significant effect.  In contrast, lower respiratory tract infections 
with wheezing showed a strong positive association with asthma at the age of 7 (OR, 
6.19 95% CI, 2.17 - 17.63) for >2 wheezing infections vs. no infection. Some 
infections appear to convey protection, while others, (especially severe lower 
respiratory tract infections) in early childhood are positively associated with the 
development of asthma.   
 
Respiratory viral illness  
Moderate to severe febrile and wheeze inducing viral lower respiratory-tract 
infections appear to play a key role in the development of asthma (38, 236), 
especially in children pre-disposed to atopy (40, 41, 237).   
 
Bronchiolitis is a respiratory illness commonly occurring in young babies under 6 
months of age which is usually viral in origin and presents with wheezing, 
tachypnoea, airway inflammation and respiratory distress.  Characterised clinically 
by pyrexia, tachypnoea, wheeze and respiratory distress, the usual causal pathogens 
are Human Rhinovirus (HRV) and Respiratory Syncytial Virus (RSV) (238-240).  
The Childhood Origins of Asthma birth cohort STudy (COAST, n=259/289 high risk 
children from 0 – 6 years, 90% follow-up) assessed the aetiology of childhood 
wheeze as it arose, using nasal lavage, culture, and multiplex reverse transcriptase–
polymerase chain reaction (241). They reported that overall, 90% of wheezing 
illnesses were of viral origin and 86.6% (26/30) of the children who had rhinovirus 
(RV) at age 3, had asthma by the age of 6.  The risk of developing asthma increased 
each year with having had rhinovirus and by year 6 the risk was extremely high (OR, 
31.7; 95% CI, 10.6 - 94.9) in this at risk group of children. 
 
The negative implications of viral exposure and asthma continue after asthma 
diagnosis.  RSV infections are the also the most common cause of childhood asthma 
exacerbations (240, 242).  In a population-based retrospective birth cohort study, 
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Carroll et al. investigated healthy term infants from 1995-2000 (n=90, 341 children) 
and demonstrated a dose-response relationship between the severity of bronchiolitis 
symptoms and both the development of early childhood asthma and asthma 
morbidity (243). Furthermore, the negative implications of viral respiratory 
infections persist into adulthood.  When exposed to rhinovirus, adults with asthma 
were reported to suffer lower respiratory infections twice more frequently with more 
severe symptoms of longer duration than non-asthmatics (244).   
 
The reasons why asthmatics are more susceptible to lower respiratory tract infections 
from viral exposure remain under investigation.  In-vitro studies have revealed that 
asthmatic bronchial epithelial cells have a deficient innate immune response to 
rhinovirus infection (245-247).   Asthmatic epithelial cells have deficient interferon 
(IFN) production, which results in impaired viral elimination (245, 247).  IFN-β and 
IFN-λ are critical in the initiation of apoptosis and viral elimination and are vital 
triggers in a cascade of protective anti-viral pathways (248, 249).  
 
The relationship between early viral respiratory infection and asthma is complex; in 
a recent review, Gern suggests that there are three main theories of association (42).  
The first theory proposes that early viral respiratory illness directly causes the 
development of asthma, rationalised by early childhood (immature immune and 
respiratory system) presenting a critical window of vulnerability to asthma from viral 
infection (250).  The second, questions viral illness as being causal and instead 
asserts that viral illness reveals children with pre-existing tendency to asthma.  The 
third, combining the former two theories, suggests that viral-induced respiratory 
infections increase the risk of the development of asthma in children who are already 
atopically predisposed (40-42).   
 
Recent evidence strongly supports the latter theory.  Maternal atopy was found to be 
significantly associated with more severe human RV bronchiolitis in a prospective 
cohort study of healthy term infants (n=630) (251).  Severe febrile viral lower 
respiratory tract infections in infancy and early atopy were found to be risk factors 
for persistent wheeze and asthma in a prospective birth-cohort study of 147 children 
(0 – 10 years) with high atopic risk (41).  Infantile respiratory infections were 
monitored and virology tests performed.  Skin prick tests for atopy were attained at 6 
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months, 2 years and 5 years.  Information regarding occurrences of wheeze and 
physician diagnosed asthma and eczema was sought at regular intervals.  At the end 
of the 10 years, they reported that 60% of the children were atopic, 25.9% had 
current eczema, 18.4% current asthma, 20.4% persistent wheeze and 35.8% 
experienced ≥1 lower respiratory infection associated with fever and/or wheeze in 
their first year of life.  Children who suffered a lower tract respiratory infection with 
a fever in infancy and were atopic by 2 years, were significantly more likely to report 
persistent wheeze (OR, 3.51; 95% CI 1.83-6.70; p<0.001) and current asthma (OR, 
4.92; 95%CI 2.59-9.36; p<0.001) at 10years.  The key risk factor for developing 
asthma was the presence of a fever during the respiratory illness, indicating severity 
(41). 
2.8.3.5 Antibiotics 
The positive association between antibiotics and allergy has been found in many 
studies, however, as antibiotics are prescribed for respiratory tract infections 
(bacterial and viral), uncertainty exists as to whether the association has merit or is 
due to reverse causation (32).  Nevertheless, increasingly animal and human 
evidence demonstrate that the risk is biologically plausible (252-254).  Antibiotics 
reduce commensal gut flora biodiversity which is necessary to maintain human-
microbial symbiosis, in order to provide optimum conditions (for TLR signalling and 
cytokine pathways) to ensure Treg activation and thereby promote normal 
immunoregulation (31).  A recent systematic review found a positive association 
between prenatal and early life exposure to antibiotics and the risk of developing 
childhood asthma (OR, 1.52; 95% CI, 1.30 – 1.77, n=20 studies) (255).  They found 
that retrospective self-reported studies demonstrated the highest risk estimate for 
asthma (OR, 2.04; 95% CI, 1.83–2.27, n=8) by comparison with database and 
prospective studies (OR, 1.25; 95% CI, 1.08–1.45, n=12).  However, they note that 
in the latter group, it was the prospective studies of relatively small sample size 
which showed nonsignificant asthma risk.  Database and retrospective studies are 
prone to recall bias and lack the ability to establish temporal occurrence of events, 
consequently, caution remains regarding their validity to determine causal inference, 
rather than reverse causality.  In 2009, a prospective cohort study in Poland of 310 
children born to non-smoking mothers aged 18 – 35 without chronic illness adjusted 
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for the severity of respiratory infections and found a significant association between 
the consumption of broad spectrum antibiotics (macrolide (OR, 2.14; 95% CI, 1.16 – 
3.95) and cephalosporin (OR, 1.98; 95% CI, 1.14 – 3.37) and the development of 
asthma by the age of 5 years having adjusted for respiratory infections (256).   
 
In Canada, a 6 year follow-up study using population-based data (n=128,872 
children, data from 1997 – 2005) (257) reported that prior to diagnosis, children with 
asthma had a higher consumption of antibiotics than those without (adjusted rate 
ratio 1.66 – 2.32).  Furthermore,  predominantly with diagnoses of upper and lower 
respiratory tract infections, over half of the children with asthma had antibiotics in 
the 6 months prior to diagnosis and antibiotic prescriptions were at their highest in 
the month prior to diagnosis compared to the previous 5 months (OR, 1.66; 95%, CI, 
1.60 – 1.71) therefore demonstrating that children with asthma were more likely to 
be misdiagnosed as having a respiratory infection and be prescribed unnecessary 
antibiotics (257).  Murk et al. describe the phenomenon of misdiagnosis of early 
asthma symptoms as respiratory infection, as a form of reverse causality and label it  
protopathic bias (255).    
 
In a large US birth-cohort study (from 1997 – 2000, n=1401 children born to 
mothers with diagnosed asthma, with asthma symptoms and a random sample 
control group without asthma or symptoms), Risnes et al.  aiming to reduce the risk 
of protopathic bias, investigated very early antibiotic use (prior to 6 months of age), 
years prior to the onset of symptoms of asthma and excluded children with asthma 
diagnosis prior to 6 months of age (258).  They also examined indications for 
antibiotic use, adjusting for and examining separately, children who were prescribed 
antibiotics for respiratory infections from those who had a diagnosis unrelated to 
asthma symptoms (258).  They reported that antibiotic consumption was associated 
with: developing asthma (OR, 1.52; 95% CI, 1.07 – 2.16), children having their first 
diagnosis of asthma after 3 years of age (OR, 1.66; 95% CI, 0.99 – 2.79), asthma 
diagnosis in children with no history of lower respiratory infection in the first year of 
life (OR, 1.66; 95% CI, 1.12 – 3.46) and allergic asthma confirmed by serum IgE or 
skin prick test (OR, 1.59; 95% CI,1.10 – 2.28).  The association was particularly 
evident in children with no family history of asthma (OR, 1.89; 95% CI, 1.00 – 
3.58).  This study demonstrated a clear association between early antibiotic 
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consumption and asthma and allergy at 6 years of age (258).  However, additional 
prospective studies are required to build the body of empirical evidence required to 
establish if a definite causal relationship exists (255, 258).    
2.8.3.6 Anthroposophic lifestyle 
Leading an anthroposophic lifestyle involves limited use of antibiotics, antipyretics 
and immunisation and promotes an organic diet in its purest, simplest form.  A cross-
sectional study involving parentally completed questionnaires and skin-prick tests 
were performed to compare the lifestyle factors and prevalence of atopy in children 
(age 5-13) from Steiner schools (n=295, born to families who lead anthroposophic 
lifestyles) and children from neighbouring schools (n=380) (259).  Steiner school 
children had lower levels of atopy (OR, 0.62; 95% CI, 0.43 – 0.91), consumed less 
antibiotics (52% vs. 90%), received less MMR immunisations (18% vs. 93%) and 
consumed a diet containing fermented vegetables and live lactobacilli (63% vs. 
4.5%) compared with children from the control schools.  An inverse relationship was 
found between the number of characteristic features of an anthroposophic lifestyle 
and risk of atopy (p for trend=0.01). 
 
To study the phenomenon further, a large multi-centre cross-sectional study of 6630 
children aged 5-13 years (n=4606 from Steiner school and n=2024 from control 
schools) was performed (PARSIFAL Study) (260).  Parentally completed 
questionnaires and blood samples for atopic sensitisation were obtained from 
consenting participants.  Confirming the findings of the previous study (259), 
Floistrup et al. found lower prevalence of current and doctor diagnosed eczema and 
rhino-conjunctivitis, doctor diagnosed asthma and atopic sensitisation in Steiner 
school children than in the control children. MMR vaccination and early 
consumption of antipyretics and antibiotics were positively associated with doctor 
diagnosis and reported symptoms of allergic disease (260), providing supporting 
epidemiological evidence for the hygiene hypothesis.   
2.8.3.7 Farm effect 
Several studies examined the prevalence of allergic conditions in children from rural 
environments and/or comparing children living the anthroposophic lifestyle with 
  
Chapter 2.    Literature Review Page 60 
 
controls from neighbouring rural areas.  The Swiss Surveillance Program of 
Childhood Asthma and Allergies with respect to Air Pollution (SCARPOL) study 
investigated children from three rural communities (age 6–15 years, n=1620 
parentally completed questionnaires and IgE serum testing for six common 
aeroallergens n=404 age 13–15 years) and found farming to be protective against 
allergic rhinitis symptoms (OR 0.34; 95% CI, 0.12–0.89) and sensitisation (OR, 
0.31; 95% CI, 0.13–0.73)  (261).  Similar protective farm effects against asthma and 
allergy have been noted in Australia (262), Finland (263), Canada (264) and England 
(265).   
 
Ege et al. combined the results of two multicentre studies conducted in Germany, 
Austria and Switzerland (PARSIFAL - Prevention of Allergy-Risk Factors for 
Sensitisation in Children Related to Farming and Anthroposophic Lifestyle and 
GABRIELA – Multidisciplinary Study to Identify the Genetic and Environmental 
Causes of Asthma in the European Community [GABRIEL] Advanced Study).  Both 
studies had compared children living on farms with a control group and found that 
the children exposed to a rural lifestyle had lower prevalences of asthma and atopy 
(266).  Measuring asthma and atopy prevalence against microbial exposure (from 
mattresses and bedrooms) revealed that a wider diversity of microbial exposure was 
inversely related to the risk of asthma (PARSIFAL: OR, 0.62; 95% CI, 0.44 – 0.89; 
GABRIELA: OR, 0.86; 95% CI, 0.75 – 0.99).   
 
In England, Perkin and Strachan, (employing the methodology of the ISAAC 
questionnaire, a food frequency questionnaire and objective allergy tests of skin 
prick testing, visible eczema examination, height and weight, venipuncture and dust 
sample collection from the children’s home) found that farmers’ children had less 
current asthma and seasonal allergic rhinitis.  However, they did not have 
significantly less eczema or atopy than their rural non-farming counterparts (265).  
Unpasteurised milk consumption was determined to be the exposure mediating the 
protective effect on the sample children irrespective of farming association.  
Previously, the Allergy and Endotoxin (ALEX) Study (performed in Austria, 
Germany and Switzerland, n=812 children), found that exposure to farm milk in the 
first year of life reduced the prevalence of atopy and continual long-term exposure to 
stables until age 5 years was associated with the lowest frequencies of asthma, hay 
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fever and atopic sensitisation (validated by random samples of serum for specific IgE 
antibodies) (267).  They also found a significant protective element to asthma and 
atopy from the combined exposures of mothers being active on the farm antenatally 
and of infants who were exposed to stables in their first year of life.  
 
Majkowska-Wojciechowska et al. (n=404 children, age 10-16 years, parentally 
completed questionnaire on diet and exposure to animals/crops, skin prick testing, 
serum IgE) compared the prevalence of allergy and atopy in children living in both 
rural and industrialised urban environments in central Poland, (268).  They also 
found a lower prevalence of allergic sensitisation and symptoms of asthma and 
allergic rhinitis in school children living rurally.  Farm milk consumption and 
antenatal contact with pigs were the protective exposures.   
 
The PARISFAL study team investigated the role of prenatal maternal farm related 
exposures and alterations in the innate immune system of their children (parentally 
completed ISAAC and ALEX questionnaires: n=8263, serum IgE: n=2086) (126).   
In a subsample (n=322), they assessed the gene expression of Toll-like receptors 
(TLR2 and TLR4) and CD14.  Prenatal maternal exposures to stables were found to 
result in atopic sensitisation and the gene expression of receptors of innate immunity 
(adjusted odds ratio, 0.58; 95% CI, 0.39-0.86).  The genes upregulated in a dose-
response fashion according to the number of different farm animals encountered 
antenatally.   Each additional farm animal species encountered, increased the 
expression of TLR2, TLR4 and CD14 by a factor of 1.16 (95% CI, 1.07-1.26), 1.12 
(95% CI, 1.04-1.2), and 1.10 (95% CI, 1.03-1.23), respectively. 
 
The effect of prenatal farming exposures has been further investigated by the 
Protection Against Allergy Study in Rural Environments Study (PASTURE).  They 
recruited women during pregnancy and examined the effects of rural exposures on 
922 mother and child pairs.  They measured cord blood IgE levels for common 
inhalant allergens and reported a protective effect from prenatal contact with animal 
sheds and cord blood IgE levels against seasonal allergens and prenatal contact with 
hay in the sheds enhanced the protective effect to grass pollen (269).  However, on 
investigation of the genetic make-up of farming-exposed populations, Ege et al. were 
unsuccessful in detecting interactions between farming related exposures and 
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500,000 genotyped SNPs, although lack of statistical power in their study may have 
been a possible reason for this failure (270).   
 
However, contradictory findings to the protective effect of farming also exist.  In 
New Zealand, Wickens et al. reported that current farm abode increased the risk of 
having symptoms associated with allergy, but not skin prick test positivity (271).  
They found that levels of endotoxin were lower in farming homes, attributable to the 
practice of removing all farming attire and washing before entering the home (271).  
Also, a Canadian cross-sectional study (n=553 children aged 6–13 years, parentally 
completed questionnaires) found that certain farming activities involving exposure to 
dust increased the odds of children developing respiratory symptoms (272).  The 
exposures of risk included emptying and filling grain bins (OR, 2.18; 95% CI, 1.03-
4.62), playing on or near hay bales (OR, 1.89; 95% CI, 1.19-3.01), (OR, 2.08; 95% 
CI, 1.07-4.06), and cleaning pens (OR = 2.70, 95% CI, 1.05-6.97).  However, the 
amount and intensity of exposures were not ascertained and may be a critical 
component to establish if associations exist.  Diaries recording the extent of exposure 
are recommended in future studies (272). 
 
While overall, children reared on farms demonstrate a lower prevalence of asthma 
and atopy than their non-farming peers, findings vary in different studies despite 
using similar methodology (19).  The ALEX study team reported that interactions 
between exposures and antibody responses were specific to the allergens found in 
each environment (57).  Protective farm effects were confined to Th2-dependant 
IgG1, IgG4 and IgE expression, which is suggestive that distinct mechanisms 
regulate individual steps.  Different allergen exposures cause varying sensitisation 
effects in different environments, therefore more investigation is required (265).  
Efforts are currently underway to combine international birth-cohort data by the 
Global Allergy and Asthma European Network (GA
2
LEN).  GA
2
LEN aims to 
increase understanding of the complex interaction between timing of exposures, 
environment and genetics (273).   
2.8.3.8 Drinking water  
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Another factor which may be protective against the development of atopic conditions 
in childhood is a high microbial content in drinking water.  There has been little 
investigation in this area.  In Karelia, two samples of school children (Russian and 
Finnish) were examined (n=563) (274).  The inhabitants of Russian Karelia obtain 
their water from Lake Ladoga, while those from Finnish Karelia acquire theirs from 
Municipal water plants. Samples of drinking water were obtained from schools and 
examined for microbial content.  Skin prick positivity tests for 14 common airborne 
and food allergens were measured.  They found that high content of micro-organisms 
in drinking water was dose-dependently inversely associated with atopy in 
schoolchildren, following adjustment for other determinants.  These findings were 
concordant with those from two earlier studies in the Tropics (275, 276).  Rural 
water is greatly affected by the microbial content of the surrounding soil (277) 
provided it is not heavily treated.  The hypothesis is that, with minimal water 
treatment, micro-organisms present in the lake from surrounding soil, will gain 
access to the gut via drinking water and may have significant immunomodulatory 
potential. Private supply may be less chemically treated than that of the public water 
supply.  As the investigation into the protective element of farming continues, it 
seems reasonable to explore the possibility that there may be an inverse relationship 
between drinking water in farms and the development of asthma and atopic 
conditions. 
2.8.3.9 Indoor exposures 
Many studies have examined the effects of indoor exposures on the development of 
childhood asthma and allergy.  Some of the factors investigated include, household 
furry pets and increased household heating causing exposure to humidity and mould 
(278). 
 Pet dander  
The association between childhood allergic disorders and home exposure to furry 
pets (cats and dogs dander) has been examined repeatedly over the years.  
Traditionally, high risk families were advised to avoid exposing their children to cats 
and dogs as empirical evidence, at the time, suggested that pet exposure was a risk 
factor for allergy development (279).  However, more recent systematic reviews and 
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meta-analyses demonstrate that the evidence regarding whether pet exposure is a risk 
factor or if it conveys protection against allergy development is inconclusive.  In 
2008 a meta-analysis of 30 birth cohort studies revealed that most studies found no 
effect of early dog/cat exposure on asthma development (280).  They also performed 
a meta-analysis of 47 cross-sectional studies and found inconsistent results.   
 
A 2012 systematic review of 8 birth cohort studies also found contradictory evidence 
(281).  One study found no association.  Six studies found perinatal exposure to dogs 
or cats conveyed protection.  Two studies found that perinatal exposure increased the 
risk of allergy in predisposed children.  This positive association may be confounded 
by pet-keeping choices in high risk families (281).  Furthermore, the reviewers noted 
that different studies examined children at different age groups and used varying 
levels of analysis, impeding the ability to draw conclusions.   Pet exposure can cause 
increased symptoms in sensitised children (282).  However, allergen avoidance 
studies have not focussed on assessing the effect of pet avoidance on allergy 
development, therefore its beneficial effect cannot be assured (278).  Overall, 
recommendations of animal avoidance are not supported by current evidence (281).  
Mould and dampness 
Cross-sectional studies over recent years, have repeatedly found a positive 
association between parentally reported mould and dampness in children’s homes 
and childhood allergy (283).  A recent meta-analysis of eight birth cohort studies (0-
10 years) by The Environmental Health Risks in European Birth Cohorts 
(ENRIECO) collaboration also revealed that early exposure to visible mould and/or 
dampness was associated with an increased risk of developing asthma by early 
childhood and allergic rhinitis by school age (284). 
 
Although a consistent positive association has been found, the causal agents have not 
been identified.  Some fungi have been implicated in immune system activation 
(285) and sensitisation (286).   For example, some studies have reported a positive 
association between exposure to Penicillium spores and respiratory 
infections/wheeze in the first year of life (287, 288).  The ENRIECO birth cohorts 
did not assess the fungal components in the air of children’s homes.  The authors 
suggest that future studies might employ highly sensitive and specific molecular 
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methods and measurements of airborne enzyme activity in order to assist in the 
identification of causal agents (284). 
Endotoxin/microbial exposures 
The protective association against allergic disease from early exposure to a high 
microbial environment is the central tenet of the hygiene hypothesis (17).  A recent 
meta-analysis of 19 cross-sectional studies/reviews demonstrated that endotoxin 
exposure was positively associated with early childhood wheeze (infants and 
toddlers) and protective against asthma development in older children (289).  A 
review of the PARSIFAL and GABRIELA studies also found a protective effect 
against the development of childhood asthma from early exposure to a wide diversity 
of microbes in mattresses and bedrooms of children from rural environments (266).   
2.8.3.1 Where does the hygiene hypothesis currently stand 
Since first proposed in 1989, the hygiene hypothesis has been responsible for 
initiating a huge amount of associated experimental, epidemiological and clinical 
research.  As a consequence of this research, the world has gained an enormous body 
of evidence which has led to increased understanding of the pathophysiology of 
asthma and allergy (21).  Previous approaches to understanding of the hygiene 
hypothesis centred on immunological mechanisms of allergy, with an emphasis on 
the Th1-Th2 paradigm.  Current evidence promotes a newly developed version of the 
hygiene hypothesis, one which embraces the notion that allergy development is not 
only mediated by microbial stimuli, but also by gene-environment interactions, gene-
gene interactions and predisposition to atopy (21, 22).   
Socio-economic influence 
The hygiene hypothesis is supported by a large body of evidence (22).  On the other 
hand, the high prevalence of asthma and allergy in inner city children from African 
American and Hispanic communities in America, living in conditions of extreme 
poverty, with high microbial content, is contradictory to the hypothesis (21).  The 
exposures of risk in these populations include cockroach, rodent urine/faeces, 
tobacco smoke, damp, mould and living in conditions of dirt and poverty (290, 291).  
However, the poverty and deprivation, combined with high smoking prevalence and 
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other exposures of risk in inner city populations do not compare with the relatively 
mild on-going oro-faecal and food borne infection exposures which have been 
demonstrated to convey protection, and support the hygiene hypothesis (21).  
Matricardi asserts that it is the concomitant chronic exposure to secondary risk 
factors such as overcrowding, dampness, smoking and poor access to health care, 
that are the most likely contributors to the high prevalence of allergic disease in this 
inner city population (21). 
 
2.9 CONTRIBUTIONS OF THIS THESIS TO THE LITERATURE 
This thesis aims to provide the trends of prevalence of childhood asthma, allergic 
rhinitis and eczema for the first time in young children (from Cork city and suburbs, 
aged 6-9 years), using the validated ISAAC methodology and protocol (Study 1).   
This Thesis will also provide comparisons of environmental exposures in both rural 
and urban environments for the first time in the Irish context and examine the effects 
of exposures in both environments (study 2).  This is particularly relevant, as 
prevalence of childhood allergic conditions and associated exposures vary between 
populations and environments (7, 130), and farming remains a significant exposure 
in the Cork region (51).  The Sturley study contained a sample of primarily urban 
and suburban children.  By extending the study to include rural children; this study 
aims to be more reflective of children from both milieus.  It also aims to perform a 
follow-on study; examining children aged 6-9 during the 2002 study who had 
reached early adolescence (age 11-13) in the 2007 study (Study 3).  This aspect of 
the thesis aims to portray the natural history of allergic disease in this population.   
Finally it will provide a continuation of prevalence trends in Irish adolescents (Study 
4).  
  
 
3 Chapter 3 Materials and Methods 
 
 
 
 
 
 
 
 
Chapter 3                                                  
Materials and Methods
  
Chapter 3.   Materials and Methods Page 68 
 
3.1 INTRODUCTION 
This chapter outlines the materials and methods used in The Study of Asthma and 
Allergy in Cork.  It contains an overview of the study design and methodology of the 
4 individual study components in the thesis.  As the ISAAC protocol is used, the 
background to ISAAC is described.  The use of a cross-sectional study design is 
critiqued.  The data analysis specific to each component of the thesis is individually 
outlined. 
3.2 STUDY DESIGN AND PARTICIPANTS 
The Study of Asthma and Allergy in Cork is an epidemiological quantitative study 
examining the trends of prevalence of asthma, allergic rhinitis and eczema and 
associated risk or protective factors in Cork schoolchildren, using the ISAAC 
questionnaire and standardised study protocol.  The ISAAC questionnaire used, was 
the parentally completed version for 6-7 year old children.   
 
The Study of Asthma and Allergy in Cork comprises of four individual studies 
(studies 1 - 4), of which two examine children aged 6-9 years, and two which 
examine adolescents aged 11-13 years. The overall study design is cross-sectional; 
however, a quasi-retrospective cohort study design is employed for Study 3.  The 
population and studies are presented in the study schematic in Figure 3.1.   
 
Study 1 is a repeat cross-sectional study of the Sturley (2002) study of children (aged 
6-9), from the same 24 urban/suburban schools.  It aims to examine the trends of 
prevalence of childhood allergic diseases in this population from 2002 to 2007.  
Sturley examined 1474 children aged 6-9 years from 24 randomly selected schools, 
using the ISAAC core questionnaire and methodology.  This study examined 
children aged 6-9, from the same 24 schools, 5 years later.  The time trend analysis 
cross-sectional studies were carried out in the same season and used identical 
methodologies, thus allowing for direct comparison.  In trends studies, for reliability 
and comparability, it is imperative that identical tools and methodology are used.  In 
ISAAC high methodological standards with standardised protocols were maintained 
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in each Phase (8, 292, 293).  This trends study used the ISAAC protocol, maintained 
the same high standards, and used identical methodology to ensure comparability.   
The inclusion criteria for the 2007 study were: 
 Children aged 6-9 from 1st and 2nd class (years 3 and 4 in primary school) 
 Children from the same 24 urban/suburban schools as Sturley (2002) 
 
Study 2 is a cross-sectional study which aims to examine the factors associated with 
the development of childhood allergic disease in 3464 schoolchildren aged 6-9 years 
from Cork city and county.  Parents were asked to complete questionnaires 
containing the core ISAAC questions with additional questions enquiring about 
putative risk and protective factors associated with the development of childhood 
allergic disease.  The specific focus of enquiry was to examine the effect of rural 
versus urban exposures on allergy development in this population.  The study 
population included 1416 students from urban schools and 2048 students from rural 
schools to allow for environmental comparisons.    
Inclusion criteria 
 Children aged 6-9 
 Children from rural and urban schools in Cork City and county 
 
Study 3 aims to examine the natural history of childhood allergic diseases in a cohort 
of children from the ages of 6-9 until 11-13 years.  In 2002, Sturley performed a 
cross-sectional study in Cork schoolchildren aged 6-9 years from 24 randomly 
selected state-funded schools in Cork city and suburbs.  This study was repeated five 
years later (Duggan, 2007), in the same season and within the same population of 
children.   The 2007 study re-examined children from the 3
rd
 year of primary school, 
(aged 6-9 during the 2002 study), again when they were in the final (8
th
) year of 
primary school (aged 11-13).  As the 2002 study (n=1474) surveyed children from 
both years 3 and 4, the 2007 study-eligible population consisted of approximately 
half the population (n=706) from the original study.  Parents were asked to complete 
identical ISAAC-based questionnaires at ages 6-9 and 11-13.  This study availed of 
the unique opportunity to re-examine children from within the same cohort.  The 
data was not individually-linked, as the dataset from 2002 was unavailable (due to 
circumstances outside the researcher’s control).  However, according to school 
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management, there is only a 5% variance in the drop-in/out rate of children in this 
period of school life.   
Inclusion criteria for the 2007 study: 
 Children aged 11-13 (year 8 of primary school) who were aged 6-9 when 
examined by Sturley (year 3-4 of primary school) in 2002 
 
Study 4 is a cross-sectional study which compares the prevalence of parentally-
reported childhood allergic diseases in cork adolescents (n=706, aged 11-13) with 
the published self-reported prevalence data from the Irish Phase 3 ISAAC study 
population (Manning et al., 2003, age 13-14, n=3089).  It aims to examine the trends 
of prevalence of childhood allergic diseases in Irish adolescents.   
 
Inclusion criteria for the 2007 study 
 Children aged 11-13 (year 8 of primary school) 
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Figure 3.1   Schematic of the study components in the study 
Csoss-sectional study 
Duggan, 2007 
N= 4170 
Children age 6-9 
N = 3464 
From 24 urban/suburban schools 
 and   
86 rural schools 
Study 1: Cross-sectional study 
 Trends of prevalence  (age 6-9, same 24 urban schools) 
 
Duggan, 2007 (n=1535) 
vs. 
Sturley, 2002 (n=1474) 
Study 2: Cross-sectional study 
 
Associations with childhood allergic disorders in rural and 
urban environments (age 6-9 ) 
 
Duggan 2007 (n=3464) 
Age 11-13 
N =706 Study 4: Cross-sectional study 
 
Trends of prevalence in Irish adolescents  
Duggan , 2007 (age 11-13, n=706) 
vs. 
Manning, 2003 (ISAAC, Phase 3, age 13-14, n=3089)  
Study 3:  Quasi-retrospective cohort study 
Natural history of childhood allergic  disease 
 
Duggan, 2007 (age 11-13, n=706) 
and 
Sturley, 2002 (age 6-9, n=1474) 
Components of the Study of Asthma and Allergy in Cork 
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3.2.1 Research protocol 
As mentioned previously, the questionnaire and protocol developed and validated by 
the  ISAAC collaboration were used in the Study of Asthma and Allergy in Cork 
(10).  This study used the ISAAC standardised methodology and documentation and 
employed a cross-sectional study design using the protocol from ISAAC Phase I and 
III.   
3.2.1.1 The International Study of Asthma and Allergies in Children (ISAAC) 
The ISAAC initiative stemmed from two multinational collaborative projects from 
New Zealand and Germany in 1990 (8).  In the 1980s and 1990s many studies, using 
different methodologies, highlighted a rising prevalence in childhood asthma and 
allergic disorders (294).  The apparently rising problem of asthma and allergy 
combined with the deficit of a standardised tool and methodology to measure their 
prevalence, raised concern regarding the inability to examine the true scale of the 
problem and compare results.  To investigate worldwide prevalence results of 
childhood asthma and atopy in a standardised fashion, the International Study of 
Asthma and Allergies in Childhood (ISAAC) was set up and a standardised 
questionnaire developed and validated (8).  Strict standardised protocols were 
devised and adhered to in all study centres in order to ensure comparability.   
ISAAC Phase 1 
The worldwide ISAAC Phase 1 involved 700 000 children, aged 6-7 and 13-14 
years, from 156 centres in 56 countries (7).   The aims of ISAAC Phase 1 were to 
examine the prevalence and severity of asthma in children in order to obtain a global 
map and make international comparisons, to obtain baseline measurements for future 
trend analysis and to provide a framework for aetiological research into lifestyle, 
environmental, genetic and medical contributing or modifying factors.    
ISAAC phase 2 
ISAAC Phase 2 examined 30,000 children aged 9-11 years and involved 36 centres 
in 22 countries (292).  It aimed to assess differences of prevalence, severity and bio-
markers of asthma and allergy in different centres in the world, to examine assumed 
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determinants in relation to prevalence and severity and make worldwide 
comparisons.  They also aimed to look at genotypes in relation to phenotypes, 
focusing on gene interactions with environmental exposures (292).  This 
comprehensive study looked at children from “informative” geographical areas, they 
were areas of previously low or high prevalence in ISAAC Phase 1 or interesting 
exposure or living conditions such as Ecuador, Iceland and West Bank.  They used 
the ISAAC Phase 1 questionnaire for parents of 6-7 year olds.  They also used skin 
prick tests and measured serum IgE and DNA for genotyping.  Standardised 
bronchial challenges and physical examinations for flexural eczema were carried out.  
Homes were examined for levels of dust mite for endotoxins and aeroallergens 
(292).  
ISAAC Phase 3 
ISAAC Phase 3 examined data obtained from 498,083 children. In the 13- to 14-yr 
age group 106 centres in 56 countries participated, and in the 6- to 7-yr age group 66 
centres in 37 countries participated.  It was a repeat of ISAAC Phase 1 and used 
identical methodology, but added an optional new environmental element 
questionnaire.  It aimed to examine the direction and magnitude of trends of 
prevalence of asthma and allergy, to extend the analysis to previously unexamined 
geographical areas and to further examine hypotheses raised from ISAAC Phase 1 
and any new hypothesis generated in the interim between the two studies, both at an 
individual and ecological level (293, 295).  The protocol recommended that data 
collection was to take place in the same time of year as the Phase 1.  The time period 
between Phases 1 and 3 was specified to be a minimum of 5 years.  This was deemed 
an appropriate interval to detect any alterations in prevalence that may have occurred 
(295). 
ISAAC Phase 4 
ISAAC Phase 4 is currently underway and will remain on-going.  Its focus is 
towards the development and expansion of the ISAAC website in which it aims to 
create an in-depth database of resources such as manuals for diagnosis of asthma and 
allergy, links to current related research and symposiums (9).  It is hoped that the 
resource section will be of great benefit to ISAAC collaborators, especially those 
from low and middle income countries.   
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Potential sources of bias in ISAAC 
The use of a standardised questionnaire and protocol in ISAAC aims to ensure 
comparability between studies and to minimise the introduction of bias. The 
protocols address in detail, the selection of participants, the measurement of 
variables, and management of several eventualities in data collection, in order to 
prevent potential selection or measurement bias and confounding (10, 295).  Overall 
good rates of compliance to the protocol guidelines were apparent in centres 
throughout the world (296).   
 
Although standardised protocols and questionnaires were developed, they do not 
guarantee precision or the absence of bias in results.  Non-response is a potential 
point of entry for bias.  This was investigated for asthma (as asthma is a major cause 
of school absenteeism), in Phase 3 and found not to be a source of bias to the results 
(297).  To reduce the risk of symptom related bias, ISAAC enquired about symptoms 
suffered in the previous year.  There is however, a strong possibility of recall bias in 
the ISAAC questionnaire, as parents are requested to provide information with 
regard to exposures which occurred several years earlier.  Another potential source 
of entry for bias occurs in the translation of the ISAAC questionnaire into different 
languages and its use in different cultures.  Disease labels differ between languages 
and don’t even exist in some languages (298).  ISAAC found that the translation 
caused a negative or positive influence for one or more questions in 7 out of 49 
translations (298). They removed the results of these questions from the worldwide 
comparisons.   
3.2.2 Cross-sectional studies 
This thesis employs a cross-sectional study design. Cross-sectional studies are 
valuable epidemiological research tools. Being descriptive in nature, they offer a 
“snapshot” in time, where disease and exposure are measured concurrently. They are 
an efficient, economical means to examine disease prevalence and fixed 
characteristics of individuals, such as socio-demographic data, and compare them 
against exposures and health-related habits, thereby facilitating health care needs 
assessments (299).  Cross-sectional studies also are beneficial for the measurement 
  
Chapter 3.   Materials and Methods Page 75 
 
of prevalence trends, which health care providers depend upon for management and 
planning resources (300).  
 
Cross-sectional studies also have their limitations.  They are also prone to recall 
error.  As with ISAAC, this study aimed to combat this by confining the period 
prevalence of asthma and allergy symptoms to one year, however, it may be said that 
some of the questions regarding early childhood experiences may be subject to this 
limitation, as they enquire about exposures from several years prior to the study.   
 
Cross-sectional studies do not have the ability to determine cause and effect 
relationships.  As they examine only one moment in time, it is not be possible to 
distinguish the temporal relationship of exposure and disease, i.e. whether the 
exposure preceded or followed the disease.  Therefore we can only assume an 
association between factors of interest and disease (301).  However, criteria which 
were described in 1965 by Sir Austin Bradford-Hill, are still used today to assist 
researchers in assessing whether a finding is likely to be causal or a chance 
association (302).  Taken in isolation, none of the criteria have the ability to 
indisputably determine cause and effect, but together they can assist the researcher in 
their judgement.   
  
1. Strength of association – is there a high relative risk or odds ratio for the 
association? 
2. Consistency – has the result been repeatedly found in other studies? 
3. Specificity – is the association specific to individual populations who are 
exposed to particular environments? 
4. Temporal relationship – does the cause precede the disease? 
5. Biological gradient – does a dose-response relationship exist? 
6. Plausibility – is the association biologically plausible? 
7. Coherence – Is the association in line with previous knowledge of the natural 
history and biology of the disease? 
8. Experiment – is the condition or disease ameliorated/prevented by removing 
the cause in experimental studies? 
9. Analogy – have alternative explanations been taken into consideration? 
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Cross-sectional studies are invaluable tools for large epidemiological studies which 
are vital to investigate the complex interaction between genes and environmental 
exposures in the development of asthma and allergy.  It is from epidemiological 
studies that hypotheses are raised regarding pathogenesis and causality from which 
further research findings may increase our understanding of these heterogonous 
diseases (300, 303, 304).   
3.2.3 Research instrument  
Although the studies were not part of ISAAC, the core questions from ISAAC and 
its methodology were used.  ISAAC support the use of their research tool as long as 
it is acknowledged (305).  As with ISAAC, the main outcome measures used  to 
assess prevalence of asthma, rhinitis and eczema, were the 12 month prevalence of 
symptoms of asthma (wheeze), allergic rhinitis (rhinitis - nasal problems in the 
absence of a cold or flu and rhino-conjunctivitis - associated with itchy eye) and 
eczema (persistent rash in flexural areas).  The questionnaire comprised of the 
validated core questions from the ISAAC questionnaire as well as additional 
questions developed by the research team to examine other possible environmental 
influences/modifying factors related to childhood allergy disease development 
(Appendix 6).  The integrity of the core questions was maintained and, as ISAAC 
recommended, the core questions preceded the questions pertaining to environmental 
exposures (295).  Timelines of exposures to potential determinants of asthma and 
allergy were prenatal, perinatal, postnatal, 1st year of life and current.  Data 
obtained, related to age, sex, birth weight, mode of delivery, breastfeeding, parental 
and child nationality and education, family size, birth order, immunisation, childcare, 
antibiotic use in the first 2 years of life, infections in the first 3 years of life, exercise, 
exposures to indoor swimming pools, pre natal, first year of life and current 
exposures to urban or rural living, unpasteurised milk consumption, pets, farm 
animals, environmental tobacco smoke, source of drinking water (Table 3.1).  
3.2.4 Pilot study  
A pilot study was performed and any necessary amendments were made to the 
questionnaire.  Questionnaires were given to work colleagues (including 2 experts in 
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the field of Immunology and Epidemiology) and friends who reflected the target 
population (parents of young children n=15).  Some formatting issues were 
highlighted and corrected, for example, making the sections more defined by 
introducing clear headings and correcting aesthetic elements.   Naturally, the core 
ISAAC questions remained in situ.  Any questions investigating exposures, or socio-
demographic data which were deemed to be ambiguous were more clearly defined.  
Subsequently, the questionnaire was redistributed to the group in the original pilot 
study and reviewed again to ensure clarifications were efficacious.   
3.3 STUDY LOGISTICS  
To facilitate expediency, as the study was large, the questionnaire was uploaded on 
to a computer containing the scanning software, Teleform
®
 (306) at design stage.   
The questionnaire was designed to a suitable format on an optical scanning field and 
uploaded to the computer.  Each questionnaire required printing (with clear 
instructions regarding the importance of due care and attention), as photocopying 
does not preserve the exact integrity required for electronic reading when inputting 
the data.   
3.3.1 School selection 
As with ISAAC, the children were sampled through schools.  State schools are the 
predominant providers of primary school education in Ireland, therefore, are 
representative of all socio-economic groups nationally.  A list of schools and all 
information regarding each school was attained from the Department of Education 
and Science website (307).  In total, The Study of Asthma and Allergy in Cork 
examined children from 110 schools, 24 of which were urban/suburban and 86 of 
which were in rural locations.  Figure 3.2 depicts the geographical location of the 
Cork City and County schools, in which the study was performed.   
School selection was achieved in two ways:   
a) In 2002, the Sturley study had randomly selected 24 schools out of a possible 
62 schools in Cork city and suburbs.  In 2007, the schools from the Sturley 
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prevalence study (2002) were again approached to repeat the 2002 study, to 
enable comparisons to be drawn.   
b) As the Sturley study examined children from urban and suburban 
environments, the 2007 study extended the number of schools examined to 
include a rural component.  From the 18 main towns in Cork, 7 were 
randomly selected, by pulling the names of towns to be included in the study, 
from a hat.  All schools from the selected towns and throughout the town 
hinterlands were invited to participate in the study.  In total 89 rural schools 
were approached, 3 of which declined involvement (reason cited was because 
of preparation for Communion), leaving 86 who took part in the study.  
 
Cluster randomisation of schools is considered the most feasible manner of 
recruitment of children for epidemiological studies (308) and was also employed by 
ISAAC.  Simple randomisation of schools for inclusion in this study, from the 
county list would have been the optimum selection method, as it reduces the risk of 
selection bias (308).  However, the random selection of towns and inviting 
participation from all schools within the towns and hinterlands was considered to be 
the most feasible because, due to limited financial resources, the researcher 
performed all the data collection and funded the travel costs.  Furthermore, it was 
envisaged that this method would minimise the risk of selection bias, as researchers 
were not individually involved in selecting or eliminating any particular school. 
 
  
Figure 3.2   Location of schools in the study  
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3.3.2 Sample size  
In total, The Study of Asthma and Allergy in Cork examined data from parents of 
4170 school children (6-9 years, n=3464 and 11-13 years, n=706) who were 
recruited from 110 randomly selected state primary schools from urban, suburban 
and rural environments throughout Cork City and County.   A large sample size is 
necessary in order to provide study power, reduce standard error of an estimate and 
guarantee precision (301).  As severe symptoms are less common, a larger sample 
size is necessary to detect relative differences in severity (10).  ISAAC chose a 
sample size of 3000 children in each centre, as it gave 99% power to detect 
differences between different centres, at 1% level of significance (where prevalence 
of wheezing is 25% in one centre and 30% in another) and 90% power at the 1% 
level of significance for the severity of wheezing (where prevalence is 3% in one 
centre and 5% in another) (10).  The core element of this study examined 3464 
children aged 6-9 years; therefore it had sufficient power to obtain precise estimates 
of both mild and severe prevalence and to identify associations.   
3.3.3 Data collection  
The groundwork for the study was set in place in March 2007.  Data collection 
closely followed the ISAAC protocol in most ways, except that the names of 
children were not requested.  As recommended by ISAAC, regular research team 
meetings were held throughout the process of planning and data collection.  The data 
was collected during the final primary school term from Easter to summer (April to 
June inclusive). This is in accordance with the recommendations of ISAAC, that at 
least half of the study population be investigated prior to the commencement of the 
main pollen season (8).  For manageability, the contact with the schools was made in 
a relay fashion of approximately 10 schools per week.  The step by step procedure 
for data collection was standardised and closely aligned to the ISAAC protocol.  The 
steps were as follows: 
1.  Each school principal was contacted initially by letter and then by telephone 
within the following week, their participation was discussed, and a suitable 
date for a visit was made. 
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2. To promote optimal response rates, teachers/principals and children were 
spoken with personally, wherever possible.  Some requested an information 
session prior to commencement of the study, which was facilitated. 
3. Questionnaires and personally hand-signed cover letters were placed in a 
sealable envelope (sticker on the outside of envelope with the researcher’s 
details and date for return). 
4. Teachers were requested to hand out the questionnaires and cover letters as 
the children were leaving the school, so that they would be fresh in the minds 
of the children, and increase the chances of their parents receiving them.   
5. Questionnaires for any absent children were left with the class teacher. 
6. A date was agreed (usually one week from distribution) for return of the 
questionnaires.   
7. A reminder phone call was made to the school the day before collection.   
8. Any questionnaires returned to the school after the  collection date were 
forwarded to the University by the principals/teachers, as stamped addressed 
envelopes were left in the school to cover this eventuality (ISAAC 
recommendation).   
9. Detailed documentation in the form of field book records was maintained 
throughout the data collection process.  
10. A thank you letter was sent to all schools at the beginning of the next term. 
11. A preliminary report of study findings was sent to each school after 1 year. 
3.3.4 Data management  
As in ISAAC, sealable envelopes were provided for the return of completed 
questionnaires to the class teachers, which were collected one week after 
distribution.  Questionnaires were processed, i.e. removed from envelopes, counted 
and stored in boxes denoting only the names of the schools.  The questionnaires were 
stored securely, with access only available to the research team.  Computer records 
were maintained on password protected computer files in a locked office.  No 
individual pupil is identifiable in any way. 
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3.3.5 Data entry 
All questionnaires were visually checked, prior to being scanned using the Bowe Bell 
& Howell SideKick 1200 scanner, which imported the data into an Excel CMV file.  
The scanner is an invaluable tool which allows large quantities of data to be scanned 
and entered electronically onto a database.  On the other hand, scanners are also 
known to have very high error rates (309), therefore extreme accuracy in the 
preparation and handling of questionnaires is required.  The questionnaire was 
prepared in a precise digital format on the computer using TeleForm
 ® 
(306). As the 
questionnaires were scanned, each scanned entry was contemporaneously visible on 
the computer monitor using the Teleform
®
 verifier and any necessary corrections 
from scanning errors were made.  Each entry was manually checked for export errors 
against the original questionnaire and any necessary corrections were made.   
 
Each electronic entry in Excel was rechecked for export integrity.   There were many 
technical issues with the export of data.  Initially, data for participants was entered as 
that of others.  A consultant company for Teleform
®
 called “Inpute” were contacted.  
Following 2-3 days of consultation on the telephone with “Inpute” (the software 
company licensed for Teleform
®
 in Ireland (306)), alterations were made to the 
design format to correct the fault.  Scanning progressed, although the excel files 
required vigilant checking as there were many entries that did not export correctly 
and were not picked up by the Teleform
®
 verifier.  This took on average 5 minutes 
per questionnaire.  After satisfactory review for export integrity, the database was 
exported to SPSS and data cleaning began.   
3.3.6 Data inspection and cleaning 
As the questionnaire was uploaded onto the Teleform
®
 in a comma delimited format, 
it scanned and exported also in this format which resulted in many variables being 
joined together in one field.  Therefore it was necessary to separate out many 
variables into binary format for analysis.  Syntax were developed for each variable to 
achieve this task.  The variables in question included height, weight, duration of 
breastfeeding, exclusive breastfeeding, date of birth, age at crèche, age at preschool, 
distance to factory, paternal atopic disorders, maternal atopic disorders, exposures to 
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farm animals during different time points and continuous data on nasal problems 
during each month of the year and antibiotic consumption.  The data was visually 
inspected for any inconsistency errors such as the age not matching the date of birth 
and females in male schools.  Range checks for ages, heights, weights were 
performed using descriptive analysis.  “Skip question” checks were performed and 
syntax were developed to counteract the issue of respondents who answered “No” to 
the questions relating to ever having suffered wheezing, nasal problem or rash and 
subsequently ignoring the “skip instructions” by responding to current symptoms 
and symptom severity.  
3.3.6.1 Coding and condensing variables 
The data was coded and labelled in SPSS.  Variables were condensed into 
meaningful codes numerically, dogs and cats into furry animals, in water supply, 
well and spring were combined, and carpets/rugs were combined.  Maternal 
Education was condensed to Junior Certificate, Leaving Certificate and Third Level.  
In large families, if the child had more than 5 siblings they were recoded as >5.  
Regarding swimming, numerically very few parents reported that their child swam 
every day, or 4-6 days a week, therefore, they were recoded into weekly and 
monthly.  To build models for logistic regression and adjust for child atopy, the other 
two atopic disorders not being examined as the dependant variable were grouped 
together by developing and running an appropriate syntax.   
3.4 ETHICS AND CONFIDENTIALITY 
Ethical approval was sought and granted from the Clinical Research Ethics 
Committee of the Cork Teaching Hospitals.  Cover letters were attached to the 
questionnaires to inform parents regarding the details of the study.  Consent was 
implied by return of the questionnaire. To promote confidentiality, sealable 
envelopes were provided for the return of completed questionnaires to the class 
teachers.   Data was collected anonymously.  No pupil is identifiable.   
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3.5 DATA ANALYSIS 
3.5.1 Study 1 – Trends of prevalence in 6-9 year old children 
The main outcome measures to assess the prevalence of asthma, allergic rhinitis and 
eczema were identical in both studies (ISAAC outcome measures).  Prevalence rates 
of childhood allergic disease in 2002 and 2007 were compared based on the 95% 
Confidence Intervals for the difference, calculated using Normal approximation to 
the Binomial distribution (310, 311). Alterations in the male:female ratio of allergic 
symptoms from 2002 to 2007 were assessed  using logistic regression models 
containing the main effects of sex and study and the interaction between the sex and 
study.   
3.5.2 Study 2 – Associations with childhood allergic disorders 
Associations between the putative risk/protective factors and the prevalence of 
childhood allergic disorders were examined univariately using chi-square tests and 
multivariately, using multiple logistic regression analysis.  To explore the effect of 
age, prevalence tables were developed symptoms of each condition, as no effect was 
apparent between age groups, age was not adjusted for in the logistic regression 
analysis.   
3.5.2.1 Univariate analysis  
The enquiry commenced with classification of linked putative factors into groups.   
The classifications defined were Genetic, Parental childhood/Prenatal/Perinatal, 
Socio-economic, Medical and Environmental exposures (Table 3.1).  Cross-
tabulations and chi-square tests were performed to look for associations between all 
variables under investigation and the dependant variables.  The dependent variables 
under examination in this study were the ISAAC outcome measures of the symptoms 
associated with asthma (wheeze ever, wheeze in the past 12 months and asthma 
ever), allergic rhinitis, (nasal problems ever, nasal problems in the past 12 months, 
nasal problems with associated ocular involvement and hayfever ever) and eczema 
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(persistent rash ever, persistent rash in the past 12 months, eczema ever).  
Significant variables (p≤0.25) were assessed for progression to multivariate analysis.   
 
Table 3.1   Categorised putative protective or risk factors  
 
 
3.5.2.2 Multivariate analysis – Logistic regression analysis  
To further explore significant associations found in univariate analysis (p≤0.25) and 
to adjust for confounding variables, multivariate logistic regression analysis was 
performed.  Multiple regression models are recommended when an outcome is 
predicted by several variables (301).  The logistic regression analysis was divided 
into several steps. Analysis at each stage of the process was performed using manual 
stepwise.  The genetic variables of parental atopy, child atopy and gender and the 
socio-economic variables of maternal education and place in the family are well 
 
 
Genetic Socio-
economic 
Parental 
Childhood & 
Pre/perinatal 
 
Medical 
Child 
Environment 
(Year 1/Current) 
Maternal/Paternal atopy ●     
Gender ●     
Birth weight   ●   
Gestation   ●   
Mode of birth   ●   
Twin   ●   
Infections <3 years    ●  
Antibiotics <2 years    ●  
Immunisations    ●  
Place in Family  ●    
Breastfeeding   ●   
Day-care attendance     ● 
Tobacco smoke   ●  ● 
Damp bedroom     ● 
Location of child’s home     ● 
Carpet     ● 
Furry animals    ●  ● 
Farm animals    ●  ● 
Drinking water     ● 
Rural/urban environment   ●  ● 
Stable   ●   
Barn   ●   
Unpasteurised milk   ●  ● 
Swimming pools     ● 
Child Atopy ●     
Maternal education  ●    
School     ● 
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established potentially confounding variables and were therefore adjusted for, in 
multivariate analysis.  Any potential cluster effect was addressed by also adjusting 
for “school” in multivariate analysis.  The schematic for the logistic regression 
pathway is presented in Figure 3.3.  The management of the three categories of 
variables under investigation are as follows:  
 
For the Medical category, we considered three multiple logistic regressions 
involving, infections prior to 3 years old, immunisations and antibiotics consumed 
prior to 2 years old respectively.  Factors emerging as significant (p≤0.25) were 
entered into a final multiple logistic regression model for this category. 
 
To examine associations in the Parental childhood, pre/perinatal category, we 
considered three logistic regressions, involving exposures during parental childhood, 
during pregnancy with the child in the study and perinatal period respectively. As in 
the medical category, factors emerging as significant (p≤0.25) were entered into a 
final multiple logistic regression model for this category. The results of the final 
multiple logistic regression models are presented as p-values, odds ratios (OR) and 
95% Confidence Intervals (CI).  Nagelkerke R
2 
is presented as a measure of model 
fit, where R
2 
= 1 is the optimum model fit (312).   
 
According to Field, it is critical to test for multicolinearity following a logistic 
regression analysis (313).  Multicolinearity pertains to a situation where there is 
strong correlation between two or more predictor variables, in which case it is 
difficult to distinguish which predictor variable which is driving the association.  
Based on the variance inflation factor (VIF), colinearity diagnostics for the terms 
included in the final model, revealed that multi-colinearity between predictor 
variables was not a problem (VIF <10).  
3.5.2.3 Missing values 
Missing data can be a major problem in multivariate models, as all subjects with 
missing data in any of the variables in a given model are excluded.  Crosstabs 
between variables under examination and the main outcome measures revealed the 
amount of missing data for the dependent variables.  For the most part, the variables 
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in the questionnaire had minimal (0.2% - 0.5%) missing data.  For the variables 
pertaining to early childhood infections and immunisations 6-9% of data was 
missing.  Crosstabs revealed no significant difference in the presence or absence of 
allergic symptom prevalence between those with and without missing data.  For the 
results, the subjects with missing values are excluded.  The use of a separate variable 
to model missing data is not recommended, as it fails to fully adjust for relevant 
variables and also it frequently results in biased estimates of the regression 
coefficients (314).   
 
Missing values were an issue for the variable “exclusive breastfeeding”.  Of those 
who reported breastfeeding, 33% (n=513 cases) did not indicate whether or not they 
had exclusively breastfed.  Therefore, exclusive breastfeeding was excluded from 
progression to the final model.   
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Figure 3.3  Schematic of logistic regression pathway 
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3.5.3 Study 3 – The natural history of childhood allergic diseases  
Prevalence of childhood allergic diseases used ISAAC main outcome measures.  
Regarding analysis of the quasi-cohort study, two problems emerged.  Firstly, the 
data were not individually linked. Therefore it was not possible to consider a 
repeated measures analysis which would allow for the correlation between repeated 
measurements on the same child.  Secondly, there was little overlap between ages in 
the two time periods making it difficult to separate age and period effects.  As a 
result, p-values are not reported; instead, estimates and 95% CI for the prevalence of 
allergic symptoms in the two time periods are presented.  Differences in prevalence 
of allergic symptoms are described and not analysed.  However, if confidence 
intervals do not overlap, the difference in prevalence in both timeframes is 
statistically significant (315).   
3.5.4 Study 4 – Trends of prevalence in Irish adolescents 
When comparing symptom prevalence between the older children in this study and 
ISAAC Phase Three, there is a problem because the age groups differ (11-13 in this 
study versus 13-14 in ISAAC).  Therefore, to report p-values would be inappropriate 
and trend results are presented as estimated prevalence and 95% confidence 
intervals.  Furthermore, in the 2007 study, the data was attained by parentally 
completed questionnaires, whereas, the ISAAC population of 13-14 year old 
adolescents completed their own questionnaires.  Comparison of parentally versus 
adolescent completed questionnaires has, on the whole, found that adolescents report 
higher prevalence of current and lifetime allergy than their parents (316, 317).  This 
fact was taken into consideration when interpreting the difference in prevalence 
between the two groups of adolescents in this study. 
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4.1 INTRODUCTION 
Chapter 4 presents the research results of the thesis.  It will commence with the 
socio-demographic and descriptive data for all the children and parents who 
participated in the research studies.  Subsequently, the results of the four studies will 
be presented individually.   
4.2 SOCIO-DEMOGRAPHIC AND DESCRIPTIVE DATA 
To present the socio-demographic and descriptive data, the study participants are 
divided into two groups, Group 1 pertains to all children aged 6-9 in Cork City and 
County, examined in the 2007 component of studies 1 and 2.  Group 2 comprises of 
the children who were examined by Sturley in 2002, when they were aged 6-9 in 
year 3-4 of primary school and again in 2007, when they were aged 11-13 years old 
(relates to the children in the 2007 component of studies 3 and 4).   
 
Group 1 comprised of 50.1% boys, only 0.9% of the children were adopted. The 
average age of the participants was 7.7 years (S.D. = 0.7), the mode was 8.  Ages 
ranged from 6 to 9 years old.  Group 2 comprised of 49.6% boys and only 1.1% of 
children were adopted. The average age of the participants was 12.11 years (S.D. = 
0.44), the mode was 12.  Ages ranged from 11 to 13 years old.   
4.2.1.1 Birth 
In Group 1, 91.8% (n=3242) were born at term. Vaginal deliveries were the most 
common mode of birth (77.9%) and 2.9% (n=99) of the children were twin 
deliveries.  Mean birth weight was 3507gms.   In Group 2, also the majority of 
children (90.4%, n=630) were born at term.  Vaginal deliveries were the most 
common mode of birth (82.3%) and 2.4% (n=17) of children were twins.  Mean birth 
weight was 3498gms.   
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4.2.1.2 Country/Continent of origin 
The continent of origin of the parents and children in the study are summarised in 
Table 4.1.  In Group 1, most of the participants were born in Ireland (89.5%) to Irish 
mothers (88.2%) and fathers (87.5%).  Similarly, in Group 2, most of the participants 
were born in Ireland, to Irish mothers (93.9%) and fathers (94.4%).   
 
Table 4.1   Country/Continent of birth of children and parents  
 
 
Group 1 
(n=3464, age 6-9) 
Group 2 
(n=706, age 11-13) 
Country Child Father Mother Child Father Mother 
N (%) N (%) N (%) N (%) N (%) N (%) 
       
Ireland 3060 (89.5) 2830 (87.5) 2876 (88.2) 652 (93.0) 614 (94.5) 622 (94.0) 
Britain 139 (4.1) 176 (5.4) 159 (4.9) 24 (3.4) 10 (1.5) 19 (2.9) 
EU 22 (0.6) 28 (0.9) 42 (1.3) 4 (0.6) 3 (0.5) 2 (0.3) 
Ac. EU 71(2.1) 69 (2.1) 68 (2.1) 7 (1.0) 6 (0.9) 6 (0.9) 
Africa 22 (0.6) 38 (1.1) 32 (1.0) 3 (0.4) 2 (0.3) 1 (0.2) 
Asia 53 (1.6) 71 (2.2) 55 (1.7) 5 (0.7) 7 (1.1) 5 (0.8) 
Oceania 8 (0.2) 8 (0.2) 6 (0.2) 0 (0.0) 1 (0.1) 1 (0.2) 
Russia 5 (0.1) 1 (0.01) 2 (0.1) 1 (0.1) 2 (0.3) 2 (0.3) 
America 38 (1.1) 14 (0.4) 22 (0.7) 5 (0.7) 5 (0.8) 4 (0.6) 
4.2.1.3 Breastfeeding 
In Group 1, 43.5% (n=1498) were breast fed ever, of which, 27.7% (n=415) were 
breastfed for ≥16 weeks.  Of the children who were breastfed ever, 20.2% (n=699) 
were exclusively breastfed, of which 26.0% (n=182) were breastfed exclusively for ≥ 
16 weeks.  In the older children in Group 2, over a third (34.8%, n=245) were 
breastfed ever, of which, 27.4% (n=67) were breastfed for ≥16 weeks.  Of the 
children who were breastfed ever, 45.7% (n=112) were exclusively breastfed, of 
which 25.0% (n=28) were breastfed exclusively for ≥ 16 weeks.  For both groups, 
the average duration of breastfeeding ever was 14 weeks and the mode was 4 weeks.  
The reported details of breastfeeding are summarised in Table 4.2. 
 
Table 4.2  Breastfeeding history of children in the study 
 Group 1 
(n=3464, age 6-9) 
Group 2 
(n=706, age 11-13) 
 N (%) N (%) 
Ever Breastfed 1498 (43.5) 245 (34.8) 
Breastfed ≥16 weeks  415 (12.0) 67 (9.5) 
Breastfed exclusively  699 (20.2) 112 (15.9) 
Breastfed exclusively ≥ 16 weeks 182 (5.3) 28 (4.0) 
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4.2.1.4 Birth order 
In both age groups of the study, two-thirds of the participants were born first or 
second in the family (Figure 4.1).   
 
Figure 4.1   Birth order of children in the study 
4.2.1.5 Crèche/preschool attendance 
In total, 16.1% (n=559) of children had attended a full-time crèche and 90.3% 
(n=3098) had attended preschool.  Figure 4.2 depicts the age (in months) that the 
children attended a day-care facility for the first time. Fewer children from this older 
study group 12% (n=85) had attended a full-time crèche than in the younger study 
group (16.1%), but similar percentage (89%, n=620) had attended preschool.   
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Figure 4.2  Age in months, when children first attended day-care 
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4.2.1.6 Immunisations 
Table 4.3 shows the uptake of the sample population of the National Immunisation 
Programme.  In Group 1, the mean percentage of uptake of immunisations is 89.7%, 
excluding BCG, as universal BCG immunisation was not offered in the Cork region 
from 1972 to 2008 (318).  Marginally less than the younger study group, the mean 
percentage of uptake of immunisations is 88.2% in the older children in Group 2 
(excluding BCG).   
 
Table 4.3  Immunisations received 
 
 
Group 1 
(n=3464, age 6-9) 
Group 2 
(n=706, age 11-13) 
Immunisation N (%) N (%) 
   
3/5-in-one 3354 (96.8) 672 (95.2) 
MMR  3305 (95.4) 682 (96.6) 
HiB  3002 (86.7) 577 81.7) 
Men C  2768 (79.9) 560 (79.3) 
BCG  1281 (37.0) 249 (35.3) 
4.2.1.7 Infections in early childhood 
Table 4.4 demonstrates the reported occurrence of disease of the participants before 
they were three years of age.   
 
Table 4.4  Infections prior to 3 years of age  
 
 
Group 1  
(n=3464, age 6-9) 
Group 2  
(n=706, age 11-13) 
Infection N (%) N (%) 
   
Measles 206 (6.0) 65 (9.2) 
Mumps 37 (1.1) 11 (1.6) 
German Measles 62 (1.8) 18 (2.5) 
Chickenpox 1744 (50.3) 363 (51.4) 
Meningitis 31 (0.9) 6 (0.8) 
Ear infection 130 (3.8) 29 (4.0) 
Gastroenteritis 836 (24.1) 181 (25.6) 
Pneumonia 122 (3.5) 33 (4.7) 
Whooping Cough 135 (3.9) 25(3.5) 
Bronchitis 390 (11.3) 80 (11.3) 
Croup 511 (14.8) 95 (14.5) 
Bronchiolitis 437 (12.6) 108 (15.3) 
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4.2.1.8 Antibiotics prior to 2 years of age 
Parents reported that 70.5% (n=2443) of children had taken antibiotics in the first 
two years of age.  In both age groups, of the majority of children who had taken 
antibiotics in the first two years of life, received 1-2 courses (Table 4.5).   
 
Table 4.5  Antibiotics received prior to 2 years of age 
 
Group 1  
(n=3464, age 6-9) 
Group 2  
(n=706, age 11-13) 
Antibiotic courses < 2yrs of age N (%) N (%) 
   
None 968 (28.4) 219 (31.0) 
Had antibiotics, amount not specified 362 (10.5) 67 (9.5) 
1-2 courses 982 (28.3) 186 (26.3) 
3-4 courses 566 (16.3) 117 (16.6) 
5-6 courses 280 (8.1) 50 (7.1) 
≥7 courses 253 (7.3) 58 (8.2) 
4.2.1.9 Home location 
Parents were asked the current location of their home and the location of their home 
during the first year of their child’s life (Table 4.6).  In Group 1, 44.3% - 36.9% of 
children lived in the city/city suburbs during Year 1 and currently, respectively.  
Group 2 children mostly resided in the city and suburbs during both timeframes.   
 
 
Table 4.6   Home location, currently and during the first year of life 
 Group 1  
(n=3464, age 6-9) 
Group 2  
(n=706, age 11-13) 
 
Home Location  
Year 1 Currently Year 1 Currently 
N (%) N (%) N (%) N (%) 
     
City 618 (18.1) 449 (13.0) 216 (30.8) 197 (27.9) 
City Suburbs 898 (26.2) 827 (23.9) 367 (52.1) 370 (52.4) 
Town 762(22.0) 749 (21.6) 56 (7.9) 57 (8.1) 
Village 302 (8.8) 369 (10.7) 20 (2.8) 30 (4.2) 
Countryside – not farm 597 (17.4) 812 (23.5) 41 (5.8) 50 (7.1) 
Farm 246 (7.2) 252 (7.3) 3 (0.4) 2 (0.3) 
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4.2.1.10 Environmental exposures 
Table 4.7 highlights the environmental exposures at two time scales, namely during 
the first year of life and current (during the study).   
 
Table 4.7  First year of life and current exposures 
 
 Group 1 
(n=3464, age 6-9) 
Group 2 
(n=706, age 11-13) 
 
Exposures  
Year 1 Currently Year 1 Currently 
N (%) N (%) N (%) N (%) 
     
Damp spots in bedroom 431 (12.5) 281 (8.1) 85 (12.0) 50 (7.1) 
Carpets (vs. bare floor) 2025 (58.5) 1250 (36.1) 515 (72.9) 255 (36.1) 
Dog 1439 (41.5) 2095 (60.5) 245 (34.7) 418 (59.2) 
Cat 578 (16.7) 928 (26.8) 82 (11.6) 119 (16.9) 
Farm Animals 353 (10.2) 480 (13.9) 22 (3.1) 25 (3.5) 
Other Animals 115 (3.3) 306 (8.8) 24 (3.4) 48 (6.8) 
Barn  134 (3.9) 229 (6.6) 9 (1.3) 16 (2.3) 
Stable 31 (0.9) 217 (6.3) 1 (0.1) 22 (3.1) 
Unpasteurised Milk 116 (3.4) 178 (5.2) 18 (2.5) 19 (2.7) 
4.2.1.11 Water Supply  
Table 4.8 shows that the majority of the participants receive their water supply from 
a municipal main water source.  In both groups, there was an increase in the use of 
water filters from the year 1 to currently. 
 
Table 4.8   Sources of water supply 
 Group 1  
(n=3464, age 6-9) 
Group 2  
(n=706, age 11-13) 
Water Supply  Year 1 Currently Year 1 Currently 
N (%) N (%) N (%) N (%) 
     
Municipal Water 2794 (81.4) 2664 (77.0) 677 (95.9) 675 (95.8) 
Home well 536 (15.6) 679 (19.6) 23 (3.3) 25 (3.5) 
Group Scheme 101(2.9) 117 (3.4) 4 (0.6) 5 (0.7) 
Water Filter 500 (14.6) 901 (26.0) 61 (8.6) 173 (24.5) 
4.2.1.12 Smoking 
The children’s smoking exposures are summarised in Figure 4.3.  In Group 1, over a 
quarter (28.9%, n=1002) of mothers reported smoking in the first year of their 
child’s life, and 26.3% (n=907) reported smoking currently. Maternal smoking 
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during pregnancy was 19.8% (n=686) and 20.5% (n=709) of parents reported that 
cigarettes are smoked in their homes.  Higher than in the younger age group, over a 
third (34.7%, n=245) of mothers in Group 2 reported smoking during the first year of 
their child’s life and 29.6% (n=209) reported currently smoking.  Maternal smoking 
during pregnancy was 23.8% (n=168).  However, 24.4% of parents reported that 
cigarettes are smoked in their homes, which is 4% higher than the parents in the 
younger age group.   
 
Figure 4.3   Current amount of cigarettes smoked in the children’s homes 
 
4.2.1.1 Paternal exposures 
Parents were asked about paternal current and childhood farm related exposures.   In 
Group 1, 19.2% (n=624) of fathers were reared on a farm, of which 74.4% (n=464) 
were actively involved with farming activities.  Only 2.2% were currently working 
as farmers during this study time period.  In Group 2, 9.1% (n=64) were reared on a 
farm and were actively involved with farming activities as children; 0.2% (n=1) 
reported working as farmers during this study period.  
4.2.1.2 Maternal exposures 
Maternal exposures are summarised in Table 4.9.  In Group 1, 18.1% (n=591) of 
mothers were reared on a farm and 3.5% (n=120) reported regular exposure to the 
farm whilst pregnant with the child involved in this study.  In Group 2, 8.2% (n=58) 
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of mothers were reared on a farm and no mother reported farm exposure during 
pregnancy.   
 
Table 4.9   Maternal exposures during childhood and pregnancy 
 Group 1  
(n=3464, age 6-9) 
Group 2  
(n=706, age 11-13) 
 
Exposures  
During 
Childhood 
During 
Pregnancy 
During 
Childhood 
During 
Pregnancy 
N (%) N (%) N (%) N (%) 
     
Unpasteurised Milk 664 (19.2) 153 (4.4) 88 (12.5) 20 (2.8) 
Dog 2129 (61.5) 1312 (37.9) 391 (55.4) 199 (28.2) 
Cat 1183 (34.2) 510 (14.7) 155 (22.0) 55 (7.8) 
Farm Animals 760 (21.9) 267 (7.7) 89 (12.6) 15 (2.1) 
Other Animals 346 (10.0) 146 (4.2) 70 (9.9) 16 (2.3) 
Barn 796 (23.0) 168 (4.8) 60 (8.5) 13 (1.8) 
Stable 316 (9.1) 106 (3.1) 48 (6.7) 9 (1.3) 
 
Figure 4.4 shows that the percentage of parents completing third level education 
increased from the older children in Group 2 to the younger children in Group 1.
 
 
Figure 4.4 Highest level of education attained by parents 
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4.3 STUDY 1 TRENDS OF PREVALENCE OF ATOPIC DISORDERS 
4.3.1 Study and population characteristics of study 1 
The 2002 Sturley study involved 1474 children aged 6-9 years, of which 47.3% were 
males (mean age = 8.0 years). The 2007 Duggan study involved 1535 children aged 
6-9 years, of which 52.1% were males (mean age = 7.6 years).  The response rates 
were 74.8% in 2002 and 76.2% in 2007.  Study and population characteristics are 
presented in Table 4.10.   
 
Table 4.10  Characteristics of the 2002 and 2007 prevalence studies 
  
Sturley, 2002 
 
Duggan, 2007 
Participants   
Male 47.3% 52.1% 
Age   
6 years  26 (1.8%) 36 (2.3%) 
7 years 357 (24.3%) 627 (40.8%) 
8 years  702 (47.8%) 722 (47.0%) 
9 years  368 (25.1%) 150 (9.8%) 
Mean age 8 years 7.6 years 
Studies   
Total Sample 1474 1535 
Response Rate 74.8% 76.2% 
4.3.2 The prevalence of childhood allergic conditions in 2002 and 2007  
Table 4.11 demonstrates the trends of prevalence of asthma, allergic rhinitis and 
eczema in 6-9 year old children, over the 5 year period from 2002 to 2007.  There 
was no significant alteration in the prevalence of current asthma, asthma ever or 
severe asthma; however, the symptom of night cough had significantly decreased 
from 31.1% to 21.8% (p<0.001) from 2002 to 2007.   In 2007, 14% (n=215) of 
children suffered from a dry night cough, current and lifetime asthma, while 14.8% 
(n=228) were being treated for asthma.  Of the children with asthma ever, 10.7% 
(n=41) suffered from a dry night cough in the absence of current wheeze, of which 
90.2% (n=37) received treatment for asthma. 
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Most symptoms of allergic rhinitis remained unchanged from 2002 to 2007, except 
for the prevalence of rhino-conjunctivitis, which had increased significantly from 
7.6% to 10.6% (p<0.005).  In 2002, the prevalence of rhinitic symptoms peaked 
(approx.12%) during winter and spring, sharply declined (6-7%) over summer and 
sharply increased again over autumn (Figure 4.5).  In 2007, symptoms peaked (12%) 
in late spring/early summer, decreased and levelled off to approximately 6% during 
late summer and autumn months and rose again to 7- 9% in winter. 
 
 
Figure 4.5  Monthly prevalence of symptoms of allergic rhinitis in children aged 6-9  
 
 
There were significant increases (all to p<0.001) in the symptoms of rash ever 
(14.2% to 20.7%), current rash (11.8% to 16.2%), current eczema (8.9% to 13.5%) 
and occurrence of rash <2 years of age (4.5% to 7.8%).   Lifetime diagnosis eczema 
had significantly reduced from 21.6% to 15.0% (p<0.001) and the severity of eczema 
symptoms suffered, remained unaltered. 
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Table 4.11 Prevalence of allergic disease symptoms in children aged 6-9 years in 2002 and 2007* 
 Sturley, 2002  
(n=1474) 
Duggan, 2007 
(n=1535) 
Difference  (95% CI) p- value 
 N (%) N (%)   
Asthma     
Ever wheezed 610 (41.3%) 620 (40.4%) 0.9% (-3.0%, 5.0%) 0.580 
Current wheeze 321 (21.7%) 360 (23.5%) 1.8% (-1.0%, 5.0%) 0.272 
Exercise-induced wheeze 228 (15.5%) 236 (15.4%) 0.1% (-3.0%, 3.0%) 0.943 
Night cough 458 (31.1%) 335 (21.8%) 9.3% (6.0%, 12.0%)  < 0.001 
Ever had asthma 375 (25.4%) 382 (24.9%) 0.5% (-3.0%, 4.0%) 0.726 
Speech limitation 54 (3.7%) 57 (3.7%) 0.1% (-1.0%, 1.0%) 0.942 
≥4 wheeze attacks/past year 96 (6.5%) 104 (6.8%) 0.3% (-2.0%, 2.0%) 0.773 
Woken by wheeze ≥1night/wk 58 (3.9%) 78 (5.1%) 1.2% (-0.4%, 3.0%) 0.130 
Allergic Rhinitis     
Nasal problems ever 433 (29.4%) 470 (30.6%) 1.2% (-2.0%, 5.0%) 0.450 
Current allergic rhinitis 385 (26.1%) 418 (27.2%) 1.1% (-2.0%, 4.0%) 0.491 
Associated itchy eye 112 (7.6%) 162 (10.6%) 3.0% (1.0%, 5.0%) 0.005 
Ever had hayfever 133 (9.0%) 159 (10.4%) 1.4% (-1.0%, 4.0%) 0.216 
Mod/Severe interference with ADL 56 (3.8%) 78 (5.1%) 1.3% (-0.2%, 3.0%) 0.088 
Eczema     
Ever had persistent rash 209 (14.2%) 318 (20.7%) 6.5% (4.0%, 9.0%) < 0.001 
Current persistent rash 174 (11.8%) 248 (16.2%) 4.4% (2.0%, 7.0%) < 0.001 
Affecting flexural areas 131 (8.9%) 207 (13.5%) 4.6% (2.0%, 7.0%) < 0.001 
Ever had eczema 319 (21.6%) 230 (15.0%) 6.6% (4.0%, 9.0%) < 0.001 
1
st
 occurrence <2yrs 66 (4.5%) 120 (7.8%) 3.3% (2.0%, 5.0%) <0.001 
 Not cleared in past year 49 (3.3%) 58 (3.8%) 0.5% (-1.0%, 2.0%) 0.501 
Kept awake ≥1night/wk 17 (1.2%) 27 (1.8%) 0.6% (-0.3%, 2.0%) 0.167 
 
 
*Parental Report  CI (Confidence Interval)* Interval)     ADL (Activities of daily living)
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4.3.3 Sex-specific prevalence 
Stratification by sex demonstrated no significant alterations in the distribution of 
asthma symptoms from 2002-2007 (Table 4.12).  In 2007, a male preponderance for 
current asthma was still apparent (M:F 1.2:1), although it had lost its significance 
since 2002 (M:F 1.5:1, p<0.001).  The move towards equalisation was due to a 
significant increase in current wheeze in girls (17.4% -21.4%, p=0.05) and the 
alteration was close to statistical significance.  Both timeframes revealed a male 
predominance in most asthma symptoms, except for severe symptoms, which were 
equally distributed between both sexes.  Although statistically non-significant, the 
M:F ratio for most of the allergic rhinitis symptoms had moved away from equal sex 
distribution to male predominance.  Most apparent, was the lifetime diagnosis of 
hayfever in which the M:F ratio moved from 1:1 to 1.5:1, due to a significant 
increase in male diagnosis ( 9.1% to 12.3%, p=0.05).  The prevalence of all the 
reported symptoms of eczema were equally distributed between the sexes during 
both timeframes, except for the lifetime diagnosis of eczema which had moved from 
male predominance to equal sex distribution (p<0.001, sex/study interaction).  
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Table 4.12  Sex distribution of allergic symptoms in children aged 6-9 years in 2002 and 2007*                                       
 
 
Male/Female  
 
             Male : Female Ratio  
 
Ratio Alteration  
 2002 2007    2002       2007 2002 - 2007  
 Boys 
(n=699) 
Girls 
(n=775) 
Boys   
(n=795) 
Girls  
(n=740) 
 
 
M:F 
Ratio 
 
p-value** 
    M:F 
Ratio 
 
p-value** 
 
p-value† 
Asthma           
Ever wheezed 317 (45.4%) 295 (38.1%) 355 (44.6%) 262 (35.4%)  1.2 : 1    0.005 1.3 : 1 < 0.001 0.563 
Current wheeze 187 (26.8%) 135 (17.4%) 200 (25.2%) 158 (21.4%)  1.5 : 1 < 0.001 1.2 : 1    0.075 0.057 
Ever had asthma 205 (29.4%) 172 (22.2%) 221 (27.8%) 158 (21.4%)  1.3 : 1    0.002 1.3 : 1    0.005 0.880 
Exercise-induced wheeze 134 (19.2%) 98 (12.7%) 139 (17.5%) 96 (13.0%)  1.5 : 1    0.001 1.3 : 1    0.018 0.486 
Night cough 239 (34.3%) 228 (29.4%) 193 (24.3%) 139 (18.8%)  1.2 : 1    0.049 1.3 : 1    0.012 0.528 
Speech limitation 29 (4.2%) 25 (3.2%) 31 (3.9%) 26 (3.5%)  1.3 : 1    0.346 1.1 : 1    0.813 0.694 
≥4 Wheeze attacks/past year 54 (7.7%) 42 (5.4%) 58 (7.3%) 46 (6.2%)  1.4 : 1    0.073 1.2 : 1    0.962 0.482 
Woken ≥1night/wk 29 (4.2%) 29 (3.7%) 42 (5.3%) 36 (4.9%)  1.0 : 1    0.688 1.1 : 1    0.559 0.954 
Allergic Rhinitis           
Nasal problems ever 220 (31.5%) 215 (27.7%) 264 (33.2%) 201 (27.2%)  1.1 : 1    0.117 1.2 : 1    0.012 0.498 
Current allergic rhinitis 197 (28.2%) 189 (24.4%) 237 (29.8%) 176 (23.9%)  1.2 : 1    0.098 1.3 : 1    0.009 0.499 
Associated itchy eye 56 (8.0%) 56 (7.2% 88 (11.1%) 73 (9.9%)  1.1 : 1    0.570 1.1 : 1    0.459 0.948 
Ever had hayfever 64 (9.1%) 69 (8.9%) 98 (12.3%) 60 (8.1%)  1.0 : 1    0.866 1.5 : 1    0.007 0.083 
Mod/Severe interfere ADL  33 (4.7%) 23 (3.0%) 51 (6.4%) 27 (3.6%)  1.6 : 1    0.079 1.8 : 1    0.118 0.763 
Eczema           
Ever had persistent rash 98 (14.0%) 112 (14.5%) 158 (19.9%) 157 (21.2%)  1.0 : 1    0.813 0.9 : 1    0.486 0.811 
Current persistent rash 79 (11.3%) 95 (12.3%) 117 (14.7%) 128 (17.3%)  1.0 : 1    0.570 0.8 : 1    0.075 0.639 
Affecting flexural areas 62 (8.9%) 69 (8.9%) 98 (12.3%) 107 (14.5%)  1.0 : 1    0.982 0.8 : 1    0.762 0.477 
Ever had eczema 172 (24.6%) 50 (19.4%) 121(15.2%) 108 (14.6%)  1.3 : 1 < 0.001 1.0 : 1    0.802     < 0.001 
Not cleared in past year 23(3.3%) 21 (2.7%) 28 (3.5%) 30 (4.1%)  1.2 : 1    0.513 0.9 : 1    0.901 0.395 
 Woken by rash ≥1night/wk 6 (0.9%) 10 (1.4%) 15 (1.9%) 12 ((1.6%)  0.6 : 1    0.424 1.2 : 1    0.365 0.384 
 
*Parental report                    
ADL (Activities of daily living)   
** P-value for difference between sex distribution of symptoms within each study 
†P-value for sex/study interaction   
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4.3.4 Co-morbidity of allergic disease 
A high level of co-prevalence of current symptoms and lifetime diagnosis of asthma, 
allergic rhinitis and eczema persists (Figure 4.6).  From 2002 to 2007, all levels of 
co-morbidity of current asthma, allergic rhinitis and eczema symptoms had increased 
(≥ 1 condition – 40% to 42.8%, ≥ 2 conditions – 15.1 to 17.1% and symptoms of all 
three conditions – 3.2% to 4.1%).  The only statistically significant increase was in 
the percentage of children suffering from current symptoms of all three conditions 
(p<0.001).  All indices of co-prevalence of lifetime diagnosis had decreased non-
significantly between 2002 and 2007 (diagnosed with at least one condition - 39.7% 
to 36.6%, at least two - 12.1% to 11.4% and diagnosed with all three conditions – 
2.2% to 2%).  
4.3.5 Tobacco smoking 
There was a significant reduction in the prevalence of maternal smoking during 
pregnancy (33.3% to 21.0%, p<0.001), in the first year of life (38.1% to 31.1%, 
p<0.001) and currently (35.4% to 28.9%, p<0.001) during the study interval (Table 
4.13).  Secondary tobacco smoke exposure in the home also decreased significantly 
(39.7% to 22.3%, p<0.001). 
 
Table 4.13 Reported prevalence and exposure to tobacco smoking in 2002 and 2007 
 Sturley, 2002  
(n=1474) 
Duggan, 2007  
(n=1535) 
Difference  
(95% CI) 
p-value 
 N (%) N (%)   
Mother smoked during pregnancy 491 (33.3) 323 (21.0) 12.3% (9.0%, 15.0%) < 0.001 
Mother smoked in Year 1  562 (38.1) 477 (31.1) 7.0% (3.7%, 10.0%) < 0.001 
Mother currently smoking 522 (35.4) 443 (28.9) 6.5% (3.2%, 9.9%) < 0.001 
Home exposure to tobacco smoke  586 (39.7) 342 (22.3) 17.4% (14.2%, 20.7%) < 0.001 
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Figure 4.6  Co-morbidity of atopic disorders in 2002 and 2007study populations (age 6-9) 
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4.4 STUDY 2 – ASSOCIATIONS WITH ASTHMA AND ALLERGY 
Study 2 examines the associations with childhood allergic diseases in 3464 children, 
aged 6-9 years, living in rural and urban locations.  The response rate was 75.8%.   
4.4.1 Study and population characteristics of study 2 
Of the 3,464 children, 2048 (59.1%) attended a rural school.  The age distribution, 
sex and nationality of the children and parents from both the rural and urban schools 
are similar (Table 4.14).  There is also strong agreement between the school and 
home location in our study.  Of the children who are living the county, 96.1% 
(n=1966) attend rural schools and 84.7% (n=1196) of the children living in the city 
attend city schools.   
 
Table 4.14   Characteristics of rural and urban schoolchildren 
 Rural schools 
(n=2048) 
N (%) 
Urban schools 
 (n=1416) 
N (%) 
Male 995 (48.9) 728 (51.8) 
Age   
6 years  52 (2.5) 35 (2.5) 
7 years  774 (37.9) 579 (40.9) 
8 years  973 (47.6) 667 (47.1) 
9 years  244 (11.9) 134 (9.5) 
Mean age 7.7 yrs. 7.6 yrs. 
Born in Ireland 1799 (89.0) 1261 (90.3) 
Born to Irish mother  1673 (86.4) 1203 (90.7) 
Born to Irish father 1665 (86.7) 1165 (88.7) 
Self-reported home location 2182 (63.1) 1276 (36.9) 
Response rate 77.2% 74.4% 
 
 
The stratification of symptom prevalence by age demonstrated no significant 
differences in prevalence rates across the age groups (Table 4.15).  
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Table 4.15  Prevalence of childhood allergic diseases stratified by age* 
 Combined ages 
(n=3458) 
N (%) 
Age 6 
(n=87) 
N (%) 
Age 7 
(n=1353) 
N (%) 
Age 8 
(n=1640) 
N (%) 
Age 9 
(n=378) 
N (%) 
 
p-value 
Asthma       
Ever wheezed 1272 (36.7) 31 (35.6) 504 (37.3) 594 (36.2) 143 (37.8) 0.905 
Current wheeze 699 (20.2) 16 (18.4) 279 (20.6) 324 (19.8) 80 (21.2) 0.863 
Exercise-induced wheeze 445 (12.8) 10 (11.6) 178 (13.3) 197 (12.1) 60 (16.0) 0.233 
Night cough 648 (18.7) 16 (18.6) 252 (18.8) 304 (18.7) 76 (20.4) 0.903 
Ever had asthma 757 (21.9) 18 (20.7) 292 (21.7) 352 (21.7) 95 (25.2) 0.472 
Speech limitation 100 (2.9) 3 (3.5) 34 (2.5) 50 (3.0) 13 (3.4) 0.552 
≥4 wheeze attacks/past year 211 (6.1) 3 (3.5) 76 (5.6) 103 (6.2) 29 (7.7) 0.271 
Woken by wheeze ≥1night/week 129 (3.7) 2 (2.3) 58 (4.3) 58 (3.5) 11 (2.9) 0.548 
Allergic Rhinitis       
Nasal problems ever 959 (27.7) 24 (27.6) 374 (27.7) 453 (27.7) 107 (28.4) 0.994 
Current allergic rhinitis 858 (24.8) 22 (25.3) 330 (24.4) 403 (24.6) 102 (27.0) 0.766 
Associated itchy eye 360 (10.4) 8 (9.2) 126 (9.3) 179 (10.9) 47 (12.4) 0.262 
Ever had hayfever 360 (10.4) 9 (10.3) 124 (9.2) 181 (11.2) 46 (12.2) 0.237 
Mod/Severe interference with ADL 151 (4.4) 5 (5.7) 61 (4.5) 61 (3.7) 24 (6.4) 0.158 
Eczema       
Ever had persistent rash 675 (19.5) 15 (17.4) 260 (19.2) 326 (19.9) 72 (19.1) 0.920 
Current persistent rash 520 (15.0) 12 (13.8) 202 (14.9) 253 (15.4) 53 (14.0) 0.786 
Affecting flexural areas 439 (12.7) 9 (10.3) 167 (12.3) 216 (13.2) 47 (12.4) 0.815 
Ever had eczema 477 (13.8) 10 (11.5) 189 (14.1) 223 (13.7) 54 (14.3) 0.908 
1
st
 occurrence <2yrs 156 (4.5) 2 (2.3) 54 (4.0) 80 (4.9) 20 (5.3) 0.235 
 Not cleared in past year 137 (4.0) 2 (2.3) 58 (4.3) 70 (4.3) 7 (1.9) 0.129 
Kept awake ≥1night/wk 49 (1.4) 1 (1.2) 17 (1.3) 26 (1.6) 5 (1.3) 0.901 
*Parental Report  ADL (Activities of daily living) 
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4.4.2 Univariate analysis 
 
The association between the 6 divisions of home location (ranging from city to farm) 
currently and during the first year of life and the 12 month prevalence of asthma, 
allergic rhinitis and eczema were examined by univariately by chi-square test and  
logistic regression analysis for trend across the categories.   An overall association 
between home location during both timeframes and the 12 month prevalence of 
asthma (year 1: p=0.005, current: p<0.001, p<0.001 for trend across categories) and 
allergic rhinitis (year 1 and current: p<0.001, p<0.001 for trend in year 1 location 
and p<0.001 for trend in current location) was found (Figure 4.7).  No association 
was evident between home location and the prevalence of childhood eczema.  It is 
apparent that the prevalence of current asthma appears to decrease as the home 
location becomes more rural.  The reduction of prevalence between city and farm 
habitation is also apparent in current allergic rhinitis; however, the dose-response 
effect as home location moves towards that of a rural abode is not graphically 
evident.  
The univariate analysis results from categorised putative factors associated with the 
three outcome measures of: current asthma, current allergic rhinitis and current 
eczema are presented in tables 4.16-4.19.  It is apparent that there were many 
associations with current atopic disorders at univariate level, which progressed to 
multivariate analysis.  Tables for the other main outcome measures are not presented.   
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Figure 4.7  Current asthma and current allergic rhinitis prevalence according to home location 
Current asthma and current allergic rhinitis prevalence according to home location  
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Table 4.16 Associations between home location and current asthma, rhinitis and eczema from univariate analysis 
*P-value based on univariate logistic regression analysis, where city is the reference category 
  
 
 
N (%)  
Current 
Asthma 
(n=699) 
N (%)  
No Current 
Asthma 
(n=2765) 
 
 
p-value 
N (%)  
Current AR  
(n=858) 
N (%)  
No current 
AR 
(n=2606) 
 
 
p-value   
N (%)  
 Current 
Eczema  
(n=439) 
N (%)  
No Current 
Eczema 
(n=3025) 
 
 
p-value*   
Year 1 Home Location           
City  144 (20.6) 474 (17.2)  157 (18.3) 461 (17.7)  82 (18.7) 536 (17.7)  
City suburbs  202 (28.9) 696 (25.2)    0.713 246 (28.7) 652 (25.0)    0.389 126 (28.7) 772 (25.5)    0.672 
Town  152 (21.8) 610 (22.1)   0.132 203 (23.7) 559 (21.5)    0.603 98 (22.3) 664 (22.0)    0.823 
Village 55 (7.9) 247 (8.9)    0.079 67 (7.8) 235 (9.0)    0.286 28 (6.4) 274 (9.1)    0.081 
Countryside – not farm  103 (14.7) 494 (17.9)    0.009 145 (16.9) 452 (17.3)    0.653 78 (17.8) 519 (17.2)    0.917 
Farm  34 (4.9) 212 (7.7)    0.002 29 (3.4) 217 (8.3) < 0.001 26 (5.9) 220 (7.3)    0.280 
Current Home Location          
City 117 (16.7) 332 (12.0)  104 (12.1) 345 (13.2)  60 (13.7) 389 (12.9)  
City suburbs  196 (28.0) 631 (22.8)    0.350 239 (27.9) 588 (22.6)    0.028 112 (25.5) 715 (23.6)    0.928 
Town  147 (21.0) 602 (21.8)    0.010 197 (23.0) 552 (21.2)    0.226 89 (20.3) 660 (21.8)    0.452 
Village 69 (9.9) 300 (10.9)    0.013 90 (10.5) 279 (10.7)    0.681 46 (10.5) 323 (10.7)    0.704 
Countryside – not farm 137 (19.6) 675 (24.4) < 0.001 191 (22.3) 621 (22.8)    0.885 104 (23.7) 708 (23.4)    0.779 
Farm  33 (4.7) 219 (7.9) < 0.001 34 (4.0) 218 (8.4)    0.002 28 (6.4) 224 (7.4)    0.388 
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Table 4.17   Associations with current asthma, rhinitis and eczema from univariate analysis in the medical category  
 
P-value based on chi-square test 
 
MEDICAL VARIABLES 
N (%)  
Current 
Asthma 
(n=699) 
N (%)  
No Current 
Asthma 
(n=2765) 
 
 
p-value* 
N (%)  
Current 
AR  
(n=858) 
N (%)  
No Current  
AR  
(n=2606) 
 
 
p-value * 
N (%)  
 Current 
Eczema  
(n=439) 
N (%)  
No Current 
Eczema 
(n=3025) 
 
 
p-value*   
INFECTIONS <3yrs           
German Measles  7 (1.0) 55 (2.0)    0.009 12 (1.4) 50 (1.9)    0.012 4 (0.9) 58 (1.9)    0.330 
Measles 42 (6.0) 164 (5.9)    0.243 49 (5.7) 157 (6.0)    0.147 30 (6.8) 176 (5.8)    0.522 
Mumps 10 (1.4) 27 (1.0)    0.128 9 (1.0) 28 (1.1)    0.125 10 (2.3) 27 (0.9)    0.021 
Croup 164 (23.5) 347 (12.5) < 0.001 182 (21.2) 329 (12.6) < 0.001 88 (20.0) 423 (14.0)    0.001 
Pertussis 46 (6.6) 89 (3.2) < 0.001 55 (6.4) 80 (3.1) < 0.001 33 (7.5) 102 (3.4) < 0.001 
Bronchiolitis 282 (40.3) 397 (14.4) < 0.001 261 (30.4) 418 (16.0) < 0.001 115 (26.2) 564 (18.6) < 0.001 
Pneumonia 47 (6.7) 75 (2.7) < 0.001 46 (5.4) 76 (2.9) < 0.001 17 (3.9) 105 (3.5)    0.907 
Gastroenteritis 255 (36.5) 581 (21.0) < 0.001 304 (35.4) 532 (20.4) < 0.001 130 (29.6) 706 (23.3)    0.016 
Ear Infections 43 (6.2) 87 (3.3) < 0.001 53 (6.2) 77 (3.0) < 0.001 24 (5.5) 106 (3.5)    0.123 
Meningitis 12 (1.7) 19 (0.7)    0.014 14 (1.6) 17 (0.7)    0.002 8 (1.8) 23 (0.8)    0.078 
Chickenpox 377 (53.9) 1367 (49.4)    0.063 458 (53.4) 1286 (49.3)    0.090 238 (54.2) 1506 (49.8)    0.209 
IMMUNISATIONS             
Three in 1 682 (97.6) 2672 (96.6)   0.154 836 (97.4) 2158 (96.6)    0.334 425 (96.8) 2929 (96.8)    0.162 
Hib 609 (87.1) 2393 (86.5)   0.274 750 (87.4) 2252 (86.4)    0.447 383 (87.2) 2619 (86.6)    0.904 
Meningitis C 568 (81.3) 2200 (79.6)   0.550 712 (83.0) 2056 (78.9)    0.034 350 (79.7) 2418 (79.9)    0.759 
BCG 249 (35.6) 1032 (37.3)   0.616 318 (37.1) 963 (37.0)    0.869 176 (40.1) 1105 (36.5)    0.338 
MMR 671 (96.0) 2634 (95.3)   0.673 818 (95.3) 2487 (95.4)    0.922 421 (95.9) 2884 (95.3)    0.489 
ANTIBIOTICS<2yrs          
Yes/No 595 (85.1) 1848 (66.8) < 0.001 711 (82.9) 1732 (66.4) < 0.001 343 (78.1) 2100 (69.4) < 0.001 
None 94 (13.4) 867 (31.4) < 0.001 137 (16.0) 824 (31.6) < 0.001    88 (20.0) 873 (28.9) < 0.001 
At least 1-amt. not specified 104 (14.9) 265 (9.6) < 0.001 116 (13.5) 253 (9.7) < 0.001 64 (14.6) 305 (10.1) < 0.001 
1-2 courses 142 (20.3) 840 (30.4)    0.002 189 (22.0) 793 (30.4)    0.003 102 (23.2) 880 (29.1)    0.362 
3-4 courses 157 (22.5) 409 (14.8) < 0.001 199 (23.2) 367 (14.0) < 0.001 84 (19.1) 482 (15.9)    0.001 
5-6 courses 83 (11.9) 197 (7.1) < 0.001 102 (11.9) 178 (6.8) < 0.001 50 (11.4) 230 (7.6) < 0.001 
≥7 courses 110 (15.7) 143 (5.2) < 0.001 106 (12.4) 147 (5.6) < 0.001 43 (9.8) 210 (6.9) < 0.001 
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Table 4.18  Associations with current asthma, rhinitis and eczema (univariate analysis in parental childhood, pregnancy and perinatal category) 
P-value based on chi-square test 
 
 
PARENTAL CHILDHOOD, 
PREGNANCY AND 
PERINATAL VARIABLES 
N (%)  
Current 
Asthma 
(n=699) 
N (%)  
No Current 
Asthma 
(n=2765) 
 
 
p-value 
N (%)  
Current  
AR 
 (n=858) 
N (%)  
No Current 
AR 
(n=2606) 
 
 
p-value   
N (%)  
 Current 
Eczema  
(n=439) 
N (%)  
No Current 
Eczema 
(n=3025) 
 
 
p-value   
PARENTAL CHILDHOOD          
Mother: Reared on Farm  109 (15.6) 482 (17.4)    0.211 119 (13.9) 472 (18.1) 0.002 81 (18.5) 510 (16.9) 0.408 
   Barn 110 (15.7) 457 (16.5)    0.613 137 (16.0) 430 (16.5) 0.714 79 (18.0) 488 (16.1) 0.324 
                 Stable 64 (9.2) 252 (9.1)    0.973 83 (9.7) 233 (8.9) 0.518 46 (10.5) 270 (8.9) 0.291 
   Furry Pets 448 (64.1) 1785 (64.6)    0.818 563 (65.6) 1670 (64.1) 0.415 284 (64.7) 1949 (64.4) 0.914 
   Farm Animals 134 (19.2) 626 (22.6)    0.048 166 (19.3) 594 (22.8) 0.034 103 (23.5) 657 (21.7) 0.409 
   Unpast. Milk 127 (18.2) 537 (19.4)    0.392 150 (17.5) 514 (19.8) 0.121 94 (21.4) 570 (18.8) 0.193 
Father:  Reared on Farm 104 (14.8) 519 (18.8)    0.014 128 (14.9) 495 (18.9) 0.003 81 (18.5) 542 (17.9) 0.827 
PREGNANCY          
Farm 20 (2.9) 100 (3.6)    0.329 17 (2.0) 103 (4.0) 0.006 15 (3.4) 105 (3.5) 0.954 
Barn 23 (3.3) 145 (5.2)    0.032 25 (2.9) 143 (5.5) 0.002 29 (6.6) 139 (4.6) 0.068 
Stable 16 (2.3) 90 (3.3)    0.185 23 (2.7) 83 (3.2) 0.457 21 (4.8) 85 (2.8) 0.025 
Furry Pets 279 (39.9) 1145 (41.4)    0.473 368 (42.9) 1056 (40.5) 0.221 171 (39.0) 1253 (41.4) 0.326 
Farm Animals 37 (5.3) 230 (8.3)    0.007 47 (5.5) 220 (8.4) 0.005 34 (7.7) 233 (7.7) 0.975 
Unpasteurised Milk 23 (3.3) 130 (4.7)    0.101 28 (3.3) 125 (4.8) 0.052 21 (4.8) 132 (4.4) 0.684 
Tobacco Smoke 172 (24.6) 514 (18.6)    0.002 180 (21.0) 506 (19.4) 0.317 81 (18.5) 605 (20.0) 0.539 
PERINATAL          
Born at Term 640 (91.6) 2602 (94.1)    0.014 794 (92.5) 2448 (93.9) 0.147 417 (95.0) 2825(93.4) 0.201 
Caesarean Section 158 (22.6) 590 (21.3)    0.545 204 (23.8) 544 (20.9) 0.092 100 (22.8) 648 (21.4) 0.617 
Twin 19 (2.7) 80 (2.9)    0.818 30 (3.5) 69 (2.7) 0.192 11 (2.5) 88 (2.9) 0.637 
Breastfed Ever 251 (35.9) 1247 (45.1) < 0.001 349 (40.7) 1149 (44.1) 0.064 202 (46.0) 1296 (42.8) 0.447 
    Breastfed ≥16 wks. (vs. ≤15) 75 (10.7) 340 (12.3)    0.402 110 (12.8) 305 (11.7) 0.069 62 (14.1) 353 (11.7) 0.236 
Birth Weight (continuous) - -    0.359 - - 0.622 - - 0.922 
Low Birth Weight ≤ 2.5KG 23 (3.3) 102 (3.7)    0.147 31 (3.6) 94 (3.6) 0.885 10 (2.3) 115 (3.8) 0.123 
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Table 4.19 Associations with current asthma, rhinitis and eczema from univariate analysis in environmental category 
P-value based on chi-square test 
 
 
 
ENVIRONMENTAL 
VARIABLES 
N (%)  
Current 
Asthma 
(n=699) 
N (%)  
No Current 
Asthma 
(n=2765) 
 
 
p-value 
N (%)  
Current  
AR 
 (n=858) 
N (%)  
No Current 
AR 
(n=2606) 
 
 
p-value   
N (%)  
 Current 
Eczema  
(n=439) 
N (%)  
No Current 
Eczema 
(n=3025) 
 
 
p-value   
EXPOSURES YEAR 1           
Full-time Crèche 97 (13.9) 462 (16.7)    0.081 145 (16.9) 414 (15.9)    0.499 80 (18.2) 479 (15.8)    0.210 
Tobacco Smoke 231 (33.0) 771 (27.9)    0.008 245 (28.6) 757 (29.0)    0.797 109 (24.8) 893 (29.5)    0.034 
Damp Bedroom 113 (16.2) 318 (11.5)    0.001 124 (14.5) 307 (11.8)    0.038 62 (14.1) 369 (12.2)    0.259 
Carpet flooring 424 (60.7) 1601 (57.9)    0.389 489 (57.0) 1536 (58.9)    0.304 248 (56.5) 1777 (58.7)   0.509 
Furry Pets 302 (43.2) 1272 (46.0)    0.184 409 (47.7) 1165 (44.7)    0.130 190 (43.3) 1384 (45.8)    0.331 
Farm Animals 46 (6.6) 307 (11.1) < 0.001 66 (7.7) 287 (11.0)    0.005 44 (10.0) 309 (10.2)    0.901 
Barn 19 (2.7) 115 (4.2)    0.078 23 (2.7) 111 (4.3)    0.038 21 (4.8) 113 (3.7)    0.287 
Stable 4 (0.6) 27 (1.0)    0.311 7 (0.8) 24 (0.9)    0.777 8 (1.8) 23 (0.8)    0.027 
Unpasteurised Milk  12 (1.7) 104 (3.8)    0.008 15 (1.7) 101 (3.9)    0.003 13 (3.0) 103 (3.4)    0.633 
Mains Drinking Water 595 (85.1) 2199 (79.5)    0.001 728 (84.8) 2066 (79.3) < 0.001    361 (82.2) 2433 (80.4)    0.516 
CURRENT EXPOSURES          
Maternal Tobacco Smoke 220 (31.5) 687 (24.8) < 0.001 219 (25.5) 688 (26.4)    0.569 111 (25.3) 796 (26.3)    0.617 
Damp Bedroom 70 (10.0) 211 (7.7)    0.039 77 (9.0) 204 (7.8)    0.278 37 (8.4) 244 (8.1)    0.798 
Carpet flooring 228 (32.7) 1022 (37.0)    0.092 271 (31.6) 979 (37.6)    0.005 134 (30.5) 1116 (37.0)    0.019 
Furry Pets 459 (65.7) 1842 (66.6)    0.634 574 (66.9) 1727 (66.3)    0.735 289 (65.8) 2012 (66.5)    0.778 
Farm Animals 65 (9.3) 415 (15.0) < 0.001 85 (9.9) 395 (15.2) < 0.001 54 (12.3) 426 (14.1)    0.313 
Stable 37 (5.3) 180 (6.5)    0.236 48 (5.6) 169 (6.5)    0.350 33 (7.5) 184 (6.1)    0.246 
Barn 33 (4.7) 196 (7.1)    0.024 34 (4.0) 195 (7.5) < 0.001 28 (6.4) 201 (6.6)    0.834 
Unpasteurised Milk 28 (4.0) 150 (5.4)    0.129 33 (3.8) 145 (5.6)    0.048 21 (4.8) 157 (5.2)    0.720 
Mains Drinking Water 576 (82.4) 2088 (75.5) < 0.001 696 (81.1) 1968 (75.5)    0.001 344 (78.4) 2320 (76.7)    0.481 
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4.4.3 Asthma 
The final models for the three main outcome measures for asthma, namely: Wheeze 
Ever, Current Asthma and Asthma Ever are presented in Tables 4.20-4.22.  The final 
logistic regression model for Wheeze Ever (Table 4.20) revealed positive 
associations for year 1 exposure to a damp bedroom (OR 1.6; 95% CI 1.25, 2.10), 
respiratory infections (OR 3.2; 95% CI 2.68, 3.87, p<0.001) and gastroenteritis (OR 
1.3; 95% CI 1.10, 1.63, p=0.003) in the first 3 years of life and antibiotics consumed 
in the first 2 years of life (p<0.001).  A protective effect was found with exposure to 
farm animals (OR 0.6; 95% CI 0.46, 0.85).   
 
In the final model for Current Asthma (Table 4.21), positive associations were found 
for having consumed antibiotics prior to 2 years of age (p< 0.001), respiratory 
infections (OR 1.9; 95% CI 1.55, 2.40, p=<0.001), gastrointestinal infections (OR 
1.3; 95% CI 1.07, 1.67, p=0.011) prior to 3 years of age and current maternal 
tobacco smoking (OR, 1.4; 95% CI 1.07, 1.73, p=0.011).  Inverse associations were 
found with current farm animal exposure (OR 0.6; 95% CI 0.40, 0.98, p=0.038) and 
having attended a crèche full-time in the first year of life (OR 0.7; 95% CI 0.53, 
0.94, p=0.018).  The protective effect of living outside the city was evident at 
univariate analysis and when partially adjusted for the main potential confounders.  
However, home location lost significance when fully adjusted in the final model.   
 
In the Asthma Ever final model (Table 4.22), as with the current asthma model, the 
risk factors of respiratory infections (OR 2.1; 95% CI 1.74, 2.64, p<0.001) and 
gastrointestinal infections (OR 1.3; 95% CI 1.07, 1.63, p=0.011) < 3years of age, 
having consumed antibiotics in the first two years of life (p<0.001) and exposure to a 
damp bedroom in the first year of life (OR 1.4; 95% CI 1.07, 1.89, p=0.015) 
emerged as significant.  The only protective factor found for lifetime asthma was 
current farm animal exposure (OR 0.6; 95% CI 0.43, 0.90, p=0.012).  The 
associations for the three outcome measures for asthma found in this study are 
presented graphically in Figure 4.8.   
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Figure 4.9 depicts the crude and percentage of antibiotic courses prescribed in 
children with asthma and without (graphs a-c) and the adjusted odds ratios for 
current asthma and antibiotic courses (graph d).  It is clear that asthmatic children 
were prescribed significantly more antibiotics than non-asthmatic children.  
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Figure 4.8 Risk and protective factors associated with the symptoms of Asthma in 
children aged 6-9 years (n=3464) 
 
 
Factors associated with symptoms of Asthma in children aged 6-9, in multivariate analysis 
(n=3464) 
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The relationship between antibiotic courses consumed ≤ 2 years of age and symptoms of Asthma in children aged 6-9 years (n=3464)  
          
 
Figure 4.9     The relationship between antibiotic courses consumed <2 years and symptoms of asthma in children aged 6-9 years    
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Table 4.20  Final model for factors associated with Wheeze Ever in children aged 6-9 years (n=3464)* 
*Parental report 
**Partially adjusted odds ratios when adjusted for sex, maternal education, parental atopy, child atopy and birth order (each variable individually adjusted) 
†Fully adjusted odds ratios when adjusted for sex, maternal education, parental and child atopy and birth order, maternal childhood exposure to farm animals, year 1 and 
current home location, born at term, pregnancy, year 1 tobacco smoke, current flooring and all other variables in the final model 
Nagelkerke R
2
=0.334 
 
 
  
 
 
 
 
N (%)  
Among Wheeze 
Ever  (n=1272) 
N (%)  
Among No Wheeze 
Ever (n=2192) 
 
Univariate 
OR 
 
 
p-value 
 
Partially 
Adjusted OR** 
 
 
p-value 
Fully 
Adjusted 
OR† 
 
 
p-value 
MEDICAL          
Infections <3yrs old         
No Respiratory  558 (43.9) 1741 (79.5) 1.0      
Yes Respiratory  714 (56.1) 450 (20.5) 5.0 (4.25, 5.76) < 0.001 4.4 (3.69, 5.14) < 0.001 3.2 (2.68, 3.87) < 0.001 
 No Gastrointestinal  717 (56.4) 1616 (73.8) 1.0      
Yes Gastrointestinal           444 (38.2) 392 (19.5) 2.6 (2.17, 3.00) < 0.001 2.1 (1.76, 2.50) < 0.001 1.3 (1.10, 1.63)    0.003 
Antibiotics <2yrs old         
Overall     < 0.001  < 0.001  < 0.001 
None 167 (13.3) 794 (36.8) 1.0      
1-2 courses 276 (22.0) 706 (32.8) 1.9 (1.50, 2.31) < 0.001 1.8 (1.44, 2.30) < 0.001 1.7 (1.29, 2.15) < 0.001 
3-4 courses 279 (22.2) 287 (13.3) 4.6 (3.66, 5.84) < 0.001 3.8 (2.92, 4.87) < 0.001 2.9 (2.17, 3.80) < 0.001 
5-6 courses 156 (12.4) 124 (5.8) 6.0 (4.48, 7.99) < 0.001 4.7 (3.43, 6.42) < 0.001 3.4 (2.44, 4.83) < 0.001 
≥7 courses 181 (14.4) 72 (3.3) 12.0 (8.68 , 16.46) < 0.001 10.0 (7.04, 14.09) < 0.001 5.6 (3.83, 8.31) < 0.001 
ENVIRONMENTAL  
Year 1 Exposures 
        
No Damp bedroom 1061 (83.4) 1943 (88.7) 1.0      
Yes Damp bedroom 202 (16.0) 229 (10.5) 1.6 (1.32, 1.98) < 0.001 1.5 (1.21, 1.91) < 0.001 1.6 (1.25, 2.10) < 0.001 
No Farm animals           1180 (92.8) 1930 (88.1) 1.0      
Yes Farm animals                           92 (7.2) 261 (11.9) 0.6 (0.45, 0.74) < 0.001 0.6 (0.44, 0.76) < 0.001 0.6 (0.46, 0.85)    0.002 
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 Table 4.21  Final model for factors associated with Current Asthma in children aged 6-9 years (n=3464)*  
*Parental report 
**Partially adjusted odds ratios when adjusted for sex, maternal education, parental atopy, child atopy and birth order (each variable individually adjusted) 
†Fully adjusted odds ratios for variables when adjusted for sex, maternal education, parental and child atopy and birth order, pregnancy farm animal exposure, born at term, year1 and current 
home location and the other variables in the model.   
Nagelkerke R2=0.302     
 
 
 
 
N (%)  
Current Asthma  
(n=699) 
N (%) No  
Current Asthma 
(n=2765) 
 
Univariate 
 OR 
 
 
P-Value 
 
Partially  
Adjusted OR** 
 
 
P-Value 
 
Fully 
Adjusted OR† 
 
 
P-Value 
MEDICAL  
Infections <3yrs old 
        
No Respiratory  306 (43.6) 1994 (72.1) 1.0      
Yes Respiratory  393 (56.2) 771 (27.9) 3.3  (2.80, 3.94) < 0.001 2.6 (2.15, 3.15) < 0.001 1.9 (1.55, 2.40) < 0.001 
No Gastroenteritis 379 (59.8) 1954 (77.1)       
Yes Gastroenteritis 255 (40.2) 581 (22.9) 2.3 (1.88, 2.72) < 0.001 1.8 (1.45, 2.19) < 0.001 1.3 (1.07, 1.67) 0.011 
Antibiotics <2yrs old        
Overall     < 0.001  < 0.001  < 0.001 
None 94 (13.6) 867 (31.9) 1.0       
1-2 courses 142 (20.6) 840 (30.9) 1.6 (1.18, 2.06)    0.002 1.4 (1.07, 1.95)    0.017 1.2 (0.88, 1.68)    0.230 
3-4 courses 157 (22.8) 409 (15.0) 3.5 (2.67, 4.69) < 0.001 2.5 (1.83, 3.40) < 0.001 1.9 (1.32, 2.59) < 0.001 
5-6 courses 83 (12.0) 197 (7.2) 3.9 (2.79, 5.42)    0.001 2.6 (1.77, 3.70)  < 0.001 1.7 (1.15, 2.57)    0.008 
≥7 courses 110 (15.9) 143 (5.3) 7.1 (5.12, 9.84) < 0.001 4.9 (3.39, 7.05) < 0.001 3.3 (2.20, 4.93) < 0.001 
ENVIRONMENTAL  
Exposures Year 1  
       
No Full-time crèche  590 (85.9) 2277 (83.1) 1.0      
Yes Full-time crèche 97 (14.1) 462 (16.9) 0.8 (0.64, 1.03)    0.081 0.7 (0.57, 0.96) 0.026 0.7 (0.53, 0.94)   0.018 
Current Exposures        
Mother not smoking tobacco 478 (68.5) 2068 (75.1) 1.0      
Mother smoking tobacco 220 (31.5) 687 (24.9) 1.4 (1.16, 1.66) < 0.001 1.4 (1.10, 1.70) 0.005 1.4 (1.07, 1.73)   0.011 
No Farm animals 634 (90.7) 2350 (85.0) 1.0      
Yes Farm animals 65 (9.3) 415 (15.0) 0.6 (0.44, 0.77) < 0.001 0.6 (0.43, 0.80) 0.011 0.6 (0.40, 0.98)   0.038 
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Table 4.22   Final model for factors associated with Asthma Ever in children aged 6-9 years (n=3464)*  
*Parental report 
**Partially adjusted odds ratios when adjusted for sex, maternal education, parental atopy, child atopy and birth order (each variable individually adjusted). 
†Fully adjusted odds ratios when adjusted for sex, maternal education, parental and child atopy and birth order, pregnancy exposure to farm animals, german measles 
infection <3 years of age, year 1 source of drinking water, year 1 and current home location, current flooring and all other variables in the model. 
Nagelkerke R
2
=0.273 
 
 N (%)  
Asthma Ever  
(n=757) 
N (%) No  
Asthma Ever 
(n=2707) 
 
Univariate  
 OR 
 
 
p-value 
 
Partially  
Adjusted OR** 
 
 
p-value 
 
Fully 
Adjusted OR† 
 
 
p-value 
MEDICAL  
Infections<3yrs old 
        
No Respiratory 325 (42.9) 1956 (72.8) 1.0       
Yes Respiratory  432 (57.1) 729 (27.2) 1.7 (1.56, 1.85) < 0.001 2.8 (2.32, 3.35)  < 0.001   2.1 (1.74, 2.64) < 0.001    
No Gastrointestinal  401 (53.0) 1917 (71.4) 1.0      
Yes Gastrointestinal  280 (41.1) 556 (22.4) 2.4 (2.02, 2.89) < 0.001 1.9 (1.55, 2.31)   < 0.001 1.3 (1.07, 1.63)    0.011 
Antibiotics<2yrs old         
Overall     < 0.001  < 0.001  < 0.001 
None 87 (11.6) 866 (32.8) 1.0      
1-2 courses 148 (19.7) 829 (31.4) 1.8 (1.34, 2.36) < 0.001 1.7 (1.23, 2.25)    0.001 1.6 (1.16, 2.21)    0.005 
3-4 courses 167 (22.2) 397 (15.0) 4.2 (3.15, 5.57) < 0.001 3.1 (2.29, 4.26) < 0.001 2.5 (1.82, 3.56) < 0.001 
5-6 courses 99 (13.2) 179 (6.8) 5.5 (3.96, 7.66) < 0.001 3.9 (2.75, 5.63) < 0.001 2.9 (1.99, 4.34) < 0.001 
≥7 courses 126 (16.8) 127 (4.8) 9.9 (7.10, 13.75) < 0.001 7.3 (5.10, 10.48) < 0.001 4.6 (3.09, 6.89) < 0.001 
ENVIRONMENTAL  
Exposures Year 1  
       
No Damp bedroom 626 (83.4) 2359 (88.6) 1.0      
Yes Damp bedroom 126 (16.6) 305 (11.4) 1.5 (1.23, 1.94) < 0.001 1.4 (1.08, 1.80)    0.011 1.4 (1.07, 1.89)    0.015 
Current Exposures        
No Farm animals 691 (91.3) 2276 (84.8) 1.0      
Yes Farm animals 66 (8.7) 414 (15.2) 0.5 (0.40, 0.70) < 0.001 0.6 (0.40, 0.75)    0.001 0.6 (0.43, 0.90)    0.012 
  
Chapter 4.   Results Page 120 
 
4.4.4 Allergic rhinitis 
The final models for the four main outcome measures for allergic rhinitis, namely, 
nasal problems ever, current allergic rhinitis, current rhinoconjunctivitis and 
hayfever ever are presented in Tables 4.23-4.26.  Figure 4.10 depicts the factors 
which are associated with the four main outcome measures for allergic rhinitis.   
 
In the final Nasal Problems Ever model (Table 4.23), positive associations were 
found with having consumed antibiotics < 2years of age (p=0.007), respiratory 
infections (OR 1.4; 95% CI 1.10, 1.87, p=0.009), gastrointestinal infections (OR 1.4; 
95% CI 1.05, 1.82, p=0.021) < 3years of age and exposure to furry pets in the first 
year of life (OR 1.4; 95% CI 1.05, 1.75, p=0.02).   
  
In the final model for Current Allergic Rhinitis (Table 4.24), positive associations 
were found for having consumed antibiotics in the first two years of life (p<0.001), 
respiratory infections (OR 1.3; 95% CI 1.04, 1.55, p=0.019) and gastroenteritis (OR 
1.4; 95% CI 1.15, 1.73, p=0.001) ≤ 3 years of age.  Inverse associations were found 
with current exposure to a barn (OR 0.6; 95% CI 0.35, 0.95, p=0.031).  Home 
location was not significant in the final model.  
 
The final model for Current Rhinoconjunctivitis (Table 4.25) demonstrated positive 
associations gastrointestinal infection < 3 years of age (OR 1.5; 95% CI 1.12, 1.91, 
p=0.005), current exposure to furry pets (OR, 1.3; 95% CI 1.02, 1.75, p=0.037) and 
antibiotic treatment prior to 2 years of age (p=0.008).  Respiratory infections and 
having ever been breastfed were significantly associated at univariate and partial 
adjustment, but lost significance when fully adjusted. 
 
In the Hayfever Ever model (Table 4.26), positive associations were found with 
having a respiratory infection < 3 years of age (OR 1.4; 95% CI 1.03, 1.76, p=0.027) 
and having consumed antibiotics prior to 2 years of age (p=0.021).   Gastrointestinal 
infections were significantly associated at univariate and partial adjustment, but lost 
significance when fully adjusted for all putatively associated covariates.    
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Figure 4.12 demonstrates the relationship between antibiotic courses consumed ≤ 2 
years of age and symptoms of allergic rhinitis, from which it is apparent that children 
with symptoms of allergic rhinitis received more antibiotics than those children 
without. 
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Figure 4.10  Risk and protective factors associated with the symptoms of Allergic Rhinitis in children aged 6-9 years (n=3464) 
Factors associated with symptoms of Allergic Rhinitis in children aged 6-9, in multivariate analysis (n=3464) 
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The relationship between antibiotic courses consumed ≤ 2 years of age and symptoms of Allergic Rhinitis in children aged 6-9 years (n=3464)  
          
 
Figure 4.11 Crude percentages of antibiotics consumed < 2years and the prevalence of Allergic Rhinitis symptoms in children aged 6-9  
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Table 4.23 Final model for factors associated with Nasal Problems Ever in children aged 6-9 years (n=3464)* 
*Parental report   
**Partially adjusted odds ratios when adjusted for sex, maternal education, parental atopy, child atopy and birth order (each variable individually adjusted).   
†Fully adjusted odds ratios for variables when adjusted for sex, maternal education, parental and child atopy, birth order, year 1 and current home location and other 
variables in the model 
Nagelkerke R
2
=0.652 
 
  
 N (%)  
Nasal Problems 
Ever (n=959) 
N (%) No  
Nasal Problems  
Ever ( n=2505) 
 
Univariate  
 OR 
 
 
P-Value 
 
Partially  
Adjusted OR** 
 
 
P-Value 
 
Fully 
Adjusted OR† 
 
 
P-Value 
MEDICAL  
Infections < 3yrs old 
        
No Respiratory  491 (51.2) 1804 (72.2) 1.0      
Yes Respiratory 468 (48.8) 695 (27.8) 2.5 (2.12, 2.89) < 0.001 1.7 (1.40, 1.98) < 0.001 1.4 (1.10, 1.87)    0.009 
No Gastrointestinal  537 (61.7) 1793 (78.1) 1.0      
Yes Gastrointestinal  334 (38.3) 502 (21.9) 2.2 (1.88, 2.63) < 0.001 1.8 (1.38, 2.02) < 0.001 1.4 (1.05, 1.82)     0.021 
Antibiotics < 2 yrs. old         
Overall     < 0.001  < 0.001     0.007 
None 160 (16.9) 798 (32.5) 1.0      
1-2 courses 210 (22.1) 772 (31.4) 1.4 (1.08, 1.71)    0.009 1.3 (1.00, 1.64)    0.053 1.2 (0.82, 1.69)    0.364 
3-4 courses 216 (22.8) 350 (14.2) 3.1 (2.42, 3.91) < 0.001 2.3 (1.75,  2.97) < 0.001 1.7 (1.17, 2.54)    0.006 
5-6 courses 111(11.7) 168 (6.8) 3.3 (2.46, 4.42) < 0.001 2.1 (1.48, 2.84) < 0.001 1.5 (0.90, 2.32)    0.127 
≥7 courses 121 (12.8) 132 (5.4) 4.6 (3.39, 6.17) < 0.001 2.6 (1.82, 3.56) < 0.001 2.5 (1.50, 4.22) < 0.001 
ENVIRONMENTAL  
Exposures Year 1  
       
No Furry pets 502 (52.3) 1385 (55.4) 1.0      
Yes Furry pets  458 (47.7) 1116 (44.6) 1.1 (0.98, 1.31)    0.104 1.2 (1.03, 1.44)    0.022 1.4 (1.05, 1.75)    0.020 
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Table 4.24   Final model for factors associated with Current Allergic Rhinitis in children aged 6-9 years (n=3464)* 
*Parental report 
**Partially adjusted odds ratios when adjusted for sex, maternal education, parental atopy, child atopy and birth order (each variable individually adjusted).   
†Fully adjusted odds ratios for variables when adjusted for sex, maternal education, parental and child atopy, birth order, year1 and current home location and other 
variables in the model 
Nagelkerke R
2
= 0.220 
  
 N (%)  
Current AR  
(n=858) 
N (%) No  
Among No Current 
AR (n=2606) 
 
Univariate  
 OR 
 
 
P-Value 
 
Partially  
Adjusted OR** 
 
 
P-Value 
 
Fully 
Adjusted OR† 
 
 
P-Value 
MEDICAL  
Infections < 3yrs old 
        
No Respiratory  455 (51.9) 1855 (71.2) 1.0      
Yes Respiratory  413 (48.1) 751 (28.8) 2.2 (1.58, 3.20) < 0.001 1.5 (1.25, 1.79) < 0.001 1.3 (1.04, 1.55)    0.019 
No Gastrointestinal  481 (61.3) 1852 (77.7) 1.0      
Yes Gastrointestinal 304 (38.7) 532 (22.3) 2.2 (1.85, 2.62) < 0.001 1.7 (1.38, 2.03) < 0.001 1.4 (1.15, 1.73)    0.001 
Antibiotics < 2 yrs. old         
Overall     < 0.001  < 0.001  < 0.001 
None 137 (16.1) 824 (32.2) 1.0      
1-2 courses 189 (22.3) 793 (31.0) 1.4 (1.13, 1.82)    0.003 1.3 (1.02, 1.71)    0.037 1.2 (0.89, 1.56)    0.250 
3-4 courses 199 (23.4) 367 (14.3) 3.3 (2.54, 4.19) < 0.001 2.3 (1.77, 3.07) < 0.001 2.2 (1.61, 2.92) < 0.001 
5-6 courses 102 (12.0) 178 (6.9) 3.5 (2.55, 4.67) < 0.001 2.1 (1.50, 2.91) < 0.001 1.9 (1.31, 2.66) < 0.001 
≥7 courses 106 (12.5) 147 (5.7) 4.3 (3.19, 5.90) < 0.001 2.3 (1.62, 3.22) < 0.001 2.2 (1.49, 3.17) < 0.001 
ENVIRONMENTAL         
Current exposures         
No barn 824 (96.0) 2411 (92.5) 1.0      
Yes Barn 34 (4.0) 195 (7.5) 0.5 (0.35, 0.74) < 0.001 0.6 (0.37, 0.82)    0.004 0.6 (0.35, 0.95)      0.031 
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Table 4.25   Final model for factors associated with Current Rhino-conjunctivitis in children aged 6-9 years (n=3464)* 
*Parental report 
**Partially adjusted odds ratios when adjusted for sex, maternal education, parental atopy, child atopy and birth order (each variable individually adjusted). 
†Fully adjusted odds ratios for variables when adjusted for sex, maternal education, parental and child atopy, birth order, home location and other variables in the model. 
Nagelkerke R
2
=0.176  
  
  
 N (%)  
Current Rhino-
conj.  (n=360) 
N (%)  
No Current Rhino-
conj.(n=3104) 
 
Univariate  
 OR 
 
 
P-Value 
 
Partially  
Adjusted OR** 
 
 
P-Value 
 
Fully 
Adjusted OR† 
 
 
P-Value 
MEDICAL  
Infections < 3yrs. old 
        
No Respiratory 172 (47.8) 2128 (68.6) 1.0      
Yes Respiratory 188 (52.2) 976 (31.4) 2.4 (1.84, 3.11) < 0.001 1.4 (1.11, 1.80)    0.005 1.2 (0.94, 1.60) 0.140 
No Gastrointestinal  190 (57.8) 2143 (75.5) 1.0      
Yes Gastrointestinal 139 (38.6) 697 (22.5) 2.3 (1.78, 2.85) < 0.001 1.6 (1.25, 2.08) < 0.001 1.5 (1.12, 1.91) 0.005 
Antibiotics < 2 yrs. old         
Overall    < 0.001  < 0.001  0.008 
None 51 (14.3) 910 (29.8) 1.0      
1-2 courses 83 (23.2) 899 (29.4) 1.7 (1.15, 2.36)    0.007 1.4 (0.95, 2.02)    0.094 1.3 (0.86, 1.92) 0.220 
3-4 courses 93 (26.1) 473 (15.5) 3.5 (2.45, 5.02) < 0.001 2.2 (1.48, 3.20) < 0.001 1.9 (1.26, 2.87) 0.002 
5-6 courses 46 (12.9) 234 (7.7) 3.5 (2.30, 5.36) < 0.001 2.0 (1.28, 3.16)    0.002 1.8 (1.10, 2.85) 0.019 
≥7 courses 47 (13.2) 206 (6.7) 4.0 (2.66, 6.22) < 0.001 1.8 (1.12, 2.81)    0.015 1.5 (0.90,  2.48) 0.118 
ENVIRONMENTAL          
Current Exposures         
No Furry pets 104 (28.9) 1059 (34.1) 1.0      
Yes Furry pets  256 (71.1) 2045 (65.9) 1.3 (1.00 – 1.62)    0.047 1.4 (1.05 – 1.76)    0.020 1.3 (1.02, 1.75) 0.037 
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Table 4.26   Final model for factors associated with Hayfever Ever in children aged 6-9 years (n=3464)* 
*Parental report 
**Partially adjusted odds ratios for variables when adjusted for sex, maternal education, parental atopy, child atopy (each variable individually adjusted). 
†Fully adjusted odds ratios for variables when adjusted for sex, maternal education, parental and child atopy, birth order, home location and other variables in the model. 
Nagelkerke R
2
=0.170    
 
 N (%) 
Hayfever Ever  
(n=360) 
N (%) 
No Hayfever  
Ever (n=3104) 
 
Univariate  
 OR 
  
 
p-value 
 
Partially  
Adjusted OR** 
 
 
p-value 
 
Fully 
Adjusted OR† 
 
 
p-value 
MEDICAL  
Infections < 3yrs. old 
        
No Respiratory 171 (47.5) 2108 (68.5) 1.0      
Yes Respiratory 189 (52.5) 969 (31.5) 2.4 (1.93, 3.00) < 0.001 1.5 (1.20, 1.94)     0.001 1.4 (1.03, 1.76) 0.027 
No Gastrointestinal 201 (60.2) 2115 (75.2) 1.0      
Yes Gastrointestinal 136 (39.8) 700 (24.8) 2.0 (1.59, 2.54) < 0.001 1.4 (1.09, 1.81)     0.009 1.3 (0.97, 1.64) 0.089 
Antibiotics < 2 yrs. old         
Overall    < 0.001      0.001  0.021 
None 53 (14.9) 898 (29.6) 1.0      
1-2 courses 77 (21.6) 898 (29.6) 2.3 (1.48, 3.45) < 0.001 1.2 (0.80, 1.71)     0.433 1.1 (0.73, 1.62) 0.698 
3-4 courses 95 (26.7) 469 (15.5) 3.4 (2.41, 4.89) < 0.001 2.2 (1.47, 3.15) < 0.001 1.8 (1.21, 2.73) 0.004 
5-6 courses 46 (12.9) 234 (7.7) 3.3 (2.19, 5.07) < 0.001 1.9 (1.21, 2.96)     0.005 1.7 (1.06, 2.70) 0.029 
≥ 7 courses 42 (11.8) 209 (6.9) 3.4 (2.21, 5.25) < 0.001 1.5 (1.00, 2.45)    0.069 1.3 (0.78, 2.14) 0.317 
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4.4.5 Eczema  
The final models for the three main outcome measures for childhood eczema (Rash 
Ever, Current Eczema and Eczema Ever) are presented in Tables 4.27-4.29.  Figure 
4.12 depicts the factors which are inversely and positively associated with the four 
main outcome measures for childhood eczema.   
 
In the final Rash Ever model (Table 4.28), positive associations were found with 
maternal consumption of unpasteurised milk in childhood (OR 1.4; 95% CI 1.10, 
1.73, p=0.005) respiratory infections < 3years of age (OR 1.5; 95% CI 1.25, 1.84, 
p<0.001).  Protective factors were pregnancy exposures to furry pets (OR 0.8; 95% 
CI 0.66, 0.97, p=0.021) and year 1 maternal smoking (OR, 0.8; 95% CI 0.62, 0.95, 
p=0.017).   
 
In the final model for Current Eczema (Table 4.29), positive associations were found 
for pregnancy exposure to barn (OR 2.0; 95% CI 1.27, 3.04, p=0.002), stable 
exposure in the 1
st
 year of life (OR 3.7; 95% CI 1.55, 8.93, p=0.003).  Maternal 
smoking in the 1
st
 year of life was found to be protective against current eczema (OR 
0.7; 95% CI 0.57, 0.94, p=0.017).  Respiratory infections were significantly 
associated at univariate analysis and following partial adjustment, but lost 
significance when adjusted. 
 
The final model for Eczema Ever (Table 4.30) demonstrated positive associations 
with respiratory infection < 3 years of age (OR 1.3; 95% CI 1.02, 1.58, p=0.035), 
mother being reared on a farm (OR 1.4; 95% CI 1.06, 1.83, p=0.017).  Inverse 
associations with pregnancy exposures to furry pets (OR 0.8; 95% CI 0.61, 0.95, 
p=0.015) and year 1 maternal tobacco smoking (OR 0.8; 95% CI 0.58, 0.97, 
p=0.026) were found.   
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Figure 4.12   Risk and protective factors associated with the symptoms of Eczema in children (6-9yrs)
Factors associated with symptoms of Eczema in children aged 6-9, in multivariate analysis (n=3464) 
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Table 4.27   Final model for factors associated with Rash Ever in children aged 6-9 years (n=3464)* 
 
*Parental report 
**Partially adjusted odds ratios for variables when adjusted for sex, maternal education, parental atopy, child atopy, birth order (each variable individually adjusted) 
†Fully adjusted odds ratios for variables when adjusted for sex, maternal education, parental and child atopy, birth order, mumps infection prior to 3 years of age, year 1 
farm animal exposure, current flooring, year 1 stable and other variables in the model. 
Nagelkerke R
2
 =0.091   
 
 
 
 
 N (%)  
Rash Ever  
(n=675) 
N (%)  
No Rash Ever 
(n=2789) 
 
Univariate  
 OR 
 
 
P-Value 
 
Partially  
Adjusted OR** 
 
 
P-Value 
 
Fully 
Adjusted OR† 
 
 
P-Value 
MEDICAL  
Infections < 3yrs old 
        
No Respiratory  368 (54.5) 1929 (69.3) 1.0      
Yes Respiratory 307 (45.5) 854 (30.7) 1.9 (1.59, 2.24) < 0.001 1.5 (1.22, 1.78) < 0.001 1.5 (1.25, 1.84) < 0.001 
PARENTAL CHILDHOOD, PRENATAL        
Maternal Childhood         
No Unpasteurised Milk 488 (77.0) 2108 (80.3) 1.0      
Yes Unpasteurised  Milk 147 (23.0) 517 (19.7) 1.2 (0.99, 1.51)    0.059 1.4 (1.07, 1.67) 0.010 1.4 (1.10, 1.73) 0.005 
Pregnancy         
No Furry pets 418 (61.9) 1618 (58.1) 1.0      
Yes Furry pets 258 (38.1) 1166 (41.9) 0.9 (0.72, 1.02)    0.073 0.8 (0.68, 1.00) 0.035 0.8 (0.66, 0.97) 0.021 
ENVIRONMENTAL         
Year 1 Exposures         
No Tobacco Smoke 502 (74.4) 1932 (70.0) 1.0      
Yes Tobacco Smoke 173 (25.6) 829 (30.0) 0.8 (0.66, 0.97)    0.025 0.8 (0.62, 0.95) 0.013 0.8 (0.62, 0.95) 0.017 
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 Table 4.28   Final model for factors associated with Current Eczema in children aged 6-9 years (n=3464)* 
 
*Parental report 
**Partially adjusted odds ratios for variables when adjusted for sex, maternal education, parental atopy, child atopy and birth order (each variable individually adjusted) 
†Fully adjusted odds ratios for variables when adjusted for sex, maternal education, parental and child atopy, birth order, antibiotic consumption, pregnancy exposure to 
stable, year 1 barn exposure, current flooring and other variables in the model. 
Nagelkerke R
2
=0.085  
 N (%)  
 Current Eczema  
(n=439) 
N (%)  
No Current 
Eczema (n=3025) 
 
Univariate  
 OR 
 
 
P-Value 
 
Partially  
Adjusted OR** 
 
 
P-Value 
 
Fully 
Adjusted OR† 
 
 
P-Value 
MEDICAL  
Infections < 3yrs old 
        
No Respiratory  246 (56.0) 2054 (67.9) 1.0      
Yes Respiratory 193 (44.0) 971 (32.1) 1.7 (1.35, 2.03) < 0.001 1.2 (1.00, 1.55) 0.054 1.3 (1.00, 1.56) 0.055 
PRENATAL        
Pregnancy         
No Barn 410 (93.4) 2886 (95.4) 1.0      
Yes Barn 29 (6.6) 139 (4.6) 1.5 (0.97, 2.22) 0.068 2.0 (1.30, 3.08) 0.002 2.0 (1.27, 3.04) 0.002 
ENVIRONMENTAL         
Year 1 Exposures         
No Tobacco smoke 330 (75.2) 2107 (70.2) 1.0      
Yes Tobacco smoke 109 (24.8) 893 (29.8) 0.8 (0.62, 0.98)    0.034 0.7 (0.57, 0.94) 0.016 0.7 (0.57, 0.94) 0.017 
No Stable 431 (98.2) 3002 (99.2) 1.0      
Yes Stable 8 (1.8) 23 (0.8) 2.4 (1.08, 5.45)    0.032 3.6 (1.52, 8.64) 0.004 3.7 (1.55, 8.93) 0.003 
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Table 4.29 Final model for factors associated with Eczema Ever in children aged 6-9 years (n=3464)* 
 
*Parental report 
**Partially adjusted odds ratios for variables when adjusted for sex, maternal education, parental atopy, child atopy and birth order (each variable individually adjusted) 
†Fully adjusted odds ratios for variables when adjusted for sex, maternal education, parental and child atopy and birth order, chickenpox prior to 3 years old, current 
flooring, year 1 damp bedroom and other variables in the model. 
Nagelkerke R
2
=0.109   
  
 N (%) 
Eczema Ever  
(n=477) 
N (%) 
No Eczema 
Ever (n=3104) 
 
Univariate  
 OR 
 
 
P-Value 
 
Partially  
Adjusted OR** 
 
 
P-Value 
 
Fully 
Adjusted OR† 
 
 
P-Value 
MEDICAL  
Infections < 3yrs old 
        
No Respiratory 262 (54.9) 2021 (68.2) 1.0      
Yes Respiratory 215 (45.1) 942 (31.8 1.8 (1.45, 2.14) < 0.001 1.3 (1.01, 1.55) 0.041 1.3 (1.02, 1.58) 0.035 
PARENTAL CHILDHOOD, PRE/PERINATAL        
Maternal Childhood         
Not reared on farm 359 (80.0) 2308 (82.3) 1.0      
Reared on farm  94 (20.0) 497 (17.7) 1.2 (0.91, 1.50)    0.228 1.4 (1.05, 1.79) 0.022 1.4 (1.06, 1.83)     0.017 
Pregnancy         
No Furry pets 301 (63.1) 1722 (58.1) 1.0      
Yes Furry pets 179 (36.9) 1245 (41.9) 0.8 (0.66, 0.99)    0.040 0.8 (0.62, 0.95) 0.016 0.8 (0.61, 0.95)      0.015 
ENVIRONMENTAL         
Year 1 Exposures         
No Tobacco smoke 359 (75.4) 2066 (70.2) 1.0      
Yes Tobacco smoke 117 (24.6) 885 (29.8) 0.8 (0.62, 0.96)    0.021 0.7 (0.57, 0.93) 0.012 0.8 (0.58, 0.97)     0.026 
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4.4.6 Co-morbidity with all three atopic conditions 
In the final model for co-morbidity with all three atopic conditions (Table 4.30), 
positive associations were found for having consumed antibiotic in the first two 
years of life (p=0.006), respiratory infections <3 years of age (OR 2.1; 95% CI 1.42, 
3.14, p<0.001).  Year 1 exposure to farm animals (OR 0.3; 95% CI, 0.11, 0.85, 
p=0.023) and having ever breastfed (OR 0.7; 95% CI 0.45, 1.10, p=0.052) were 
found to be protective.  Figure 4.13 depicts the factors which are associated with 
childhood co-morbidity of asthma, rhinitis and eczema.   
 
 
 
 
 
 
Figure 4.13 Factors associated with the co-morbidity of symptoms of asthma, allergic 
  rhinitis and eczema in children aged 6-9 years (n=3464) 
Factors associated with symptoms of co-morbidity of childhood asthma, allergic 
rhinitis and eczema in children aged 6-9, in multivariate analysis (n=3464) 
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Table 4.30   Final model for factors associated with co-morbidity with all three conditions in children aged 6-9 years (n=3464) 
 
*Parental report 
**Partially adjusted odds ratios for variables when adjusted for sex, maternal education, parental atopy and birth order (each variable individually adjusted). 
†Fully adjusted odds ratios for variables when adjusted for sex, maternal education, parental atopy, birth order, current flooring and other variables in the model.. 
Nagelkerke R
2
= 0.102
 N (%)  
Co-morbid with all 
3 conditions  
(n=135) 
N (%)   
Not co-morbid with 
all 3 conditions 
(n=3329) 
 
 
Univariate 
 OR 
 
 
 
P-Value 
 
 
Partially  
Adjusted OR** 
 
 
P-Value 
 
 
Fully 
Adjusted OR† 
 
 
 
P-Value 
MEDICAL  
Infections < 3yrs old 
        
No Respiratory 54 (40.0) 2246 (67.5) 1.0      
Yes Respiratory 81 (60.0) 1083 (32.5) 3.1 (2.19, 4.42) < 0.001 2.7 (1.86, 3.88) < 0..001 2.1 (1.43, 3.14) < 0.001 
Antibiotics < 2 yrs old         
Overall    < 0.001  < 0.001    0.006 
None 13 (9.8) 948 (28.9) 1.0      
1-2 courses 26 (19.5) 956 (29.2) 2.0 (1.01, 3.88) < 0.001 1.9 (0.96, 3.71)    0.067 1.7 (0.85,  3.32)    0.138 
3-4 courses 35 (26.3) 531 (16.2) 4.8 (2.52, 9.17) < 0.001 4.1 (2.12, 7.90) < 0.001 3.1 (1.59, 6.09)    0.001 
5-6 courses 16 (12.0) 264 (8.1) 4.4 (2.10, 9.30) < 0.001 3.3 (1.53, 7.25)    0.002 2.4 (1.09, 5.31)    0.030 
≥7 courses 22 (16.5) 231 (7.0) 7.0 (3.45, 13.99) < 0.001 5.6 (2.72, 11.61) < 0.001 3.6 (1.70, 7.73)    0.001 
PARENTAL CHILDHOOD, 
PRE/PERINATAL 
        
Perinatal         
Never Breastfed 92 (61.8) 1855 (55.7) 1.0      
Breastfed Ever 43 (31.9) 1455 (44.0) 0.6 (0.41, 0.86) 0.005 0.6 (0.41, 0.86)     0.006 0.7 (0.45, 1.10)     0.052 
ENVIRONMENTAL         
Year 1 Exposures         
No Farm animals 128 (94.8) 2983 (89.6) 1.0      
Yes Farm animals 7 (5.2) 346 (10.4) 0.5 (0.22, 1.02)    0.050 0.4 (0.15, 0.92)    0.032 0.3 (0.11, 0.85)    0.023 
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4.5 STUDY 3 – QUASI RETROSPECTIVE COHORT STUDY 
Table 4.31 summarises the characteristics of the studies and participants in both 
elements of the quasi-cohort study; namely, the 2002 study population, half of which 
were surveyed again in their final year of primary school, in the 2007 study (the other 
half had moved onto second level education and were therefore lost to follow-up).                                                                                                                                                                                                               
 
Table 4.31   Characteristics of children in the quasi-retrospective cohort study 
 
 Sturley 2002 Duggan, 2007 
Population   
Male 699 (47.3%) 357 (49.4%) 
Mean age 8.0 years 12.1 years 
Study   
Sample size 1474 706 
Response rate 74.8% 70.8% 
 
Table 4.32 demonstrates the results of the quasi-retrospective cohort study, which 
consisted of two identical cross-sectional studies in the same cohort of children, in 2002 
(school years 3 and 4, age 6-9) and 2007 (school year 8, age 11-13).  The prevalence of 
current asthma had reduced in this cohort of children from 21.7% in 2002, to 17.1% in 
2007.  The symptom of night cough had also diminished (31.0% to 16.0%).  Exercise-
induced wheeze and the severity of asthma symptoms suffered remained unaltered.  
  
In terms of allergic rhinitis, having nasal problems ever and current allergic rhinitis 
remained unchanged, however there were increases in rhino-conjunctivitis and the 
interference with daily living as a result of the symptoms of allergic rhinitis.  The 
prevalence of lifetime hayfever also increased from 9.0% to 14.9%.  Examination of 
seasonal variations in the prevalence of rhinitis symptoms revealed higher 
winter/springtime prevalence in both studies (Figure 4.14).  The prevalence of 
symptoms indicative of eczema remained unchanged over time, but the prevalence of 
lifetime eczema decreased from 21.6% to 12.0% in this cohort of children.   
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There was a shift in the male:female ratio of asthma symptom prevalence, from male 
dominance to equalisation in current wheeze (1.5:1 to 1.2:1) and night cough (1.5:1 to 
1.3:1), while severe symptoms were more prevalent in females (Table 4.33).  Exercise 
induced wheeze remained more prevalent in boys (1.3:1 to 1.5:1).  The sex distribution 
of symptoms of allergic rhinitis remained at equal dispersion over the intervening years.  
All eczema symptoms moved to female dominance from childhood to early adolescence. 
 
Figure 4.15 demonstrates the co-morbidity of atopic conditions in 2002 and 2007 (age 6-
9 to 11-13 years).   Decreases were found in current symptom co-morbidity of asthma 
with rhinitis (8.8% to 7.2%) and asthma with eczema (1.4% to 1.1%).  Current symptom 
co-morbidity of asthma with eczema increased from 1.7% to 2.8%.  Co-morbidity 
increased with age in lifetime comorbid asthma with hayfever (1.7% to 5.0%) and 
hayfever with eczema (1.5% to 4.5%).  Co-morbid lifetime asthma with eczema, 
decreased with age (6.7% to 3.1%).  However, co-morbidity remains high, as 11.1% of 
children suffered from current symptoms of two conditions, 12.6% were diagnosed with 
two co-morbid conditions and 3.0% suffered current symptoms and were diagnosed with 
all three conditions.   
 
 
 
Figure 4.14  Monthly allergic rhinitis symptoms prevalence in children aged 6-9 and 11-13 
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Table 4.32   Prevalence of allergic disease symptoms in the 2002-2007 retrospective cohort study (from 6-9 years to 11-13 years)* 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Parental Report  95% CI (Confidence Interval)   ** Based upon degree of overlap of confidence intervals 
 
 
 
 
 
 
 
 
 
 Sturley, 2002 (n=1474, age 6-9)  Duggan, 2007 (n=706, age 11-13)  
 N (%) 95% CI  N (%) 95% CI Direction**  
Asthma       
Ever wheezed 610 (41.4) 38.8, 43.8  265 (37.5) 34.0, 41.2 ↔     
Current wheeze 321 (21.7) 19.6, 23.8  121 (17.1) 14.5, 20.1 ↓   
Exercise induced wheeze 228 (15.5) 13.5, 17.3  97 (13.7) 11.4, 16.4 ↔      
Night cough 458 (31.1) 28.6, 33.4  113 (16.0) 13.4, 18.9 ↓     
Ever had asthma  375 (25.4) 23.2, 27.6  174 (24.7) 21.6, 27.9 ↔ 
Speech limitation 54 (3.7) 2.7, 4.7  18 (2.5) 1.6, 3.9 ↔ 
≥4 wheeze attacks/past year 96 (6.5) 5.3, 7.9  36 (5.1) 3.7, 6.9 ↔ 
Woken by wheeze ≥1 night/week 58 (3.9) 2.9, 4.9  17 (2.4) 1.5, 3.9 ↔ 
Allergic Rhinitis       
Nasal problems ever 433 (29.4) 26.9, 31.5  209 (29.6) 26.3, 33.1 ↔    
Current allergic rhinitis 385 (26.1) 23.9, 28.3  184 (26.1) 22.9, 29.4 ↔    
Associated itchy eye 112 (7.6) 6.2, 8.0  97 (13.7) 11.4, 16.4 ↑ 
Hayfever ever 133 (9.0) 7.5, 10.5  105 (14.9) 12.4, 17.6 ↑ 
Mod/severe interference/daily living 56 (3.8) 2.9, 4.9  52 (7.4) 5.6, 9.5 ↑ 
Eczema       
Persistent rash ever 209 (14.2) 12.4, 16.0  111 (15.7) 13.8, 18.6 ↔    
Current persistent rash 174 (11.8) 10.2, 13.4  83 (11.8) 9.5, 14.3 ↔    
Affecting flexural areas 131 (8.9) 7.4, 10.4  74 (10.5) 8.4, 12.9 ↔    
Eczema ever 319 (21.6) 19.5, 23.7  85 (12.1) 9.8, 14.6 ↓ 
Not cleared in past year 49 (3.3) 2.5, 4.3  24 (3.4) 2.3, 4.9 ↔ 
Kept awake ≥ 1 night/week 17 (1.2) 0.7, 1.8  6 (0.8) 0.4, 1.7 ↔ 
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Table 4.33   Sex-distribution of allergic symptoms in children aged 6-9 to 11-13 years* 
 
 
Male/Female  
 
Male : Female Ratio 
 2002 2007 2002 2007 
 Boys (n=699) Girls (n=775) Boys   
(n=349) 
Girls  
(n=357) 
 
 
M:F 
Ratio 
 
p-value** 
    M:F 
Ratio 
 
p-value** 
Asthma          
Ever wheezed 317 (45.4%) 295 (38.1%) 144 (41.3) 121(33.9)  1.2 : 1    0.005 1.2 : 1 0.043 
Current wheeze 187 (26.8%) 135 (17.4%) 65 (18.6) 56 (15.7)  1.5 : 1 < 0.001 1.2 : 1 0.844 
Ever had asthma 205 (29.4%) 172 (22.2%) 95 (27.2) 79 (22.1)  1.3 : 1    0.002 1.2 : 1 0.116 
Exercise-induced wheeze 134 (19.2%) 98 (12.7%) 57 (16.3) 40 (11.2)  1.5 : 1    0.001 1.4 : 1 0.049 
Night cough 239 (34.3%) 228 (29.4%) 63 (18.1) 50 (14.0)  1.2 : 1    0.049 1.3 : 1 0.142 
Speech limitation 29 (4.2%) 25 (3.2%) 7 (2.0) 11 (3.1)  1.3 : 1    0.346 0.7 : 1 0.365 
≥4 Wheeze attacks/past year 54 (7.7%) 42 (5.4%) 15 (4.3) 21 (5.9)  1.4 : 1    0.073 0.7 : 1 0.086 
Woken by wheeze ≥1night/wk 29 (4.2%) 29 (3.7%) 8 (2.3) 9 (2.5)  1.0 : 1    0.688 0.9 : 1 0.548 
Allergic Rhinitis          
Nasal problems ever 220 (31.5%) 215 (7.8%) 112 (32.1) 97 (27.2)  1.1 : 1    0.117 1.2 : 1 0.152 
Current allergic rhinitis 197 (28.2%) 189 (24.4%) 100 (28.7) 84 (23.5)  1.2 : 1    0.098 1.2 : 1 0.121 
Associated itchy eye 56 (8.0%) 56 (7.2% 53 (15.2) 44 (12.3)  1.1 : 1    0.570 1.2 : 1 0.270 
Ever had hayfever 64 (9.1%) 69 (8.9%) 52 (14.9) 53 (14.9)  1.0 : 1    0.866 1.0 : 1 0.996 
Mod/Severe interference 
with daily living 
33 (4.7%) 23 (3.0%) 26 (7.5) 26 (7.3)  1.6 : 1    0.079 1.0 : 1 0.483 
Eczema          
Ever had persistent rash 98 (14.0%) 112 (14.5%) 47 (13.5) 64 (19.7)  1.0 : 1    0.813 0.7 : 1 0.097 
Current persistent rash 79 (11.3%) 95 (12.3%) 29 (8.3) 54 (15.1)  1.0 : 1    0.570 0.6 : 1 0.005 
Affecting flexural areas 62 (8.9%) 69 (8.9%) 26 (7.5) 48 (13.4)  1.0 : 1    0.982 0.6 : 1 0.009 
Ever had eczema 172 (24.6%) 50 (19.4%) 36 (10.3) 49 (13.7)  1.3 : 1 < 0.001 0.8 : 1 0.156 
Not cleared in past year 23(3.3%) 21 (2.7%) 7 (2.0) 17 (4.8)  1.2 : 1    0.513 0.4 : 1 0.458 
Woken by rash ≥1night/wk 6 (0.9%) 10 (1.4%) 1 (0.3) 5 (1.4)  0.6 : 1    0.424 0.2 : 1 0.312 
 
*Parental report     
** P-value for difference between sex distribution of symptoms within each study using a chi-square test 
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Figure 4.15   Comorbidity (%) of atopic conditions in a cohort of Irish schoolchildren aged 6-9 and 11-13 years 
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4.6 STUDY 4 – TRENDS OF ASTHMA AND ALLERGY IN OLDER CHILDREN 
Comparing the prevalence of allergic conditions between our population of 11-13 
year old children and the Irish element of ISAAC (age 13-14), we found the 2007 
prevalence of asthma and lifetime hayfever were lower than the Irish adolescent 
ISAAC study with no overlap of confidence intervals.  Other reported symptoms 
remained largely unchanged (Table 4.34).   
 
Table 4.34   Prevalence of allergic disease in Irish adolescents 2002-2007  
  Manning, 2002/3 (13-14 years)† 
(n=3089) 
Duggan, 2007 (11-13years)* 
(n=706) 
 
 N (%) 95% CI N (%) 95% CI Trend** 
Current asthma 825 (26.7) 25.2,  28.3 121 (17.1) 14.5, 20.1 ↓ 
Asthma ever 667 (21.6) 20.2,  23.1 174 (24.6) 21.6, 27.9 ↔ 
Current rhinoconjunctivitis 478 (15.5) 14.2, 16.8 97 (13.7) 11.4, 16.4 ↔ 
Hayfever ever 973 (31.5) 29.9, 33.2 105 (14.9) 12.4, 17.6 ↓ 
Current Eczema 226 (8.6) 6.4, 8.3 74 (10.5) 8.4, 12.9 ↑ 
Eczema ever 442 (14.3) 13.1, 15.6 85 (12.0) 9.8, 14.6 ↔ 
 
*Parental Report          † Self Report 95% CI (95% Confidence Interval) 
**Based upon degree of overlap of confidence intervals 
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Figure 4.16 depicts the overall trends of prevalence of current symptoms of asthma, 
rhinoconjunctivitis and eczema in Irish adolescents since 1995.  The prevalence of 
asthma and rhinoconjunctivitis are on a declining trend, while eczema decreased 
between Irish ISAAC Phases 1 and 3, but has increased in the older children in 2007.  
 
 
Figure 4.16   Trends of prevalence of current allergic conditions in Irish adolescents 
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5.1 INTRODUCTION 
This thesis is the first Irish study to examine trends of asthma, allergic rhinitis and 
eczema in young children aged 6-9 years.  It is also the first Irish study to attain data 
pertaining to the same cohort of children over two time periods (age 6-9 until 11-13), 
providing some insight into the natural history of allergy in this population.  By 
extending the prevalence study to examine a rural population, this study has enabled 
comparisons of the effects of exposures from different environments.  This extension 
also provides a baseline prevalence which is reflective of populations from different 
environments, from which to compare the findings of future studies.   
 
In this final chapter, I intend to discuss the main findings of this thesis in the context 
of intra-study factors and in relation to current international literature.  Strengths and 
limitations of each individual study will be highlighted.  I also propose to discuss the 
implications of the findings of this body of research and make recommendations for 
future research.     
5.2 STUDY 1 – TRENDS OF PREVALENCE IN 6-9 YEAR OLD CHILDREN 
Study 1, which examined the trends of prevalence in 6-9 year old children from Cork 
city and suburbs, found that the previously high prevalence of asthma has plateaued.    
The prevalence of rhino-conjunctivitis and eczema has increased and a large 
percentage of young children continue to suffer the burden of co-morbidity of two or 
all three conditions.  Sex-specific trends revealed an increase in the current 
prevalence of asthma in females causing the distribution to move towards sex 
equalisation, and the increase in the prevalence of lifetime hayfever in males 
resulting in equal sex-distribution. 
5.2.1 Asthma prevalence              
In this young population (6-9 years), the prevalence of current asthma and lifetime 
diagnosed asthma had remained constant, but high in relation to many other 
countries (7).  The finding of a broadly static prevalence of current asthma is in 
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agreement with  ISAAC Phase Three findings in Hong Kong and in Belgium and 
Austria in a similar age group (age 6-7) (7).   Conversely, in Western Europe nine 
out of eleven centres found increases in the prevalence of current asthma in 6-7 year 
old children, albeit the increases were small in many instances (7).  Many variations 
exist worldwide; Irish ISAAC data were not gathered for this age group. 
 
The prevalence of the symptom of night cough significantly decreased over the five 
year period.   The lower prevalence of dry night cough in our 2007 study compares 
favourably with others worldwide (137, 162).  Night cough is a recognised 
associated symptom of asthma and shares many of the long-term effects of classic 
wheezing asthma e.g. airway remodelling (70).  However, while cough variant 
asthma is well recognised in adults, there is a paucity of related empirical data in 
children (72).  In the 2007 study, 9.5% of children who suffered from a dry night 
cough without wheeze had lifetime asthma compared with only 1% of children in 
2002.  Recognition and treatment of cough variant asthma is included in the GINA 
guidelines (5).  Increased ascertainment of cough variant asthma, following the 
implementation of the GINA guidelines, is a possible explanation for our findings.  
Reduced exposure to tobacco smoke may also have been a contributory factor.  In 
this study the prevalence of maternal smoking during pregnancy, the first year of the 
child’s life and currently, combined with smoking in the home had decreased 
significantly over the study periods; this reduction is in agreement with national 
figures (319) and is most likely as a result of anti-smoking legislation and 
governmental educational campaigns during the intervening years.   
5.2.2 Allergic rhinitis prevalence  
We found a significant increase in the prevalence of rhino-conjunctivitis in the study 
interval.  This finding is in agreement with the worldwide trend of an overall 
(although slight) increase in the prevalence of rhino-conjunctivitis in 6-7 year olds 
(320).  There is increasing evidence that exposure to busy roads has negative 
respiratory and sensitisation implications for children (321, 322).   ISAAC Phase 3 
found an exposure-response relationship between self-reported truck traffic exposure 
(validated by objective measures of traffic density) and rhino conjunctivitis 
prevalence (323).   Between 2002 and 2007, the Irish population moved from public 
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transport to private car ownership (22% greater), whilst car dependence, even for 
short journeys and commute times increased significantly (46).  It is possible that the 
consequent higher traffic-related air pollution may have been a significant factor in 
the increasing prevalence of rhino-conjunctivitis.  Examination of seasonal 
prevalence of rhinitis symptom demonstrated different patterns in both studies.  In 
2002, there was high winter/spring prevalence, which alleviated during the summer 
months and increased again for winter, indicating that symptoms were possibly of 
infectious rather than allergic origin (320).  In 2007, the prevalence of symptoms of 
rhinitis peaked in late spring early summer, which is more suggestive of allergic 
aetiology. 
 
In both time periods, the reported prevalence of current allergic rhinitis and eczema 
symptoms was significantly higher than the reported lifetime prevalence of hayfever 
and eczema respectively.  Over-estimation of symptom prevalence is a recognised 
limitation of epidemiological questionnaires, and misclassification of symptoms has 
also been found to often lead to physician underdiagnosis (102, 324).  Alterations in 
disease labelling and diagnostic practice greatly challenge epidemiological findings.  
Our study found good agreement between the prevalence of reported current asthma 
symptoms and lifetime asthma in both 2002 and 2007. 
 
The finding that asthma prevalence had stabilised while rhino-conjunctivitis had 
increased in this study is paradoxical, considering that both diseases are so related in 
pathogenesis (325).  However, it was the increase in prevalence of allergic rhinitis 
and eczema, as found in the current study, which supported the original proposal of 
the “hygiene hypothesis”.  Much debate and speculation exists about the differing 
impacts of environment on the development of childhood allergy in different 
populations and ages.  Asher et al. (7) suggest that environmental changes may have 
a greater impact on the prevalence of eczema and rhinitis, rather than asthma, in 
young children.  The complex interactions of environmental factors and the diversity 
of any subsequent changes that occur within these factors, vary between exposure, 
location and population, often resulting in contradictory findings (7, 102, 320).  
Nevertheless, some environmental factors authentically operate at population level, 
and the assessment of determinants and/or modifiers in the prediction of health 
effects can be of critical importance in highlighting interventions (7).    
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5.2.3 Eczema prevalence         
We found the prevalence of current eczema had significantly increased in our young 
population (age 6-9 years).  Raised symptom awareness from media and internet 
sources, may have resulted in reporting mild, non-persistent symptoms, however, our 
finding concurs  with ISAAC worldwide trends in 6-7 year old children (102).   The 
increasing prevalence is most likely due to strong environmental influences, rather 
than simply being of genetic origin (102).  It is plausible that the increasing eczema 
prevalence in the young children in our study is associated with elevated hygiene 
practices around young children and their activities, influenced by increased 
affluence and standard of living linked to Ireland’s economic success in the 1990s 
and early 2000s (46, 96, 326, 327).  In contrast to the rising prevalence of current 
eczema symptoms, the prevalence of lifetime eczema decreased over the study 
period.  This may be due to recall bias; however, alterations are more like to be 
multifactorial.  Improved diagnostic practice from the implementation of new criteria 
may have reduced physician misclassification of contact dermatitis as eczema.  Also, 
parents may self-treat mild symptoms rather than present to their doctor.   
5.2.4 Sex-specific prevalence of allergic disease 
We stratified our prevalence results by sex and in so doing, were able to demonstrate 
the direction of sex-specific alterations attributing to distributional changes.  The 
most striking changes were firstly, the increase of reported current wheeze in girls 
(23%), decreasing the ratio of male:female dominance, towards sex equalisation and 
secondly, the increase of lifetime prevalence of hayfever in boys (6%), resulting in 
equal sex-distribution.    
 
Male preponderance to asthma in young children had traditionally been the accepted 
norm, however, this male:female gap appeared to diminish in many studies, as 
substantial increases in asthma prevalence in young female children were reported 
(137, 143, 144, 162, 166).   Increased awareness and reporting of mild symptoms is a 
possible cause for the increase in female current asthma symptoms (143), although it 
is unlikely to be the only factor, as it would have affected both sexes.  Another 
hypothesis, is that current increasing levels of female precocious puberty (328) may 
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be decreasing the age of disadvantage for young males and in turn have contributed 
to the relatively higher increases in asthma prevalence in girls than in boys (166).  
However, further examination of sex-specific trends and risk factors are required to 
assess this hypothesis (143). 
 
The sex-specific prevalence of rhinitis and eczema are not reported to the same 
extent as asthma and to date, no clear pattern has emerged (137, 162, 166).  In the 
current study, the only sex-specific alteration in the prevalence of eczema related 
symptoms was the equalisation in the distribution of lifetime eczema, as a result of a 
significant reduction in the prevalence of lifetime eczema in boys.   
5.2.5 Co-morbidity of allergic disease 
We demonstrated that a high percentage of young Irish children continue to suffer 
symptoms of more than one allergic disease.  Our 2007 study showed a significant 
increase (3.2 - 4.1%, p<0.001) since 2002, in the current symptom prevalence of all 
three conditions.  Both study findings are significantly higher than ISAAC Phase 
Three, in which only 1% of 6-7 year old children suffered symptoms of all three 
conditions (7).  From 2002 to 2007, we also found increases (non-significant) in 
children suffering comorbidity of two conditions.   Internationally, ISAAC Phase 
Three also reported overall increases in co-prevalence at all levels, however the 
increases were very small, ranging from 0.1% to 0.4%.   Lifetime prevalence of all 
three allergic disorders in our 2007 study was 2%, minimally lower than in 2002 
(2.2%).  Our results compare favourably with those of Punekar and Sheikh, who 
found a clinician diagnosed co-prevalence of 2.5% for all three conditions (59).  
Although a cohort study (0–18 years),  a significant portion of children in their study 
who suffered co-morbidity of allergic disorders were diagnosed with all three 
conditions in early childhood allowing comparisons to be made with our study 
population.    
5.2.6 Strengths and limitations of Study 1 
The use of the validated ISAAC core questionnaire and methodology aim to ensure 
the comparability of results.  Our sample size of circa 1500 during both timeframes 
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may have limited our statistical power to detect severity of symptoms and our study 
interval of five years may have contributed to many of our unchanged indices.  On 
the other hand, although ISAAC recommended a sample size of 3000, they accepted 
trend data from centres with >1000 participants and also deemed five years as being 
an acceptable time interval for trend studies (7). Our study population were 
marginally younger in 2007 than in 2002, and the children in both our studies are 
slightly older than ISAAC (6-7 versus 6-9).  However overall, the trends found in 
our studies correlate well with worldwide ISAAC trends. 
 
We investigated the possibility of demographic alterations between 2002 and 2007 
threatening the comparability of our results.  From 2002, Ireland was experiencing 
an economic boom, which attracted migrant workers and their families to work and 
settle in Ireland.  According to National statistics, a large immigration from Eastern 
Europe occurred in 2004, after the Sturley study of 2002 (46).  The 2002 study did 
not collect data on nationalities; however, immigration was not evident in the 2007 
study, as it contained 88.2% Irish parents (the remaining 11.8% were divided evenly 
over several different nationalities).  Therefore, it is fair to say that demographically, 
both populations examined in each timeframe are comparable.   
 
As with many ISAAC centres, both studies were performed in the same mixed urban 
and suburban settings, different patterns may be apparent in rural populations which 
were not reported in this phase of our project. We did not perform clinical reviews of 
every respondent or diagnostic testing for the allergic phenotypes being studied.    
5.3 STUDY 2 – ASSOCIATIONS WITH ASTHMA AND ALLERGY 
Study 2, which examined the associations with asthma and allergy in 6-9 year old 
children (n=3464) from urban and rural locations in Cork, observed many positive 
and negative associations with parental and child exposures (exposures ranging from 
during parental childhood to currently in the child’s life).  Early childhood antibiotic 
consumption was positively associated with the development of asthma and allergic 
rhinitis (both current and lifetime).  Having had an early childhood respiratory 
infection was a risk factor for current and lifetime asthma, current and lifetime 
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allergic rhinitis and lifetime eczema. Positive associations between early 
gastrointestinal infection and current asthma and current allergic rhinitis were also 
found.  Passive smoking was a risk factor for current asthma, while maternal 
smoking in the child’s first year of life was found to protect against lifetime and 
current eczema prevalence.  An inverse association was observed between current 
exposure to farm animals and both current and lifetime asthma.  Current barn 
exposure was protective against the development of current allergic rhinitis, while 
positive associations between lifetime eczema and the mother being farm reared 
were observed.  Pregnancy barn exposure and year 1 stable exposure were risk 
factors for current eczema.  An inverse association was found between exposure to 
furry pets during pregnancy and lifetime eczema and current furry pet exposure was 
positively associated with current rhinoconjunctivitis.  Damp bedroom exposure 
during the first year of life was positively associated with lifetime asthma and full 
time crèche attendance in the first year of life was inversely associated with current 
asthma.  
5.3.1 Antibiotics and allergic airway disorders 
This study demonstrates that children with asthma and/or allergic rhinitis are more 
likely to have been prescribed antibiotics in the first two years of life.  Asthma and 
allergic rhinitis are intrinsically linked, often concomitant allergic airway disorders, 
which have been described as “one airway one disease”(85).  The mechanism of 
association between allergic disease and antibiotic consumption is biologically 
plausible, as GALT is a prime site for potential immunomodulatory effects.  GALT 
is not only the largest lymphoid organ in the body, it also houses a large amount of 
Treg cells and transcription factor Foxp3
 
Treg cells, which are critical for immune 
regulation (25).  Antibiotics destroy naturally occurring gut bacteria, thereby causing 
a reduction in flora diversity which may have a negative impact on 
immunoregulation (31).  Another factor supporting the causal role of antibiotics in 
this study is dose response relationship which is evident for asthma.  This dose-
response relationship for antibiotics was not evident for allergic rhinitis and the 
strength of association between antibiotic exposure and allergic rhinitis is weak with 
odds ratios ranging from 1.2 – 2.2 for all levels of antibiotics consumed.  This is a 
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slight anomaly considering that the two conditions are closely related, in terms of 
pathophysiology (325).   
5.3.2 Respiratory infections and allergy development 
The strength of the positive associations between having had a respiratory infection 
prior to 3 years of age and the prevalence of current and lifetime asthma, allergic 
rhinitis and lifetime eczema in this study are weak.  However, supporting evidence 
of a causative role of severe respiratory infections is strong for asthma (the 
investigated allergy is most commonly asthma), if the infection is viral in nature (41, 
241, 243).  A US population-based retrospective birth cohort study observed a dose-
response relationship between the severity of bronchiolitis symptoms and both the 
development of and severity of early childhood asthma (243).   Our study does not 
have data relating to the type of respiratory infection each child suffered, however, 
bronchiolitis is a very commonly reported childhood respiratory infection, and is 
usually of viral aetiology (241).   
 
Initial understanding of the hygiene hypothesis supported the notion that infections 
promoted Th2 cell maturation and therefore protected against allergy development.  
However, early childhood viral respiratory infections, which are severe in nature, 
have been found to be positively associated with slow Th1 development and allergic 
disease (40).  The proposed causative link is complex, but three main theories exist 
(42).  Firstly, it is suggested that early exposure may cause asthma in a period when 
the respiratory and immune system are immature and vulnerable (250).  Secondly, it 
is hypothesised that respiratory viral infections may be more evident in children who 
are pre-disposed to allergy. Thirdly, combining the two former theories, it is 
postulated that respiratory infections increase the risk of the development of asthma 
in children who already have a pre-existing risk of developing an atopic condition 
(40-42).  This is thought to be caused by a synergistic interaction between the 
inflammatory response and pre-existing sensitisation in rapidly developing immature 
lungs (229, 329).  Evidence is increasingly emerging to support the latter theory.  A 
recent birth cohort study reported that severe viral lower respiratory tract infections 
in infancy and early atopy were found to be risk factors for persistent wheeze and 
asthma in a cohort of children with high atopic risk (41) and COAST found that 
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having suffered from RV by the age of 3, hugely increased the risk of developing 
asthma by the age of 6 (OR, 31.7; 95% CI, 10.6 - 94.9) in a high risk population 
(241).    
 
The literature naturally focusses upon the allergic disease of asthma, as opposed to 
eczema and allergic rhinitis and therefore, the current study does not have supporting 
evidence towards the associations found between early respiratory infections and the 
development of these allergic diseases.  However, the causal link found for eczema 
and allergic rhinitis is biologically plausible, considering that asthma development is 
often preceded by eczema in pre-disposed children, and the close aetiological link 
between asthma and allergic rhinitis, compounded by the fact that many children 
suffer concomitant allergic disorders (61, 88). 
5.3.3 Respiratory infections, antibiotics and allergic airway disorders  
The joint association with current allergic airway disease, early exposure to 
antibiotics and early respiratory infections in this study highlights the possibility that 
children may have been incorrectly diagnosed and treated with antibiotics for what 
may have been viral infections.  While it may be due to reverse causation, the 
association is biologically plausible and merits exploration.   
 
Respiratory infections are common in early childhood, often causing parents in 
developed countries to consult their General Practitioner (GP).  Despite the majority 
of respiratory symptoms being of viral aetiology, and therefore self-limiting, with no 
proven benefit from antibiotic therapy (330), GPs often prescribe antibiotics for their 
treatment (331).  It is accepted that it can be very difficult to make a diagnosis of 
asthma rather than of viral respiratory infection in children, as the symptoms may be 
similar and children without asthma can present with the classic symptoms of 
wheeze or cough (146).  In recognition of this, the Global Strategy for the Diagnosis 
and Management of Asthma in Children 5 Years and Younger was developed as a 
resource of evidence based information which provides step-by-step guidance 
regarding diagnosis and care of children with asthma (146).   
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There is widespread recognition that the overuse of antibiotics has negative 
implications in terms of population resistance (332-334), nevertheless, GPs often 
prescribe antibiotics because they have diagnostic uncertainty and fear potential 
complications associated with respiratory tract infections(331) (331).  The National 
Institute for Health and Clinical Excellence (NICE) recently published evidence-
based guidelines regarding the management of patients with respiratory tract 
infections, presentations of respiratory infections which are likely to develop 
complications and antibiotic management strategies (no antibiotic prescribing, 
delayed antibiotic prescribing and immediate antibiotic prescribing) (335).   
Advising to delay “filling the antibiotic script” and only to fill the prescription if the 
symptoms persist is already employed by many GP’s (336, 337).   However, GPs 
need to be convinced with regard to the available evidence; antibiotic prescriptions 
are on the increase and have shifted towards antibiotic prescription for non-specific 
upper respiratory symptoms (256).  Scepticism exists amongst GPs regarding the 
balance of prescribing to prevent complications and the risk of antibiotic resistance 
(338).  The fear is that they may be side-stepping the guidelines by avoiding using 
the formal diagnoses for which NICE have recommended delayed or no antibiotic 
therapy (256).   
 
Perceived parental pressure has also been demonstrated to affect antibiotic 
prescribing practices (331, 339) although, communication of information and 
negotiation regarding management between parents and their GP has been 
demonstrated to be effective in relieving this pressure (340-343).  Effective 
communication negotiating antibiotic strategies, combined with setting realistic 
expectations about the duration of the signs and symptoms, may reduce parental fear 
and anxiety (341, 342, 344).  Time is not a relevant argument, as no difference has 
been found between the time spent by GPs with children who receive antibiotics and 
those who do not (345).  Nonetheless, it is accepted that parental expectation can be 
a powerful persuasive factor in the prescribing of antibiotics.  Many studies have 
shown that parents expect that their child will be prescribed antibiotics when they go 
to their GP for a consultation (339, 346, 347).   
 
An Irish study examining the practices and attitudes of GPs revealed that most felt 
under pressure to prescribe and over half had prescribed antibiotics inappropriately.  
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Practitioners with heavy workloads and younger GPs (under 40 years) were more 
likely to inappropriately prescribe antibiotics (339).  Antibiotic resistance is a cause 
for concern in Ireland as there has been a dramatic increase in antibiotic 
consumption (especially broad spectrum penicillin) in the recent years (mid-to-high 
range use in Europe), raising concern about developing resistant bacteria (348-350).  
A programme of GP education has been put in place to address the rising antibiotic 
prescriptions (348) and public awareness campaigns are reducing public expectation 
of antibiotic therapy (256), however in order for campaigns to be successful they 
need to employ modern marketing strategies and technical expertise to attract 
attention and effect change (351).  Continuing Medical Education programmes 
provide an ideal forum for educating GPs regarding treatment of viral respiratory 
illness without antibiotics.  Qualitative assessment of a blended-learning initiative 
for GPs called Stemming the Tide of Antibiotic Resistance (STAR) Educational 
Program increased GP awareness of the dangers of antibiotic resistance and built 
confidence in diagnosing viral illness while improving their communication skills 
(352).    
 
The information in our study in relation to antibiotics during the first two years of 
life was attained retrospectively when the children were aged 6-9 years, and 
therefore recall bias has to be considered.  Furthermore, it has been suggested that 
parents of asthmatic children may remember more about treatment of their children 
than those of non-asthmatic children, however no empirical evidence exists to 
support this bias (37).  Associations with allergy development are mainly found with 
broad-spectrum antibiotic consumption (32, 353, 354).  We did not acquire 
information regarding the type of antibiotics consumed (narrow or broad spectrum). 
5.3.4 Gastrointestinal infections and allergic disease 
This study found a positive association between gastrointestinal infections and the 
prevalence of asthma and current allergic rhinitis symptoms.  We do not know the 
temporality of the gastrointestinal infection and allergy development in this study 
and the strength of association is weak (current asthma: OR 1.3; 95% CI 1.07, 1.67, 
lifetime asthma: OR 1.3; 95% CI 1.07, 1.63) and current allergic rhinitis: OR 1.4 
95% CI 1.15, 1.73).  However, this finding is biologically plausible because of the 
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potential immunomodulatory effect of alterations, caused by infectious allergens, to 
the gut microflora in GALT (25).  The hygiene hypothesis would support a 
protective effect from gastrointestinal infections, that being said, the literature to-
date is inconsistent.  Exposures to foodborne infections, HAV, H pylori, T gondii 
have been found to protect against the development of allergy (26, 27, 233).  The 
outcome of no association between gastroenteritis in early childhood and allergy 
development has also been reported (30).  On the other hand, the findings in this 
study are supported by those of the MAC study, which reported that ≥ 3 episodes of 
gastroenteritis in the first two years of life was associated with an increased risk of 
developing asthma by 6 years of age (29).  The authors suggest that an 
exposure/response relationship may exist.  We do not have data on the number of 
infections suffered by each child.    
 
The immunomodulatory capacity of GALT remains an enigma, primarily due to the 
complexity of gut microflora.  Probiotics may hold the key to allergy prevention.  
Initial studies examining the effect of probiotics such as lactobacilli or bifidobacteria 
on allergy development appeared promising, although methodological issues were 
evident (355).    However, in 2010, a review of 7 randomised controlled trials which 
examined the association of pro, pre and synbiotics concluded that the results were 
conflicting and therefore no conclusions could be drawn nor recommendations made 
(356).  It is apparent that further examination is merited, as current knowledge of the 
properties and functionality of probiotics, as well as the inherent complexity of gut 
flora remains limited.  Genome-wide association studies (GWASs) may assist in 
unravelling some of the complex interactions between gut flora and allergy 
development (229).   
5.3.5 Maternal smoking and allergic disease 
This study demonstrated a positive association with current maternal tobacco 
smoking and current asthma symptoms. The risk of developing childhood asthma 
from exposure to environmental tobacco smoke has been repeatedly investigated 
with positive associations (180, 181, 357), although the evidence from systematic 
reviews initially supported that its effect was confined to younger children (358) 
(rationalised by its effect resulting in transient wheezers due to immature narrow 
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bronchial structures) and children born to high-risk parents (183).  Nevertheless, a 
recent meta-analysis of cohort studies examining the association of home tobacco 
smoke exposure on asthma development, found a positive association, irrespective of 
age or risk (184).  Environmental tobacco smoke contains approximately 4000 toxic 
chemicals (182).  The biological mechanism through which exposure to tobacco 
smoke might lead to asthma has also been explored and although the evidence is 
inconclusive, some theories exist.  Suggested mechanisms include exposure to 
smoking as being a direct irritant to the lungs, causing inflammation, or resulting in 
immunological hypersensitivity to allergens and exposure resulting in genetic 
mutations (180, 182).  Endotoxin exposure (high levels found in tobacco smoke) 
from exposure to tobacco smoke in the home has also been implicated.  The 
suggested mechanism is that endotoxin exposure causes high IgE levels, thereby 
predisposing exposed children to atopy (184).   
 
Smoking is a modifiable behavioural risk factor and therefore merits on-going focus 
in legislation and public health campaigns.  Ireland has been a world leader in anti-
smoking initiatives through prohibiting smoking in the workplace (359) and the 
overall prevalence of tobacco smoking in Ireland is steadily declining (23.6% in 
2010) (360).  Public health campaigns to highlight the dangers of passive smoking to 
children and legislation to ban smoking in the presence of children in cars are 
currently being debated (361). 
 
In contrast, a protective association between maternal smoking during the child’s 
first year of life and the prevalence of current and lifetime eczema was also found in 
this study.  Inverse associations have been previously reported (362).  However, the 
findings in the literature are inconsistent, as no association (187, 188, 363) and 
positive associations (186, 189, 364) have also been found.  It may be beneficial to 
employ Bradford-Hill’s criteria (302), when evaluating the likelihood of the finding 
being true or as a result of chance (Table 5.1). 
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Table 5.1    Application of the Bradford Hill Criteria to examine the inverse association 
between maternal tobacco smoking and childhood eczema 
Bradford Hill Criteria 
 
Study findings 
Strength of association  OR is small (current eczema: OR 0.7; 95% 
CI 0.57, 0.94 and lifetime eczema: OR 0.8; 
95% CI 0.58, 0.97).   
 
Consistency  
 
The finding has been previously reported 
(362). 
 
Specificity  The association is not specific to children 
exposed to tobacco smoke, as eczema also 
occurs in unexposed children. 
 
Temporal relationship  
 
The temporal relationship cannot be 
ascertained, but it is likely that maternal 
smoking preceded childhood eczema.   
 
Biological gradient  A dose-response relationship does not exist. 
 
Plausibility  Bacterial endotoxin is an active component 
of cigarette smoke (365).  Endotoxin 
exposure has been found to protect against 
eczema development (366). Therefore The 
association is biologically plausible.  
 
Coherence  
 
The finding is supported by the predominant 
theory of the microbial (hygiene) hypothesis.   
Experiment  It is unethical to experiment with childhood 
exposure to tobacco smoke. 
Analogy  Parents who may have ceased to smoke 
when their child presented with an allergy 
may have incorrectly reported their child as 
being unexposed in early life, thereby not 
reflecting the reality and pushing the relative 
risk downwards (184).  Also, parental 
smoking behaviour in relation to their child’s 
health is a sensitive subject and results may 
be skewed by under-reporting (183).   
 
 
Taking all these considerations into account demonstrates that maternal smoking 
may be protective against the development of childhood eczema.  However, 
irrespective of whether or not protection is conveyed, smoking has such deleterious 
effects on human health; it will not be posited as a preventative measure against 
childhood eczema development.      
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5.3.6 Rural exposures and allergic disease 
This study found that the prevalence of current and lifetime asthma decreased 
steadily as home location became more rural.  In logistic regression analysis, farm 
home location was significantly associated with current asthma and current allergic 
rhinitis at univariate level; however, the association lost significance when adjusted.  
Following full adjustment, current farm animal exposure remained inversely 
associated with both current and lifetime asthma and current barn exposure remained 
protective against the development of current allergic rhinitis.  These inverse 
associations between the environmental exposures of barns and livestock and 
childhood allergic diseases are have been demonstrated by many studies throughout 
the world since the nineties (262, 263, 265, 267, 268, 367-369).  Despite this, the 
mechanism of the protective effect is not fully understood.  This is most probably 
due to the complexity and timing of a multitude of gene-environment interactions 
with different stages of innate and adaptive immunity (20).  The diversity of 
microbes to which farming children are exposed appears to be a key factor in 
promoting modulation of the immune system (266).    
 
While most protective effects were associated with current exposures to farming 
interactions in this study, we also observed that exposure to farm animals in the first 
year of life protected against co-morbidity with the three allergic diseases of asthma, 
allergic rhinitis and eczema.  Epidemiological data highlights early exposure 
(prenatal, perinatal and the first three years of life) as being a critical period of 
importance for the beneficial epigenic and immunomodulatory effects from exposure 
to a farming environment (20, 126).  For example, cord blood analyses from 
neonates of farming mothers have demonstrated higher Treg cell counts and  more 
efficient Treg cell functioning in comparison to cord blood from neonates of non-
farming mothers (329). 
 
Much evidence exists demonstrating the consumption of unpasteurised milk as being 
protective against the development of childhood allergic disease (267, 268, 369), 
however, this was not apparent in the current study. This is unusual, considering that 
raw milk consumption is a commonplace practice in Irish farming families (54).  The 
vague wording of the question relating to unpasteurised milk may have contributed 
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to the lack of association found in this study.  Parents were asked if they or their 
child regularly consumed unpasteurised milk, but “regularly” was not defined.  
Furthermore, there are many types of milk available on the market, it is possible that 
parents may have been confused by what was meant by the term “unpasteurised 
milk”.   
 
Paradoxically, this study found a positive association between pregnancy barn 
exposure and year 1 stable exposure and the development of current eczema and also 
between the mother being farm reared and lifetime eczema.  Perkin and Strachan 
also found that the protection of farming environments did not extend to protection 
against eczema although they did not find them as a risk factor either (265).  The 
relationship between eczema and farming has not been extensively reported in the 
literature.  The PARSIFAL study examined the effect of the farming environment on 
the development of eczema symptoms and reported that the only apparent significant 
association was a protective effect from the child’s involvement in haymaking (370).  
This was associated with elevated TLR levels in children, indicating the innate 
immune system’s recognition of microbes.  Alternatively, this finding may be due to 
reverse causation, as children with eczema may be unable to participate in 
haymaking (370).  That being said, perhaps another confounding exposure exists to 
explain the causation of childhood eczema in the rural setting. 
 
Results worldwide are variable, most likely reflecting the different farming practices 
and microbial exposures. Further studies which assess the multitude of microbial 
exposures associated with different types of farming and in different populations are 
merited.  For example, arable farming has different environmental exposures to 
livestock farming.  Arable farming exposure demonstrated no protective effects 
against childhood allergy in an Australia, however, farming methods are perhaps 
different in Australia to those in Europe (262).  Modern technological advances such 
as GWAS may be useful in classifying the various interactions and presentations.   
 
As the prevalence of current asthma decreased from urban to rural habitation in this 
study, the impact of air quality must be addressed.  A recent review of prospective 
cohort studies which examined the effect of traffic exhaust on allergic sensitisation 
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and asthma development concluded that exposure to traffic exhaust fumes increases 
the risk of respiratory symptoms in children (371).  This study did not enquire about 
distance from busy roads or traffic exposure; instead, it used the proxy of self-
reported location of home to assess air quality exposure and therefore cannot make 
any causal inferences.   
5.3.7 Furry pets and allergic disease 
This study found a protective association between exposure to furry pets during 
pregnancy and lifetime eczema.  Paradoxically, current furry pet exposure was 
positively associated with current rhinoconjunctivitis.  The strength of the inverse 
and positive associations are weak (OR 0.8; CI 0.61, 0.95 and OR 1.3; 95% CI 1.02, 
1.75 respectively), nonetheless, they are supported by findings in other studies.  A 
recent systematic review of birth cohort studies reported that that perinatal exposure 
to dogs or cats conveyed protection against eczema by 3 years of age (281).  
Furthermore, as mentioned earlier, the prenatal period appears to be a “critical 
window” for immune system modulation towards protection against allergic diseases 
from animal and microorganism exposures (126, 266, 270, 281, 329). As with the 
effects from rural exposures, potential mechanisms of the protective 
immunomodulatory effects of pet exposure also remain elusive, although, cat 
allergen exposure in the home has been demonstrated to effect chemokine receptor 
expression on CD8
 + 
cells (372).   
 
Current evidence suggests that pet allergen exposure exacerbates the symptoms of 
allergy once sensitisation has occurred (282), which might explain the positive 
association of current pet exposure in relation to rhino-conjunctivitis in our study.  A 
factor to consider is the possible variation in levels of contact that people have with 
their pets both within each household and throughout the world. For example, it is 
suggested that protective associations may be confounded by avoidance behaviour in 
families who are at high risk (281).  Cultural norms may also be influential.  
Traditionally, in Ireland, dogs and cats were reared for their functionality on farms 
for animal and vermin control, as opposed to being family pets.  This cultural 
attitude still prevails (373) and while many Irish families have a pet, it is often the 
case that the pets live outdoors, especially in the countryside.  In other cultures, pets 
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are generally accepted as indoor co-inhabitants.  Future studies need to elucidate 
further information regarding the pet environment, by enquiring whether the pet is 
kept indoors or outside and establish the amount and intensity of pet contact to 
which the child is regularly exposed.    
5.3.8 Damp bedroom and allergic disease 
Our finding that damp bedroom exposure in the first year of life was a risk factor for 
lifetime asthma (OR 1.4; 95% CI 1.07, 1.89) is in line with international evidence 
(283, 374).  Despite the fact that this exposure has been implicated in the 
development of asthma for several years, the mechanisms of the effects and all of the 
causal agents have not yet been identified.  Some fungi have been associated with 
immune system activation (285) and sensitisation (286).  Positive associations have 
been found between exposure to Penicillium spores and the prevalence of wheeze 
and respiratory infections in the first year of life (287, 288).  However, studies to 
date have not collected fungal components from children’s homes for analysis or 
identification (284).  With current technological advancements, this may be an area 
which would merit further investigation.  Identification of causal agents may reveal 
further knowledge regarding the mechanisms of causality.  
5.3.9 Early daycare attendance and allergic disease 
This study found that having attended a crèche full-time in the first year of life was 
protective against the development of current asthma at 6-9 years.  Although the 
association is weak (OR, 0.7; 95% CI, 0.53, 0.94), this finding correlates with the 
Tucson Children’s Respiratory Study and MAAS birth cohort study, both of whom 
reported inverse associations between early daycare attendance and wheezing by the 
ages of 13 and 5 years respectively (194, 202).  In accordance with the hygiene 
hypothesis, the assumed mechanism of protection is that early daycare attendance 
provides a microbial rich environment which promotes immune system development 
(194).   This is plausible as attendance at day-care centres exposes children to many 
infections and is associated with increased risk of upper and lower respiratory tract 
infections (195, 200).   
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We did not find any significant associations between allergic rhinitis and eczema.  
Perhaps a more comprehensive questionnaire would elucidate the size of the day-
care centre attended, as well as the frequency and duration of attendance.   
5.3.10 Strengths and limitations of study 2 
This is a cross sectional study and therefore is unable to definitively ascertain 
causality, as the temporality of exposure and disease cannot be determined.  
However, international cross-sectional studies, such as ISAAC, have provided 
valuable associations for further investigation.  Many exposures may genuinely 
operate at population level, and the identification of modifying factors in disease 
development can be of huge benefit in highlighting areas for further research (7).  
Furthermore, to assess causal links, associations were evaluated using the Bradford-
Hill criteria.   
 
Recall bias most likely exists, as many of the questions pertain to events from 
several years prior to the study.  This may have been particularly evident in the 
relatively large number of positive responses to questions relating to children having 
suffered the notifiable childhood infections of meningitis and measles.  That being 
said, this study demonstrated many significant associations which are in accordance 
with current literature.   
5.4 STUDY 3 – QUASI-RETROSPECTIVE COHORT STUDY  
Study 4, which examined the natural history of allergic disease in children aged 6-9 
until they were aged 11-13 (2002-2007) found a decrease in current asthma 
prevalence, while lifetime asthma prevalence remained stable.  There was an 
increase in current rhino-conjunctivitis and lifetime hayfever, whereas the prevalence 
of current allergic rhinitis remained stable.  It also found a stabilisation of current 
eczema prevalence, but an increase in lifetime eczema.  Most asthma symptoms 
moved from male dominance to sex equalisation or female dominance, eczema 
symptoms had shifted to female preponderance and there were no differences in the 
sex-distribution of the symptoms of allergic rhinitis.   
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5.4.1 Asthma prevalence (age 6-9 to 11-13 years) 
In this cohort of children, we found that the prevalence of current asthma had 
decreased since they were surveyed in 2002.  Most asthma symptoms moved from 
male dominance to sex equalisation or female dominance.  The trajectory found in 
this study for asthma of reducing prevalence during middle childhood and early 
adolescence is in agreement with long term studies of the natural history of the 
disease (81).  Furthermore, we can presume that the reduction is most likely to be 
due to an age effect rather than a period effect, as the simultaneous study of young 
children in the same schools (Study 1) revealed a 23.5% asthma prevalence, which is 
much higher than the older children in this study when they were concurrently 
examined.   
5.4.2 Allergic rhinitis prevalence (age 6-9 to 11-13 years)  
We found that the prevalence of current rhino-conjunctivitis and the severity of 
allergic rhinitis symptoms became higher as our children grew older and that the 
prevalence of lifetime hayfever also increased.  Similar findings were reported by a 
German multi-centre cohort study (0-13years), which found that the prevalence of 
allergic rhinitis symptoms increased steadily each year from the age 4 to 13 years, 
with over half of the children affected being classified as having severe/persistent 
allergic rhinitis by 13 years of age (89).  Paradoxically, the prevalence of current 
allergic rhinitis symptoms remained stable over time. 
 
The prevalence of allergic rhinitis symptoms in the 2002 study were higher in spring 
than in the peak pollination season of summer, indicating that symptoms may have 
been  associated with infection rather than allergy (320), although the possible 
effects of tree pollination cannot be ruled out.  The 2007 study demonstrated a peak 
in reported allergic rhinitis symptoms in late spring/early summer, which coincided 
with the data collection period.  However, of note, the question pertaining to 
seasonal symptom prevalence is prone to recall bias in cross-sectional studies.  We 
found no differences in the sex-distribution of the symptoms of allergic rhinitis.  
Different gender effects have been noted between atopic and non-atopic rhinitis (89, 
375), however, we did not perform sensitisation diagnostics on our study population.    
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5.4.3 Eczema prevalence (age 6-9 to 11-13 years) 
We found a sizable decrease in the prevalence of lifetime diagnosed eczema (21.6% 
to 12.0%), which may be partly due alterations in disease labelling and diagnostics 
over the study interval, which are recognised issues with longitudinal studies (102). 
On the other hand, we found no alteration the prevalence of current eczema 
symptoms from 2002 to 2007 in our cohort of children.  The natural history of 
eczema is unclear, as examination has uncovered several phenotypes with varying 
patterns of remission and relapse (376).  However, the general consensus from birth 
cohort studies is that eczema symptoms present prior to 2 years of age with 
approximately 50% remission into adolescence and adulthood (376, 377).  Our 
finding of a shift to female preponderance of eczema symptoms in adolescence is in 
line with other studies (376, 378).  Puberty is considered a critical period for the 
transition of sex-distribution of eczema and is thought to be attributable to hormonal 
triggered alterations in skin surface pH and/or stimulation of pro-inflammatory 
cytokines (376).   
5.4.4 Co-morbidity of allergic disease (age 6-9 to 11-13 years) 
The prevalence of co-morbidity with current allergic symptoms remained largely 
unchanged.  However, lifetime diagnosed co-morbidity of asthma with hayfever and 
hayfever with eczema increased, while co-morbid asthma and eczema decreased 
with age.  Co-morbidity remains an issue of concern for our population of children 
aged 11-13.  Further in-depth, matched longitudinal studies are required to assess the 
temporality of symptom incidence in this population. 
 
The decrease in the prevalence of asthma, combined with the stabilisation of eczema 
prevalence and the increase in the prevalence of rhino-conjunctivitis from young 
children to adolescents, is in agreement with the findings of other studies throughout 
the years (81, 89, 375, 376).  To examine the prevalence of asthma and allergy into 
adulthood is problematic, as no adult version of ISAAC exists.  The National Asthma 
Campaign Manchester Asthma and Allergy Study (n=5687) found that 9.7% of 
adults were diagnosed with asthma, 20.6% with hayfever and 13% with eczema 
(379).  The prevalence for adult asthma and eczema was predominantly female and 
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allergic rhinitis prevalence was equally distributed between the sexes.  These 
findings further support the trajectory we found in our cohort study. 
5.4.5 Strengths and limitations of study 3 
A limitation to this quasi-retrospective cohort study is the fact that the data was not 
individually linked; however, we know that only a 5% variance of class drop-in/out 
existed, which is unlikely to be associated with the prevalence of asthma and allergy.   
Also, the 2007 study only included half of the 2002 study population.  We cannot 
account for prevalence in the other half of the population, as they had progressed to 
secondary school; however, there is no reason to suggest that their inclusion would 
have altered the prevalence in any direction. 
 
However, these facts considered, the findings in this study are well supported by the 
reports of other longitudinal studies.  There is a strong possibility of recall bias in 
questions relating to early childhood exposures from 8-10 years earlier.  Parents of 
children with allergic conditions may remember more about treatment of their 
children than those without, however no empirical evidence exists to support this 
bias (37).  
5.5 STUDY 4 – TRENDS OF PREVALENCE IN IRISH ADOLESCENTS 
Study 4, which examined the trends of prevalence in adolescents, aged 11-13 in this 
2007 study and adolescents aged 13-14 years in the Irish ISAAC study of 2002/3, 
revealed a decrease in the prevalence of current asthma and a stabilisation in the 
prevalence of lifetime asthma.  Lifetime hayfever had decreased, while rhino-
conjunctivitis prevalence remained stable.  The prevalence of current eczema had 
increased, while lifetime eczema prevalence had stabilised.   
 
When interpreting these data it is important to consider the slight age variation 
between study populations and that the data in the ISAAC study was attained by 
self-report, whereas in the 2007 study, the data was achieved by parental report.   
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The finding of a large decrease in the prevalence of current asthma (26.7% to 17.1%) 
is in agreement with the ISAAC Phase Three finding of decreases in current asthma 
prevalence in centres with previously high prevalence (7), as Ireland was previously 
found to have the 2
nd
 highest asthma prevalence in Europe (380).  The research 
comparing parental and adolescent responses have found that adolescents report 
higher prevalence of asthma than their parents (316, 317, 381), therefore perhaps the 
actual decrease may not be as large as found in this study. 
 
We found that the prevalence of rhino-conjunctivitis remained unaltered since 
2002/3.  Phase Three ISAAC found a slight overall increase in adolescent rhino-
conjunctivitis prevalence since Phase One, however, the Irish ISAAC data revealed a 
significant decrease in lifetime prevalence in the study interval (320).  In contrast, 
we found that the prevalence of lifetime hayfever had plummeted from 31.5% to 
14.9%. Perhaps part of the reduction in lifetime hayfever could be explained by the 
fact that adolescents tend to report higher prevalences of allergic rhinitis than their 
parents (316, 317).  That being said, it is also fair to say that as the decrease in 
prevalence is so large, a true reduction in prevalence is also a likely conclusion.   
 
We also found rising current eczema prevalence while lifetime eczema prevalence 
had stabilised.  This is in concordance with the international findings of stabilising or 
decreasing rates in many centres (from developed countries) with previously high 
rates (102).  In this age group, Irish ISAAC data revealed a significant decrease from 
Phase One to Phase Three having previously had a high prevalence in the former 
(102).  Comparisons show higher current eczema prevalences when reported by 
adolescents, whereas higher lifetime eczema prevalences are evident when 
questionnaires are parentally reported.  These factors give further credence to the 
findings in this study.   
5.5.1 Strengths and limitations of Study 4 
This study has two major limitations.  Firstly, the age of the two study populations is 
slightly different (ISAAC age 13-14, Duggan, age 11-13), however, it is unlikely 
that a marked variance in prevalence would exist between the age groups; bar the 
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possible deleterious effect should the children have commenced smoking in the 
interim (382).   
 
Secondly, the data in the ISAAC study was attained by self-report, whereas, in the 
2007 study, parentally reported data was used, as the adolescents were younger.  
Except for lifetime eczema prevalence, in ISAAC, adolescents have been 
demonstrated to report higher prevalences of allergic disease than parental report.  
The potential variation in results have been taken into consideration when examining 
the prevalence results in this study, however it does impede our ability to estimate 
prevalence trends. 
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5.6 IMPLICATIONS OF THIS THESIS 
This thesis contributes to the published work in a number of ways.  Providing 
baseline prevalence rates and on-going trends of prevalence of childhood allergic 
disease are critical components of healthcare planning and management, as they 
assist in formulating policy to source and allocate funding and resources towards the 
care of those who are in most need.  Furthermore, they ensure that the burden of 
childhood allergies remain high on the public health agenda, thereby promoting 
targeted national and international research funding for investigation into causative, 
preventative and treatment measures.  Moreover, the prevalence estimates in this 
thesis are likely to be generalisable to the Irish population.  Cork is reflective socio-
demographically to the rest of Ireland, as each county has a city or large town and a 
rural component.  
 
This study provides an insight into the natural history of allergic disease in Irish 
school children.  It increases the body of knowledge regarding the impact of age and 
gender on expression of these allergic diseases from childhood to adolescence in this 
population. Longitudinal studies are important as they assist with clinical 
recognition, prognosis assessment and ultimately improve management.   
 
The finding of early childhood respiratory infection and antibiotic therapy as risk 
factors for developing asthma and allergic rhinitis, raises the possibility that children 
with allergic airway disease may have been incorrectly diagnosed and treated for 
viral infections, prior to diagnosis.  The time is right for antibiotic stewardship, as 
antimicrobial resistance is an issue of worldwide concern.  This study finding may 
increase the impetus for antibiotic stewardship and provide a focus for educational 
campaigns for both GPs and the public.  Educational programmes which encourage 
the use of effective communication during consultations, to ensure realistic parental 
expectations about the duration of the signs and symptoms, may reduce fear and 
anxiety in parents and reduce the pressure brought to bear on physicians to prescribe 
antibiotics unnecessarily.   
 
The finding that passive smoking was a risk factor for current childhood asthma 
supports the continuation of public health campaigns to highlight the dangers of 
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passive smoking to children.  This positive association also gives credence to future 
legislative action in order to protect children from exposure to tobacco smoke, such 
as the one planned in Ireland of banning smoking in cars when children are present.   
   
The study finding of lower prevalence of allergic airways disorders in rural 
schoolchildren and the protective association between early childhood farm animal 
exposure and current asthma, adds to previous calls regarding the potential benefits 
of early exposure to an environment with a wide diversity of microbes.  This adds to 
the burgeoning evidence which is moving the world towards a new understanding of 
the hygiene hypothesis; perhaps in the future the “microbial hypothesis” will be the 
conversant descriptive expression. 
5.7  RECOMMENDATIONS FOR FUTURE RESEARCH 
Trend analyses of asthma and allergy needs to continue in this population and can 
now examine trends in young children from both urban and rural environments.  A 
longitudinal study to examine the course of allergic disease is now also possible as 
this study included data to enable matching.  This thesis highlighted some very 
interesting associated risk and protective factors with childhood asthma and allergy, 
some of which merit further interrogation.   
 
The urban/rural gradient in asthma and allergic rhinitis prevalence, found in this 
study, requires further enquiry.  Questionnaires need to be more specific in their 
examination, for example, to quantify how much farm animal exposure and to which 
animals are children exposed.  Also, when enquiring about regular unpasteurised 
milk consumption, questionnaires need to ensure clarity of what is meant by 
unpasteurised milk, as well as defining the term “regularly”.  Additional exploration 
of microbial exposures and determination of dietary components (for example, raw 
milk) may unravel more knowledge regarding the protective elements in a rural 
environment.   
 
Birth cohort studies to examine allergic diseases in Ireland are warranted as they are 
the ideal study design to determine causality.  Ireland is one of the few countries 
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where farming remains a viable occupation for many families and where children 
still partake in farming activities. It is an ideal location to examine diverse farming 
exposures in children as there are 117, 900 agricultural holdings, of which 94% are 
family owned and run (53).  The Irish farming exposures are predominantly 
associated with livestock.  In 2007, 93% of farms specialised in livestock of which, 
16% focussed on dairy farming, 23% in breeding sheep, goats and other grazing 
livestock and 54% mainly reared cattle.  Further identification of protective farm 
related exposures may advance our understanding of the protective mechanism and 
may potentially lead to the development of preventative measures to alleviate the 
global burden of these complex childhood allergic diseases. 
 
It is possible that other unidentified protective exposures exist in the rural 
environment. For example, new evidence is emerging that Vitamin D plays a 
significant role in immune development (374); and considering that farming involves 
a large outdoor component, this may be another mediating factor conveying 
protection.  Future studies might include measurement of Vitamin D serum levels, 
diet and sunlight exposure in rural and urban environments.  
 
This study included questions about the source of drinking water in the first year of 
life and currently, but found no association with childhood allergy.  Rural water has 
been demonstrated to be greatly affected by the microbial content of the surrounding 
soil (277) provided it is not too heavily chemically treated.  This study did not 
enquire into the presence or absence of chemical treatments of home wells/group 
scheme water sources.  Future studies may be more specific in their questions and/or 
obtain samples from wells in an effort to examine this hypothesis further. Another 
factor to consider is to extend the enquiry to elucidate if the household regularly uses 
bottled water for consumption.  
 
We used self-reported location of home to assess air quality exposure.  Future work 
in this area might obtain home addresses and employ GIS-based measures, to 
examine location characteristics, such as proximity to roads, traffic speeds, traffic 
jams, truck lanes, bus stops, intersections, industry and population density and trends 
in air quality (weather/seasonal patterns).  The development of statistical models to 
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assess associations with allergy using this data have been found to be of particular 
benefit in other studies, but remains at developmental stage (383).  
 
In view of the associations found in this study in relation to gastrointestinal 
infections, future studies might include detailed assessments of hygiene practices in 
early childhood as well as qualitative information regarding the type and frequency 
of gastrointestinal infections to which each child is exposed. Furthermore, taking 
into consideration the immunomodulatory capability of microbiota on GALT, 
continued interrogation of probiotics is warranted.  Research needs to investigate the 
possible as-yet-unknown probiotic interactions between probiotics and gut 
microflora, the complex functions of different probiotics, as well as the impact of a 
wide diversity of probiotics on allergy development.   
 
Respiratory infections are implicated as causative for childhood allergic airways 
disease.  Therefore the type, frequency and treatment of those infections require 
more detailed inspection.  Considering the powerful negative association between 
asthma and RSV-induced bronchiolitis, another avenue which may deserve further 
investigation is prophylaxis through the administration of anti-viral agents.  This is 
not a new concept; anti-viral agents are available, but very expensive and their long-
term benefits have not been proven (384, 385). 
 
The issue of the putative role of antibiotics in the development of allergic disease 
deserves further attention, as it may have implications for practice.  Future studies 
might investigate the type of antibiotics consumed, narrow or broad spectrum, as 
associations with asthma development are mainly found with broad-spectrum 
antibiotic consumption and atopic sensitisation (32, 353, 354). Qualitative 
assessment of practices might be effective in highlighting consultation process 
issues.  It would be particularly advantageous to examine the experiences of parents 
and children regarding the process of symptom development, prescriptions, 
diagnosis of allergic disease, their experiences with associated health services and 
the effect upon quality of life.    
 
On-going dynamic research into different populations and environments is critical to 
unravel protective exposures so that we may increase our understanding of the 
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complex mechanism through which these exposures convey their effect.  This may 
guide future interventions to alleviate the burden of childhood allergic disease.
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Headed Notepaper 
 
 
 
 
Date 
 
 
Dear XXXX, 
 
We are writing to ask if your school would be willing to participate in a follow-up study 
investigating the recent increase in allergies and asthma in children. You may remember 
assisting us with such a study a few years ago. That study found very high rates of 
allergy in children in Cork and we have been given funding by the Irish Lung 
Foundation to repeat the study this year. This study will pertain to first and second class 
students, however, we also wish to re-examine the sixth class students involved in the 
2002 study, as performed by Ms. Jennifer Sturley, who was awarded a PhD for this 
project, last year. 
 
As with the previous study, this study does not involve the children directly, but is 
based on information provided by the parents of children in first, second and sixth class, 
on questionnaires relating to the health of their child. Your assistance would be 
appreciated (through the class teachers) to facilitate the distribution and collection of the 
questionnaires provided by us.  
 
We will contact you by phone within a week to offer you further information and 
discuss possible participation in the study. We would be very happy to visit your school 
to discuss any concerns or questions you or your staff might have. 
 
By participating in this study, which is approved by the Cork Clinical Research Ethics 
Committee, you can contribute to improving the health of children in Ireland. Your 
participation would be greatly valued. 
 
Yours faithfully, 
 
_________________ 
Eileen Duggan, MA in Health Promotion 
Researcher, UCC 
 
Principal Investigators: 
Professor Jonathan Hourihane,  
Head of Department of Paediatrics and Child Health, UCC  
Professor Ivan Perry,  
Head of Department of Epidemiology and Public Health, UCC 
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Headed Notepaper 
 
 
Date 
 
 
 
Dear XXXX, 
 
We are writing to ask if your school would be willing to participate in a follow-up study 
investigating the recent increase in allergies and asthma in children.  In 2002, a study of 
children, in 25 Cork city and suburban Primary Schools found very high rates of asthma 
and allergy.  We have been given funding by the Irish Lung Foundation to repeat the 
study in Cork city and to extend it to include Primary Schools in Cork county.  
 
The study will pertain to first and second class students.  It does not involve the children 
directly, but is based on information provided by the parents, on questionnaires relating 
to the health of their child. Your assistance would be appreciated (through the class 
teachers) to facilitate the distribution and collection of the questionnaires provided by 
us.  
 
We will contact you by phone within a week to offer you further information and 
discuss possible participation in the study. We would be very happy to visit your school 
to discuss any concerns or questions you or your staff might have. 
 
By participating in this study, which is approved by the Cork Clinical Research Ethics 
Committee, you can contribute to improving the health of children in Ireland. Your 
participation would be greatly valued. 
 
Yours faithfully, 
 
_________________ 
Eileen Duggan, MA in Health Promotion 
Researcher, UCC 
 
Principal Investigators: 
Professor Jonathan Hourihane,  
Head of Department of Paediatrics and Child Health, UCC  
Professor Ivan Perry,  
Head of Department of Epidemiology and Public Health, UCC 
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Headed Notepaper 
 
Dear Parent/Guardian, 
 
The number of children with allergic breathing and skin problems is increasing.  The 
Department of Paediatrics and Child Health in UCC is carrying out a large study to 
investigate these conditions in children in first, second and sixth classes in Primary 
schools in the Cork area. If your child is in sixth class you may remember filling in a 
similar form a few years ago. That study found very high rates of allergy in Cork and 
we have been given funding by the Irish Lung Foundation to repeat the study this year. 
The study does not involve the children directly and is based on information provided 
by you, the parents, in the enclosed questionnaire. Most of the questions only require 
you to fill in the circle beside the correct answer, and it does not take long to fill in.   
 
If your child is adopted or fostered you may not know the answers to all the questions 
relating to your child, but please answer as many as you know.  However, please do not 
answer the questions relating to the child’s biological father and mother if your child is 
adopted or fostered. 
 
We would greatly appreciate it if you would fill in and return the questionnaire to the 
school, sealed in the envelope provided, even if your child doesn’t have any breathing 
or skin problems. We need information from as many parents as possible in order to 
assess the size of the problem and to increase our understanding of why these 
conditions are becoming more common. 
 
The information that you give is confidential.  Once the questionnaire has been returned 
you will not be contacted again, however, if you would like further information, please 
do not hesitate to contact the department at 021/4205015. 
 
This study is approved by the Cork Clinical Research Ethics Committee.  By 
participating, you may help to improve the health of children in Ireland.  Your 
contribution is greatly appreciated.      
 
Yours faithfully, 
 
__________________ 
Eileen Duggan, MA in Health Promotion 
Researcher, UCC 
 
Principal Investigators: 
Professor Jonathan Hourihane,  
Head of Department of Paediatrics and Child Health UCC  
Professor Ivan Perry,  
Head of Department of Epidemiology and Public Health UCC 
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Headed Notepaper 
 
 
 
 
Dear Parent/Guardian, 
 
The number of children with allergic breathing and skin problems is increasing, and the 
Department of Paediatrics and Child Health in UCC is carrying out a large study to 
investigate these conditions in children in first and second classes in Primary schools in 
the Cork area. A study in 2002 found very high rates of allergy in Cork and we have 
been given funding by the Irish Lung Foundation to repeat the study this year. The 
study does not involve the children directly and is based on information provided by 
you, the parents, in the enclosed questionnaire. Most of the questions only require you 
to put a tick in a box, and it does not take long to fill in.   
 
If your child is adopted or fostered you may not know the answers to all the questions 
relating to your child, but please answer as many as you know.  However, please do not 
answer the questions relating to the child’s biological father and mother if your child is 
adopted or fostered. 
 
We would greatly appreciate if you would fill in and return the questionnaire to the 
school, sealed in the envelope provided, even if your child doesn’t have any breathing 
or skin problems. We need information from as many parents as possible in order to 
assess the size of the problem and to increase our understanding of why these 
conditions are becoming more common. 
 
The information that you give is confidential.  Once the questionnaire has been returned 
you will not be contacted again, however, if you would like further information, do not 
hesitate to contact the department at 021/4205015. 
 
By participating in this study, which is approved by the Cork Clinical Research Ethics 
Committee, you can contribute to improving the health of children in Ireland. Your 
participation is greatly appreciated.      
 
Yours faithfully, 
 
__________________ 
Eileen Duggan, MA in Health Promotion 
Researcher, UCC 
 
Principal Investigators: 
Professor Jonathan Hourihane,  
Head of Department of Paediatrics and Child Health, UCC  
Professor Ivan Perry,  
Head of Department of Epidemiology and Public Health, UCC 
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INSTRUCTIONS FOR COMPLETION 
 
 PLEASE FILL IN THE QUESTIONNAIRE AND RETURN IN THE 
ENVELOPE TO THE CLASS TEACHER AS SOON AS POSSIBLE. 
 
 MOST QUESTIONS REQUIRE YOU TO ANSWER BY FILLING IN THE 
CORRECT CIRCLE, FOR EXAMPLE IF YOUR CHILD WAS BORN BY 
NORMAL DELIVERY, ANSWER AS FOLLOWS: 
 
 ● Normal vaginal delivery                ○ Vacuum delivery 
    ○ Forceps delivery   ○ Caesarean section 
 
 PLEASE WRITE ANY ANSWERS IN BLOCK CAPITALS INTO THE 
BOXES PROVIDED, FOR EXAMPLE IF YOUR CHILD WAS BORN IN 
IRELAND, ENTER      AS FOLLOWS: 
  
 
 
 
 PLEASE FILL IN ANY NUMBERS INTO THE BOXES PROVIDED, FOR 
EXAMPLE IF YOUR CHILD WEIGHED 6 POUNDS 5 OUNCES, AT 
BIRTH, ENTER AS FOLLOWS: 
 
               
               POUNDS      OUNCES 
                         
 
             OR, IF YOUR CHILD WEIGHED 3650 GRAMS AT BIRTH, ENTER AS: 
 
 
 
 
 
 PLEASE FILL IN THE DATE OF BIRTH OF THE CHILD AS FOLLOWS:  
  
 FOR EXAMPLE IF YOUR CHILD WAS BORN ON THE 19
TH
 OF MAY  
1995 ENTER AS: 
 
 
9 9 1 5 0 9 1 5 
3 6 5 0 
0 6 0 5 
I R E L A N D 
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Ballyhass Mixed National School, Cecilstown, Mallow, Co.  Cork  
Ballygown Mixed National School, Mallow, Co. Cork  
Scoil Ghobnatain Mixed National School, Mallow, Co. Cork   
Mercy Convent, Mixed National School, Buttevant, Mallow, Co. Cork  
Glantane Mixed National School, Glantane, Mallow, Co.  Cork  
Saint Patrick’s Boys National School, Mallow, Co. Cork   
Rathan Mixed National School, Rathan, Mallow, Co.  Cork  
Lisgriffin Mixed National School, Lisgriffin, Buttevant, Mallow, Co.  Cork  
Dromahane Mixed National School, Dromahane Mallow, Co. Cork 
Castletownroche Mixed National School, Castletownroche, Mallow, Co. Cork  
Burnfort Mixed National School, Burnfort, Mallow, Co. Cork  
Mallow No. 1 Mixed National School, Shortcastle, Mallow, Co. Cork  
Ath Na Lionta Mixed National School, Mourneabbey, Mallow, Co. Cork  
Baltydaniel Mixed National School, Newtwopothouse, Mallow, Co.  Cork 
Ballyclough Mixed National School, Ballyclough, Mallow, Co. Cork  
Mercy Convent Girls National School, Doneraile, Mallow, Co. Cork  
Little Island Mixed National School, Little Island, Co. Cork  
Ringaskiddy Lower Harbour Mixed National School, Ringaskiddy, Co. Cork  
Shanbally Mixed National School, Shanbally, Ringaskiddy, Co. Cork  
Crosshaven Girls National School, Crosshaven, Co.Cork   
Walterstown Mixed National School, Walterstown, Cobh, Co. Cork  
Bellevue Mixed National School, Bellevue, Cobh, Co. Cork  
Templebrady Mixed National School, Crosshaven, Co. Cork   
Rushbrook Mixed National School, Cobh, Co. Cork   
Monkstown Mixed National School, Monkstown, Co. Cork   
Crosshaven Boys National School, Crosshaven, Co. Cork   
Kilcredan Mixed National School, Ladysbridge, Castlemartyr, Co. Cork 
Baile Ui Chroinín Mixed National School, Cloyne, Midleton, Co. Cork 
Scoil Naisiúnta Na Scarta Leithe, Saleen, Cloyne, Midleton, Co. Cork  
Shanagarry Mixed National School, Shanagarry, Midleton, Co. Cork  
Castlemartyr Mixed National School, Castlemartyr, Midleton, Co. Cork   
Whitegate Mixed National School, Whitegate, Midleton, Co. Cork 
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St. John the Baptist Mixed National School, Midleton, Co. Cork   
Scoil Mhuire Naofa Boys National School, Carrigtwohill, Midleton, Co. Cork  
Ballintotas Mixed National School, Castlemartyr, Midleton, Co. Cork   
Scoil Realt Na Mara Mixed National School, Ballycotton, Midleton, Co. Cork  
Gaelscoil Mhainastir na Corann, Midleton, Co. Cork   
Midleton Convent Girls National School, Midleton, Co. Cork   
Cloyne Mixed National School, Cloyne,Midleton, Co. Cork  
Kildorrery Mixed National School, Kildorrery,Mitchelstown, Co. Cork  
Scoil Mhuire Mixed National School, Ballyhooley, Fermoy, Co. Cork   
Glanworth Mixed National School, Glanworth, Fermoy, Co. Cork   
Cahermore New Central Mixed National School, Cahermore, Eyeries, Bantry, Co. Cork 
Scoil Chaitigheirn na hAoirí Mixed National School, Eyries, Bantry, Co. Cork  
St James' Mixed National School, Durrus, Bantry, Co. Cork 
Kealkill Mixed National School, Bantry, Co. Cork   
Drumclough Mixed National School, Drumclough, Bantry, Co. Cork 
Derrycreha Mixed National School, Derrycreha, Bantry, Co. Cork  
St Brendan’s Mixed National School, Bantry, Co. Cork   
Óir Cheann Mixed National School, Eyries, Bantry, Co. Cork  
Inchiclough Mixed National School, Inchiclough, Bantry, Co. Cork  
Scoill Fhiachna Mixed National School, Glengarriff Co. Cork   
Adrigole Mixed National School, Adrigole, Bantry, Co. Cork 
Scoil An Chroí Ró Naofa Mixed National School, Castletownbere, Bantry, Co. Cork 
Bantry Boys National School, Bantry, Co. Cork   
Gaelscoil Bheanntraí Mixed National School, Warner House Bantry, Co. Cork  
Our Lady of Mercy Girls National School, Bantry, Co. Cork   
Kilcrohane Mixed national School, Durrus, Bantry, Co. Cork  
Carrigboy Mixed National School, Durrus, Bantry, Co. Cork  
Rushnacarra Mixed National School, Rushnacarra, Durrus, Bantry, Co. Cork 
Mochomhog Mixed National School, Cappaboy, Kealkil, Bantry, Co. Cork  
Ballyvognane Mixed National School, Aghina, Macroom, Co. Cork 
Chúil Aodha Barr d’Inse Mixed National School, Cúil Aodha, Macroom, Co. Cork 
Canovee Mixed National School, Carrigadrohid, Macroom, Co. Cork  
Scoil na Mona Fliche Mixed National School, Macroom, Co. Cork   
Carraig An Ime Mixed National School, Macroom, Co. Cork 
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Tarelton Mixed National School, Tarelton, Macroom, Co. Cork  
Rusheen Mixed National School, Coachford, Macroom, Co. Cork  
Kilbarry Mixed National School, Kilbarry Macroom, Co. Cork  
Dromleigh Mixed National School, Dromleigh, Macroom, Co. Cork  
Ballinagree Mixed National School, Ballinagree, Macroom, Co. Cork  
Ballyvourney Mixed National School, Carraig and Adhmaid, Macroom, Co. Cork  
Macroom Convent Mixed National School, Macroom, Co. Cork   
Scoil Lachtán Naofa Mixed National School, Cill na Martra, Macroom, Co. Cork  
Inchigeela Mixed National School, Inchigeela, Macroom, Co. Cork 
Clondrohid Mixed National School, Clondrohid, Macroom, Co. Cork   
Scoil Bhríde Mixed National School, Crossmahon, Bandon, Co. Cork   
Timoleague Mixed National School, Timoleague, Bandon, Co. Cork   
Presentation Convent Mixed National School, Bandon, Co. Cork   
Laragh Mixed National School, Laragh, Bandon, Co. Cork  
Ballinadee Mixed National School, Ballinadee, Bandon, Co. Cork  
Castlealack Mixed National School, Castlealack, Bandon, Co. Cork   
Bandonbridge Mixed National School, Bandon, Co. Cork   
Newcestown Mixed National School, Newcestown, Bandon, Co. Cork  
Gaelscoil Droichead na Bandán, Charley Hurley Park, Bandon, Co. Cork  
St Catherine’s Girls National School, Model Farm Road, Cork   
Scoil and Spiorad Naoimh Girls National School, Curraheen Road, Bishopstown, Cork 
STt Patrick’s Boys National School, Gardiners Hill, Ballyhooley Road, Cork  
Our Lady of Lourdes Girls National School, Ballinlough, Cork   
Scoil Muire na nGrás Greenmount, Cork   
Togher Boys National School, Togher, Cork   
Scoil Maoimh Bríd Girls National school, Eglantine House, Ballinlough, Cork 
Scoil Athair Maitiu Girls National School, Togher, Cork   
Scoil Mhuire Banríon  Girls National School, Mayfield, Cork  
Realt na Maidine Mixed National School, Ballyphehane, Cork   
Scoil Iosagáin Boys National School, Faranree, Cork   
Scoil Barra Naofa Boys National School, Beaumount, Cork   
Scoil Barra Naofa Girls National School, Beaumount, Cork   
St Joseph’s Boys National School, Mardyke, Cork   
Scoil Aiseiri Chriost Girls National School, Faranree, Cork   
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Mhuire ar Chnoc hAoine Mixed National School, Knocknaheeney, Cork 
Maria Assumpta Girls National School, Ballyphehane, Co. Cork   
Scoil Mhuire Gan Smal Girls National School, Glasheen Road, Glasheen, Cork  
Scoil Mhuire Gan Smal Boys National School, Glasheen Road, Glasheen, Cork  
Scoil Naoimh Eoin Easpal, Mayfield, Cork   
Naoimh Antaine Boys National School, Ballinlough Cork   
Cloghroe Mixed National School, Blarney, Co. Cork  
Scoil Barra, Innishmore, Ballincollig, Co. Cork  
Scoil Naoimh Eoin Boys National School Ballincollig, Co. Cork   
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